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FSP Section 20,000
Checklists and Illustrative Financial 
Statements for Life Insurance Companies
.01 The checklists and illustrative financial statements in this section have been developed by the staff 
of the Accounting and Auditing Publications Team of the AICPA as nonauthoritative technical practice aids. 
Readers should be aware of the following:
• The checklists and illustrative financial statements do not include all disclosures and presentation 
items promulgated; as a result, pronouncements deemed unlikely to be encountered in financial 
statements of life insurance companies are not included.
• The checklists and illustrative financial statements are "tools" and in no way represent official 
positions or pronouncements of the AICPA.
• The checklists and illustrative financial statements have been updated to include relevant accounting 
pronouncements through AICPA Statement on Auditing Standards No. 85, FASB Statement of Financial 
Accounting Standards (SFAS) No. 131, FASB Interpretation No. 42, FASB Technical Bulletin No. 94-1, 
AICPA Statement of Position 96-1, the AICPA Industry Audit Guide Audits of Stock Life Insurance 
Companies, AICPA Practice Bulletin No. 14, and EITF consensuses adopted up to and including the 
September 1997 Emerging Issues Task Force meeting. In addition, a supplemental checklist outlines 
disclosure requirements for life insurance companies that are SEC registrants. The checklists and 
illustrative financial statements should be modified, as appropriate, for subsequent pronouncements. In 
determining the applicability of a pronouncement, its effective date should also be considered.
• A description of the insurance industry and a description of common accounting and reporting 
features of stock life insurance companies are presented in the AICPA Industry Audit Guide Audits 
of Stock Life Insurance Companies.
• The checklists and illustrative financial statements should be used by, or under the supervision of, 
persons having adequate technical training and proficiency in the application of generally accepted 
accounting principles, generally accepted auditing standards, and statements on standards for 
accounting and review services.
.02 Users of the checklists and illustrative financial statements are urged to refer directly to applicable 
authoritative pronouncements when appropriate. If you have further questions, call the AICPA Technical 
Hotline at (800) 862-4272.
Note: This publication was extracted from sections 20,000 through 20,600 of the AICPA Financial Statement 
Preparation Manual (FSP).
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FSP Section 20,100
Introduction
.01 Life insurance companies provide for the pooling of risks among many persons who are exposed to 
similar risks. The provisions of the AICPA Industry Audit Guide Audits of Stock Life Insurance Companies, 
apply to stock life insurance companies. For mutual insurance companies, financial statements prepared on 
a statutory basis are considered, in practice, to be prepared in accordance with generally accepted accounting 
principles ("GAAP").1 AICPA Professional Standards, AU section 623.09, Special Reports, states that "when 
reporting on financial statements prepared on a comprehensive basis of accounting other than GAAP, the auditor 
should consider whether the financial statements (including accompanying notes) include all informative 
disclosures that are appropriate for the basis of accounting used." AU section 623.10 states that when "the 
financial statements (prepared on another comprehensive basis of accounting) contain items that are the same 
as, or similar to, those in financial statements prepared in conformity with GAAP, similar disclosures are 
appropriate." Therefore, the checklists and illustrative financial statements contained herein may apply to 
mutual life insurance companies as well as to statutory financial statements. The auditor should refer to AU 
section 623, Special Reports, Auditing Interpretation 9623, Evaluation of the Appropriateness of Informative 
Disclosures in Insurance Enterprises' Financial Statements Prepared on a Statutory Basis, and the National Associa­
tion of Insurance Commissioners' ("NAIC") Annual Statement instruction, Annual Audited Financial Reports.
1 The AICPA has a project underway to prepare an Audit and Accounting Guide, Life and Health Insurance Entities, which covers 
audits of mutual life insurance companies as well as stock life insurance companies. The new Audit and Accounting Guide would 
replace the Industry Audit Guide Audits of Stock Life Insurance Companies.
Significant Changes
.02 Presented below is a list of significant changes to the current edition of the Stock Life Insurance 
checklist. Changes normally result from new authoritative pronouncements issued since the last edition of 
the checklist. Changes may also represent improvements in the manner in which the checklist is presented.
• SFAS No. 128, Earnings per Share—This Statement specifies the computation, presentation, and 
disclosure requirements for earnings per share for publicly held common stock or potential common 
stock. The disclosure and presentation requirements of this Statement have been added into the 
checklist.
• SFAS No. 129, Disclosure of Information about Capital Structure—This Statement establishes standards 
for disclosing information about an entity's capital structure and has been incorporated into the 
checklist.
• SFAS No. 130, Reporting Comprehensive Income—This Statement establishes standards for reporting 
and display of comprehensive income and its components. The requirements of this Statement have 
been reflected in the checklist.
• SFAS No. 131, Disclosures about Segments of an Enterprise and Related Information—This Statement estab­
lishes standards for the way that public business enterprises report information about operating segments 
in annual financial statements. The requirements of this Statement have been reflected in the checklist.
3

FSP Section 20,200
Checklists—General
.01 AICPA disclosure checklists have been designed as practice aids to assist accountants in the 
preparation of financial statements and to assist auditors in their evaluation of the adequacy of disclosures 
in the financial statements they audit. Authoritative literature does not require the use of checklists, nor does 
it prescribe their format or content.
.02 This checklist consists of a number of questions or statements that are accompanied by references to 
the established sources of GAAP in which the disclosure requirements are found. These sources include 
Statements of Financial Accounting Standards, FASB Interpretations, Accounting Principles Board Opinions, 
Accounting Research Bulletins, AICPA Audit and Accounting Guides, AICPA Statements of Position, and 
EITF consensuses. Checklists are designed to serve as convenient memory aids but should not be used as a 
substitute for direct reference to authoritative literature.
.03 To use this checklist, simply check "yes," "no," or "not applicable" for each question. If additional 
information needs to be documented, include separate cross-referenced memoranda.
.04 At the beginning of certain sections a □ appears in the "N/A" column. If the entire section is deemed 
to be non-applicable, place a check mark in the □ and proceed to the next section.
Practice Tip
A "no" answer to a question indicates a potential GAAP departure. If a "no" answer is checked, the auditor 
or accountant should investigate the reasons for the noncompliance and should determine the effects of the 
GAAP departure on the overall financial statements. All work and conclusions related to a "no" answer 
should be documented in the workpapers.
.05 As you use this checklist, please remember that:
• The exercise of sound professional judgment is of paramount importance in applying the checklist 
provisions.
• The checklist may require modification based on the engagement circumstances.
• The checklist may not be all-inclusive.
• Users need to modify the checklist for any pronouncements issued subsequent to those mentioned 
in the checklist.
5

FSP Section 20,300
Financial Statements and Notes Checklist
.01 This checklist has been developed by the Accounting and Auditing Publications Team of the AICPA 
as a nonauthoritative practice aid for use by accountants in preparing financial statements and by auditors 
in auditing them.
This checklist includes disclosures commonly encountered in the financial statements of stock life insurance 
companies and reporting issues likely to be encountered by accountants who audit, compile, and review 
those types of financial statements. They do not include all disclosures required by GAAP or address all 
reporting situations that may arise in performing engagements in accordance with GAAS and SSARS.
.02 Explanation of References:
SFAS = FASB Statement of Financial Accounting Standards
FASBI = FASB Financial Accounting Standards Board Interpretation
AC = Reference to section number in FASB Accounting Standards—Current Text
APB = AICPA Accounting Principles Board Opinion
ARB = AICPA Accounting Research Bulletin
FTB = Technical Bulletin issued by the staff of the FASB
AAG = Industry Audit Guide Audits of Stock Life Insurance Companies
SOP = AICPA Statement of Position
EITF = Emerging Issues Task Force Consensus
PB = AICPA Practice Bulletin
SAS = AICPA Statement on Auditing Standards
AU = Reference to section number in AICPA Professional Standards (vol. 1)
NAIC = NAIC Accounting Practices and Procedures Manual for Life, Accident, and 
Health Insurance Companies
App. K =
App. N =
Appendix K of AAG containing SOP 92-3, Accounting for Foreclosed Assets
Appendix N of AAG containing SOP 94-5, Disclosures of Certain Matters in the 
Financial Statements of Insurance Enterprises
.03 Checklist Questionnaire:
This checklist is organized into the sections listed below. Carefully review the topics listed and consider 
whether they represent potential disclosure items for the life insurance company. Place a check mark by the 
topics or sections considered not applicable; these sections need not be completed.
Place   by 
Sections Not Applicable
• Balance Sheet
A. General _________
B. Cash _________
C. Investment Securities _________
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Place   by
Sections Not Applicable
D. Investments Accounted for by the Equity Method
E. Impairment of a Loan
F. Accounts and Notes Receivable and Agents' Balances
G. Reinsurance Receivables
H. Lease Finance Receivables
I. Deferred Acquisition Costs
J. Property and Equipment
K. Lessee Leases
L. Other Assets
M. Separate Account Assets
N. Policy Liabilities
O. Income Taxes
P. Current Liabilities, Notes Payable, and Long-Term Debt
Q. Other Liabilities
R. Shareholders' Equity
• Income Statement
A. Premium Revenue
B. Investment Income
C. Other Income
D. Benefits and Expenses
E. Income Taxes
F. Discontinued Operations
G. Extraordinary Items
H. Earnings Per Share
I. Comprehensive Income
J. Other
• Statement of Changes in Shareholders' Equity
• Statement of Cash Flows
• General
A. Titles and References
B. Disclosure of Accounting Policies
C. Comparative Financial Statements
D. Accounting Changes
E. Risks and Uncertainties
F. Contingencies and Commitments
G. Environmental Remediation Liabilities
H. Related-Party Transactions and Economic Dependency
I. Pension and Employee Stock Ownership Plans
J. Postretirement Health Care and Life Insurance Benefits
K. Consolidations
L. Financial Instruments
M. Foreign Currency
N. Futures Contracts
O. Derivatives
P. Transfers and Servicing of Financial Assets
Q. Nonmonetary Transactions
R. Subsequent Events
S. Costs to Exit an Activity
8
Place  by
Sections Not Applicable
T. Business Combinations
U. Segment Information
V. Stock Compensation Plans
• Auditors' Reports Checklist
• Supplemental Checklist for Life Insurance Companies That Are 
SEC Registrants
General
Balance Sheet
A. General
B. Investments—Other Than Investments in Related Parties
C. Cash
D. Securities and Indebtedness of Related Parties
E. Accrued Investment Income
F. Accounts and Notes Receivable
G. Reinsurance Recoverable on Paid Losses
H. Deferred Policy Acquisition Costs
I. Property and Equipment
J. Title Plant
K. Other Assets
L. Assets Held in Separate Accounts
M. Total Assets
N. Policy Liabilities and Accruals
O. Other Policyholders' Funds
P. Other Liabilities
Q. Notes Payable, Bonds, Mortgages, and Similar Obligations 
(Including Capitalized Leases)
R. Indebtedness to Related Parties
S. Liabilities Related to Separate Accounts
T. Commitments and Contingent Liabilities
U. Minority Interest in Consolidated Subsidiaries
V. Preferred Stock Subject to Mandatory Redemption
W. Nonredeemable Preferred Stock
X. Common Stock
Y. Other Stockholders' Equity
Z. Total Liabilities and Stockholders' Equity
AA. Dividend Payment Restrictions
BB. Warrants or Rights Outstanding
Income Statement
A. General
B. Premiums
C. Net Investment Income
D. Realized Investment Gains and Losses
E. Other Income
F. Benefits, Claims, Losses, and Settlement Expenses
G. Policyholders' Share of Earnings on Participating Policies, 
Dividends, and Similar Items
H. Underwriting, Acquisition, and Insurance Expenses
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Place   by
Sections Not Applicable
I. Income or Loss Before Income Tax Expense and Other 
Appropriate Items
J. Income Tax Expense
K. Minority Interest in Income of Consolidated Subsidiaries
L. Equity in Earnings of Unconsolidated Subsidiaries and 50% 
or Less Owned Persons
M. Income or Loss From Continuing Operations
N. Discontinued Operations
O. Income or Loss Before Extraordinary Items and Cumulative 
Effects of Changes in Accounting Principles
P. Extraordinary Items, Less Applicable Tax
Q. Cumulative Effect of Changes in Accounting Principles
R. Net Income or Loss
S. Earnings-Per-Share Data
T. Cash Flows
U. Changes in Other Stockholders' Equity
V. Schedules
W. Other SEC-Related Disclosures
Practice Tip
Reminder. A "no" answer is indicative of a potential GAAP departure. The reason for the "no" answer and 
the resolution of the matter should be documented in the workpapers.
Yes No NLA
Balance Sheet
A. General
1. For classified balance sheets, are assets and liabilities segregated into
current and noncurrent classifications, with totals presented for cur­
rent assets and current liabilities? ____ ____ ____
[ARB 43, Ch. 3A, par. 3; SFAS 78, pars. 5 and 13 (AC B05.102-.109B);
SFAS 6, par. 15 (AC B05.118); FASBI 8, par. 3 (AC B05.117); TB 79-3, 
par. 2 (AC B05.501-.503)]
2. Are assets not expected to be realized during the current operating
cycle classified as noncurrent? ____ ____ ____
[ARB 43, Ch. 3A, pars. 5 and 6 (AC B05.106 and .107)]
3. Are valuation allowances for assets shown as deductions from their
related assets with appropriate disclosure? ____ ____  ____
[APB 12, par. 3 (AC V18.102)]
B. Cash
1. Is restricted cash appropriately segregated from cash available for
current operations? ____ ____ ____
[ARB 43, Ch. 3A, par. 6 (AC B05.107)]
2. Are restrictions on cash appropriately disclosed? ____ ____ ____
[SFAS 5, pars. 18 and 19 (AC C59.120)]
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Yes No N/A
3. Is the policy for determining cash equivalents disclosed? ____ ____ ____
[SFAS 95, par. 10 (AC C25.108)]
4. If the company has material bank overdrafts or material balance of 
undelivered checks as of the balance-sheet date, are:
a. Bank overdrafts presented as a separate caption within current
liabilities? ____ ____ ____
b. Undelivered checks classified as accounts payable? ____ ____ ____
[Generally accepted]
5. If a concentration of credit risk arises from deposits in excess of
federally insured limits, is it disclosed? ____ ____ ____
[SFAS 105, par. 20 (AC F25.115)]
Practice Tip
Be sure that the amount of cash and cash equivalents displayed on the balance sheet equals the amount of 
cash and cash equivalents displayed on the statement of cash flows.
C. Investment Securities
1. Are there separate captions for each of the following investment 
categories:
a. Fixed-maturity securities?
b. Mortgage loans on real estate?
c. Investment real estate?
d. Policy loans?
e. Other long-term investments? 
[AAG, App. A]
2. Are debt and equity securities classified as (a) held-to-maturity, (b) 
available-for-sale, or (c) trading?
[SFAS 115, par. 6 (AC I80.103)]
3. If the reporting institution presents a classified balance sheet, are all 
trading securities reported as current assets?
[SFAS 115, par. 17 (AC I80.116)]
4. Are held-to-maturity securities and available-for-sale securities re­
ported separately and, if a classified balance sheet is presented, clas­
sified as current or noncurrent assets as appropriate?
[SFAS 115, par. 17 (AC I80.116)]
Practice Tip
Presentation of individual amounts for trading securities, held-to-maturity securities, and available-for-sale 
securities on the face of the balance sheet is not required as long as the information is provided in the notes 
to the financial statements.
5. For investments in debt and marketable equity securities classified as 
available-for-sale or held-to-maturity, are the following disclosures 
made by major-security type, for each balance sheet presented:
a. Aggregate fair value?
b. Gross unrealized holding gains or losses?
11
Yes No N/A
c. Amortized cost basis?
[SFAS 115, par. 19 (AC I80.118)]
d. Disclosure of major-security types including:
(1) Equity securities?
(2) Debt securities issued by the U.S. Treasury and other U.S. 
government corporations and agencies?
(3) Debt securities issued by states of the United States and 
political subdivisions of the states?
(4) Debt securities issued by foreign governments?
(5) Corporate debt securities?
(6) Mortgage-backed securities?
(7) Other debt securities?
6. For investments in debt securities classified as available-for-sale and 
separately for securities classified as held-to-maturity:
a. Is disclosure made about their contractual maturities as of the date 
of the latest balance sheet presented (maturity information may be 
combined in appropriate groupings)?
b. Is disclosure made of the fair value and the amortized cost of debt 
securities in at least four maturity groupings:
(1) Within one year?
(2) After one year through 5 years?
(3) After five years through 10 years?
(4) After 10 years?
c. Securities not due at a single maturity date, such as mortgage- 
backed securities, may be disclosed separately rather than allo­
cated over several maturity groupings; if allocated, is the basis for 
allocation disclosed?
[SFAS 115, par. 20 (AC I80.119)]
7. For each period for which an income statement is presented, are the 
following disclosed:
a. The proceeds from sales of available-for-sale securities and gross 
realized gains and losses from those sales?
b. The basis on which cost was determined in computing realized 
gain or loss (i.e., specific identification, average cost, or other 
method used)?
c. The gross gains and losses included in earnings from transfers of 
securities from the available-for-sale category to the trading cate­
gory?
d. The change in net unrealized holding gain or loss on available-for- 
sale securities that has been included in the separate component 
of shareholders' equity?
e. The change in net unrealized holding gain or loss on trading 
securities that has been included in earnings?
[SFAS 115, par. 21 (AC I80.120)]
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Yes No N/A
8. For any sales of, or transfers from, securities classified as held-to-ma­
turity, are the following disclosed for each period for which an earn­
ings statement is presented:
a. Amortized cost amount of the sold or transferred security?
b. Related realized or unrealized gain or loss?
c. The circumstances leading to the decision to sell or transfer the 
security?
[SFAS 115, par. 22 (AC I80.121)]
9. Are significant concentrations of credit risk arising from concentra­
tions of securities of a particular issuer disclosed?
[SFAS 105, par. 20 (AC F25.115); AAG-BNS, par. 5.96]
10. Are mortgage loans that are purchased at a discount or premium 
reported at amortized cost with an allowance for uncollectible 
amounts, if any?
[SFAS 60, par. 47 (AC In6.153)]
11. Are changes in the allowance for uncollectible amounts relating to 
mortgage loans reported in income as prescribed in SFAS 114, Ac­
counting by Creditors for Impairment of a Loan?
[SFAS 60, par. 47, as amended by SFAS 114, par. 23 (AC In6.153)]
12. Are real estate investments reported at cost less accumulated depre­
ciation?
[SFAS 60, par. 48, as amended by SFAS 121, par. 28(a) (AC In6.154)]
13. Are reductions in the carrying amounts of real estate investments 
resulting from the application of SFAS 121, Accounting for the Impair­
ment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of 
included in realized gains and losses?
[SFAS 60, par. 48, as amended by SFAS 121, par. 28(b) (AC In6.154)]
14. If investments in high-risk CMOs are significant, are the following 
disclosures made in the financial statements:1
1 These disclosure requirements do not apply to instruments subject to SFAS 125, paragraph 14.
a. The effective yield calculated as of the reporting date, either for 
each CMO or for the CMO portfolio (this yield will be used to 
accrue income in the following period)?
b. The carrying amount and fair value of investments in high-risk 
CMOs?
(1) If market quotations are not available, are estimates made? 
[EITF 89-4; SFAS 125, par. 14 (AC F38.107)]
15. For those entities that enter into options with no intrinsic value at 
acquisition in order to purchase securities accounted for under SFAS 
115, is disclosure made of the accounting policy for the premium paid 
(time value) to acquire the option that is classified as held-to-maturity 
or available-for-sale disclosed?
[EITF 96-11]
16. Are mortgage loans that are acquired at par value reported at out­
standing principal balances?
[SFAS 60, par. 47 (AC In6.153)]
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Yes No N/A
D. Investments Accounted for by the Equity Method
1. Are investments in common stock shown in the balance sheet of the
investor as a single amount, and is the investor's share of earnings or 
losses of the investee shown in the income statement as a single 
amount (except for extraordinary items or prior period adjustments)? ____
[APB 18, par. 19 (AC I82.109c)]
2. Are the following disclosures made for investments in common stock 
accounted for by the equity method:
a. The name of each investee and their percentage of ownership of
common stock? ____
b. The accounting policies of the investor with respect to investments
in common stock? ____
c. The difference between the amount at which an investment is
carried and the amount of underlying equity in net assets? ____
d. The accounting treatment of the difference described in c.? ____
e. For investments in common stock for which a quoted market price
is available, the aggregate value of each identified investment 
based on the quoted market price? ____
(This is not required for investments in common stock of subsidi­
aries.)
f. For investments in common stock, corporate joint ventures, or
other investments which are in the aggregate material in relation 
to the financial position or results of operations of an investor, 
summarized information as to assets, liabilities, and results of 
operation of the investees as appropriate? ____
g. Material effects of conversions of outstanding convertible securi­
ties, exercises, or contingent issuances? ____
[APB 18, par. 20 (AC I82.110)]
3. If the reporting entity holds 20 percent or more of the voting stock of 
a significant investee corporation but does not account for the invest­
ment using the equity method, are the following disclosed:
a. The name of such investee? ____
b. The reasons why the equity method is not considered appropriate? ____
[APB 18, par. 20, fn. 13 (AC I82.110, fn. 14)]
4. If the reporting entity holds less than 20 percent of the voting stock of 
a significant investee corporation and accounts for the investment 
using the equity method, are the following disclosed:
a. The name of such investee? ____
b. The reasons why the equity method is considered appropriate? ____
[APB 18, par. 20, fn. 13 (AC I82.110, fn. 14)]
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Practice Tip
The significance of an investment to the investor's financial position and results of operations should be 
considered in evaluating the extent of disclosures relating to the financial position and results of operations 
of an investee.
Yes No N/A
E. Impairment of a Loan
1. Is the allowance deducted from the related assets? 
[APB 12, par. 3 (AC V18.102)]
2. Is the following information disclosed, either in the body of the 
financial statements or in the accompanying notes for impaired 
loans:2
2 In certain circumstances, information about an impaired loan that has been restructured in a troubled debt restructuring involving 
a modification of terms need not be included in the disclosures in Steps 2.a. and 2.b. (l)-(3).
a. As of the date of each balance sheet presented:
(1) Total recorded investment in the impaired loans at the end of 
each period and the amount of the recorded investment for 
which there is a related allowance for loan losses?
(2) The amount of the allowance?
(3) The amount of the recorded investment for which no allow­
ance for loan losses was recorded?
(4) The company's policy for recognizing interest on impaired 
loans, including how cash receipts are recorded?
b. For each period for which a statement of income is presented:
(1) Average recorded investments?
(2) Related amount of interest income recognized using the cash 
basis method of accounting during the time within the period 
the loans were impaired?
(3) If practicable, the amount of interest income recognized using 
cash basis method of accounting during the time within the 
period the loans were impaired?
(4) The activity in the allowance for loan losses related to im­
paired loans including the following:
(i) Opening balance?
(ii) Additions charged to operations?
(iii) Direct write-down charged against the allowance?
(iv) Recovery of amounts previously charged off?
(v) Ending balance?
[SFAS 114, par. 20, as amended by SFAS 118, par. 6 (AC 
108.118 and 118A)]
3. When a loan is restructured in a troubled debt restructuring (as 
defined in SFAS 15) into two (or more) loan agreements, are the 
restructured loans considered separately when assessing the applica­
bility of the disclosures described in Step 2 above?
[EITF 96-22]
F. Accounts and Notes Receivable and Agents' Balances
1. Are uncollected life insurance premiums and deferred premiums 
included in assets?
[AAG, pars. 5.02 and 5.03]
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Yes No N/A
2. Are accident and health uncollected premiums due within three 
months of the reporting date included in assets?
[AAG, par. 5.05]
3. Are amounts due from reinsurers on paid losses on life and accident 
and health insurance included as assets?
[AAG, par. 5.06]
4. Are hypothecation or other pledging of receivables disclosed? 
[SFAS 5, pars. 18 and 19 (AC C59.120)]
5. Are accounts and notes receivable from officers, employees, and 
affiliated entities shown separately with appropriate disclosures? 
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]
6. If a note is noninterest bearing or has an inappropriate stated interest 
rate:
a. Is the discount or premium presented as a deduction from or 
addition to the face amount of the note?
b. Does the disclosure include the effective interest rate and face 
amount of the note?
c. Is amortization of discount or premium reported as interest in the 
income statement?
[APB 21, par. 16 (AC I69.109)]
7. Is the unamortized balance of loan origination, commitment, and 
other fees and costs and purchase premiums and discounts that is 
being recognized as an adjustment of yield reported as part of the loan 
balance to which it relates?
[SFAS 91, par. 21 (AC I20.120)]
G. Reinsurance Receivables
1. Are fronting arrangements treated as reinsurance arrangements for 
purposes of disclosures required by SFAS 60 and SFAS 113?
[SFAS 113, par. 6 (AC In6.169)]
2. Are the following disclosed in relation to ceded insurance transac­
tions:
a. Nature of the transaction(s)?
b. Purpose of the transaction(s)?
c. Effect of the transaction(s)?
d. The fact that the insurer is not relieved of its primary obligation to 
the policyholder in a reinsurance transaction?
[SFAS 113, par. 27(a) (AC In6.191)]
3. Are the following disclosed for short-duration reinsurance contracts 
on both a written and an earned basis:
a. Premiums from direct business?
b. Reinsurance assumed?
c. Reinsurance ceded?
[SFAS 113, par. 27(b) (AC In6.191)]
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4. Are the following disclosed for long-duration reinsurance contracts:
a. Premiums and amounts assessed against policyholders from di­
rect business?
b. Reinsurance assumed?
c. Reinsurance ceded?
d. Premiums and amounts earned? 
[SFAS 113, par. 27(b) (AC In6.191)]
5. Are the methods used for income recognition on reinsurance contracts 
disclosed?
[SFAS 113, par. 27(c) (AC In6.191)]
6. Are concentrations of credit risk associated with reinsurance receiv­
ables and prepaid reinsurance premiums disclosed for a ceding enter­
prise under the provisions of SFAS 105?
[SFAS 113, par. 28 (AC In6.192)]
7. Are the following items reported separately as assets for those com­
panies participating in ceding transactions:
a. Estimated reinsurance receivables arising from ceding transac­
tions?
b. Amounts paid to the reinsurer relating to the unexpired portion 
of reinsured contracts (prepaid reinsurance premiums)?
[SFAS 113, par. 14 (AC In6.178)]
8. Are amounts receivable and payable between the ceding company 
and an individual reinsurer offset only when a right of offset exists as 
defined in FASB Interpretation 39?
[SFAS 113, par. 15 (AC In6.179)]
9. Are the amounts of earned premiums ceded and recoveries recog­
nized under reinsurance contracts reported in the statements of earn­
ings as separate line items or disclosed in the notes?
[SFAS 113, par. 16 (AC In6.180)]
H. Lease Finance Receivables
1. Do disclosures include:
a. Appropriate components of the net investment in the leases as of 
the date of each balance sheet presented?
b. Future minimum lease payments to be received for each of the five 
succeeding fiscal years as of the date of the latest balance sheet 
presented?
c. Total contingent rentals included in income for each period for 
which a statement of income is presented?
[SFAS 13, par. 23a, as amended by SFAS 91, par. 25d (AC L10.119a)]
2. Are leasing arrangements described?
[SFAS 13, pars. 23 and 29 (AC L10.119 and .125); SFAS 91, par. 25 (AC 
L10.119a(l)-(3)); SFAS 98, pars. 17-19 (AC L10.130k-m)]
3. Are leveraged leases appropriately accounted for and reported? 
[SFAS 13, pars. 41-47 (AC L10.143-.149)]
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I. Deferred Acquisition Costs
1. Are unamortized acquisition costs presented in the balance sheet as a 
deferred charge?
[AAG, pars. 8.37 and 10.03]
2. Are the following disclosed relating to deferred acquisition costs:
a. The nature of costs capitalized?
b. The method of amortizing these costs?
c. The amount of these costs amortized for the period? 
[AAG, pars. 8.37 and 10.03; SFAS 60, par. 60c (AC In6.166c)]
3. Is the fact that the company considers anticipated investment income 
in determining if a premium deficiency relating to short-duration 
contracts exists disclosed?
[SFAS 60, par. 60e (AC In6.166e)]
J. Property and Equipment
1. Is the carrying basis of property and equipment disclosed? 
[AAG, App. A; APB 12, par. 5 (AC D40.105)]
2. For depreciable assets, does disclosure include:
a. Depreciation expense for each period for which an income state­
ment is presented?
b. Balances of major classes of depreciable assets, by nature or func­
tion, at the balance-sheet date?
c. Accumulated depreciation, either by major classes of depreciable 
assets or in total, at the balance-sheet date?
d. A general description of the method or methods used in comput­
ing depreciation for major classes of depreciable assets?
[APB 12, par. 5 (AC D40.105)]
3. Are pledged assets and material commitments for property expendi­
tures disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]
4. For any accounting period in which interest costs are capitalized, is 
the total amount of interest cost incurred during the period, and the 
amount thereof that is capitalized, disclosed?
[SFAS 34, par. 21b (AC I67.118)]
5. Is the amount of interest cost incurred and charged to expense during 
the period disclosed for an accounting period in which no interest cost 
is capitalized?
[SFAS 34, par. 21a (AC I67.118)]
6. For an existing property with an asbestos problem, are the costs 
incurred to treat the problem, if charged to expense, not classified as 
an extraordinary item?
[EITF 89-13]
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7. If an impairment loss is recognized for assets to be held or used, are 
the following disclosures made in financial statements that include 
the period of impairment write-down:
a. A description of the impaired assets and the facts and circum­
stances leading to the impairment? ____
b. The amount of the impairment and how fair value was deter­
mined? ____
c. The caption in the statement of income in which the impairment
loss is aggregated if that loss has not been presented as a separate 
caption or reported parenthetically on the face of the statement? ____
d. The business segment(s) affected, if applicable? ____
[SFAS 121, par. 14 (AC I08.133)]
8. If assets to be disposed of are accounted for in accordance with 
paragraphs 15-17 of SFAS 121, are the following disclosed in financial 
statements that include a period in which those assets are held:
a. A description of assets to be disposed of, the facts and circum­
stances leading to the expected disposal, the expected disposal
date, and the carrying amount of those assets? ____
b. The business segment(s) in which assets to be disposed of are held,
if applicable? ____
c. The loss, if any, resulting from the application of paragraph 15 of
SFAS 121? ____
d. The gain or loss, if any, resulting from changes in the carrying
amounts of assets to be disposed of that arises from application of 
paragraph 17 of SFAS 121? ____
e. The caption in the statement of income in which the gains or losses
in c. and d. are aggregated if those gains have not been presented 
as a separate caption or reported parenthetically on the face of the 
statement? ____
f. The results of operations for assets to be disposed of to the extent 
that those results are included in the company's statement of
income for the period and can be identified? ____
[SFAS 121, par. 19 (AC I08.138)]
9. If an impairment loss is recognized, is it reported as a component of
income from continuing operations? ____
[SFAS 121, pars. 13 and 18 (AC I08.137)]
K. Lessee Leases
1. Is the following information disclosed with respect to capital leases:
a. The gross amount of assets recorded under capital leases as of the
date of each balance sheet presented by major classes according to 
nature or function (this information may be combined with the 
comparable information for owned assets)? ____
b. Future minimum lease payments as of the date of the latest 
balance sheet presented, in the aggregate and for each of the 
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next five fiscal years, with separate deductions from the total for 
executory costs, including any profit thereon that is included in 
the minimum lease payments and for the amount of the imputed 
interest necessary to reduce the net minimum lease payments to 
present value?
c. The total of minimum sublease rentals to be received in the future 
under noncancelable subleases as of the date of the latest balance 
sheet presented?
d. Total contingent rentals actually incurred for each period for 
which an income statement is presented?
[SFAS 13, par. 16 (AC L10.112)]
e. Separate identification of:
(1) Assets recorded under capital leases?
(2) Accumulated amortization of capital leases?
(3) Obligations under capital leases?
(4) Amount of amortization of capital lease assets or the fact that 
the amortization of capital lease assets is included in depre­
ciation expense?
[SFAS 13, par. 13 (AC L10.112)]
2. Are the following disclosed for operating leases that have initial or 
remaining noncancelable lease terms in excess of one year:
a. Future minimum rental payments required, as of the date of the 
latest balance sheet presented, in the aggregate, and for each of the 
five succeeding fiscal years?
b. The total of minimum rentals to be received in the future under 
noncancelable subleases as of the date of the latest balance sheet 
presented?
[SFAS 13, par. 16 (AC L10.112)]
3. For all operating leases, do disclosures include rental expense for each 
period for which an income statement is presented, with separate 
amounts for minimum rentals, contingent rentals, and sublease rent­
als (rental payments under leases with terms of a month or less that 
are not renewed need not be included)?
4. Do disclosures include a general description of the lessee's leasing 
arrangements including, but not limited to, the following:
a. The basis on which contingent rental payments are deter­
mined?
b. The existence and terms of renewal or purchase options and 
escalation clauses?
c. Restrictions imposed by lease agreements, such as those concern­
ing dividends, additional debt, and further leasing?
[SFAS 13, par. 16 (AC L10.112)]
5. Is the nature and extent of leasing transactions with related parties 
disclosed?
[SFAS 13, par. 29 (AC L10.125)]
6. If material, is the accounting policy used in recognizing amounts 
related to a modification of an operating lease (that does not change 
the lease classification) disclosed?
[EITF 95-17]
20
Yes No N/A
7. If the conditions of EITF 90-15 are met, does the lessee consolidate 
special-purpose entities established for both the construction and 
subsequent lease of an asset and does consolidation occur at the 
inception of the lease rather than at the beginning of the lease 
term?
[EITF 90-15]
L. Other Assets
1. Do disclosures include the method and period of amortization of 
intangible assets?
[APB 22, par. 13 (AC A10.106)]
2. For an unidentified intangible asset arising as a result of the fair value 
of liabilities assumed in a purchase method business combination 
exceeding fair value of tangible and identified intangible assets ac­
quired in a combination initiated after September 30, 1982, is the 
method and period of amortization disclosed?
[APB 17, par. 30 (AC I60.111)]
M. Separate Account Assets
1. Are separate account assets reported as summary totals in the finan­
cial statements?
[SFAS 60, par. 54 (AC In6.160)]
N. Policy Liabilities
1. Is the aggregate reserve for life policies presented net of reserves 
ceded under reinsurance arrangements?
[AAG, par. 6.06]
2. Is the liability for supplementary contracts without life contingencies 
and dividend accumulations reflected separately in the annual state­
ment?
[AAG, par. 6.07]
3. Is the basis for estimating the liabilities for impaid claims and claim 
adjustment expenses disclosed?
[SFAS 60, par. 60a (AC In6.166a)]
4. Are the methods and assumptions used in estimating the liability for 
future policy benefits and the average rate of assumed investment 
yields in effect for the current year disclosed?
[SFAS 60, par. 60b (AC In6.166b)]
5. Is the carrying amount of liabilities for impaid claims and claim 
adjustment expenses relating to short-duration contracts that are 
presented at present value in the financial statements and the range 
of interest rates used to discount those liabilities disclosed?
[SFAS 60, par. 60d (AC In6.166d)]
6. For each fiscal year for which an income statement is presented is the 
following information about the liability for unpaid claims and claim 
adjustment expenses disclosed:
a. The balance in the liability for unpaid claims and claim adjustment 
expenses at the beginning and end of each fiscal year presented, 
and the related amount of reinsurance recoverable?
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b. Incurred claims and claim adjustment expenses with separate 
disclosure of the provision of insured events of the current fiscal 
year and of increases or decreases in the provision for insured 
events of prior fiscal years?
c. Payments of claims and claim adjustment expenses with separate 
disclosure of payments of claims and claim adjustment expenses 
attributable to insured events of the current fiscal year and to 
insured events of prior fiscal years?
[SOP 94-5, par. 10]
7. If changes in the provision for incurred claims and claim adjustment 
expenses are attributable to insured events of prior fiscal years are the 
following disclosed in the financial statements:
a. The reasons for the change?
b. Whether additional premiums or return premiums have been 
accrued as a result of the prior-year effects?
[SOP 94-5, par. 10]
8. Is the fact that the company considers anticipated investment income 
in determining if a premium deficiency relating to short-duration 
contracts exists disclosed?
[SFAS 60, par. 60e (AC In6.166e)]
9. For participating insurance, does disclosure include:
a. The relative percentage?
b. The method of accounting for policyholders' dividends?
c. The amount of dividends?
d. The amount of any additional income allocated to participating 
policyholders?
[SFAS 60, par. 60g (AC In6.166g); AAG, pars. 10.07 and 10.08]
10. Are the methods employed and the assumptions used in calculating 
policy reserves disclosed in the financial statements, and is similar 
information disclosed for annuities, accident and health insurance, 
and other material lines of business?
[AAG, pars. 10.05 and 10.06]
Note: SOP 95-1, Accounting for Certain Insurance Activities of Mutual Life 
Insurance Enterprises applies to life insurance contracts that have both of 
the following characteristics:3
3 SFAS 120, Accounting and Reporting by Mutual Life Insurance Enterprises and by Insurance Enterprises for Certain Long-Duration 
Participating Contracts, permits stock life insurance enterprises with participating life insurance contracts that meet the conditions listed 
above to account for those contracts in accordance with SOP 95-1.
[SFAS 120, par. 6]
• They are long-duration participating contracts that are expected to 
pay dividends to policyholders based on actual experience of the insur­
ance enterprise.
• Annual policyholder dividends are paid in a manner that identifies 
divisible surplus and distributes that surplus in approximately the 
same proportion as the contracts are considered to have contributed 
to divisible surplus (commonly referred to in actuarial literature as 
the contribution principle).
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11. Are premiums from participating insurance contracts reported as 
revenue in the statement of income when due from policy holders? 
[SOP 95-1, par. 12]
12. Are death and surrender benefits incurred reported as expense in the 
statement of income?
[SOP 95-1, par. 13]
13. Are annual policyholder dividends:
a. Reported separately as an expense in the statement of income?
b. Based on estimates of amounts incurred for policies in effect 
during the period?
[SOP 95-1, par. 14]
14. Does the liability for future policy benefits relating to participating 
life insurance contracts include:
a. The net level premium reserve for death and endowment policy 
benefits?
b. The liability for terminal dividends?
c. Any probable loss (premium deficiency) as described in para­
graphs 35 to 37 of SFAS 60, Accounting and Reporting by Insurance 
Enterprises?
[SOP 95-1, par. 15]
15. Are the following disclosed in the financial statements with respect to 
participating contracts:
a. The methods and assumptions used in estimating the liability for 
future policy benefits?
b. The average rate of assumed investment yields used in estimating 
expected gross margins?
c. The nature of acquisition costs capitalized, the method of amortiz­
ing those costs, and the amount of those costs amortized for the 
period?
[SOP 95-1, par. 24]
O. Income Taxes
1. Are deferred tax assets and liabilities determined for each tax-paying 
component (an individual company or group of companies that is 
consolidated for tax purposes) in each tax jurisdiction presented 
separately?
[SFAS 109, par. 17 (AC I27.116)]
2. Are the components of the net deferred tax liability or asset recog­
nized in the balance sheet disclosed as follows:
a. The total of all deferred tax liabilities?
b. The total of all deferred tax assets?
c. The total valuation allowance for deferred tax assets?
[SFAS 109, par. 43 (AC I27.142)]
3. Is the net change during the year in the total valuation allowance 
disclosed?
[SFAS 109, par. 43 (AC I27.142)]
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4. Is the following information disclosed whenever a deferred tax liabil­
ity is not recognized because of the exceptions to comprehensive 
recognition of deferred taxes for any of the the areas addressed by 
APB 23, Accounting for Income Taxes—Special Areas (as amended by 
SFAS 109, Accounting for Income Taxes):
a. A description of the types of temporary differences for which a 
deferred tax liability is not recognized and the types of events that 
would cause those temporary differences to become taxable?
b. The cumulative amount of each type of temporary differences?
c. The amount of the unrecognized deferred tax liability for tempo­
rary differences related to investments in foreign subsidiaries and 
foreign corporate joint ventures that are essentially permanent in 
duration if determination of that liability is practicable, or a state­
ment that determination is not practicable?
d. The amount of the deferred tax liability for temporary differences 
other than those in c. above (i.e., undistributed domestic earnings, 
the bad debt reserve for tax purposes of a U.S. savings and loan 
association or other qualified thrift lender, the policyholders' sur­
plus of a life insurance enterprise, and the statutory reserve funds 
of a U.S. steamship enterprise) that is not recognized in accordance 
with the provisions of paragraphs 31 and 32 of SFAS 109 (AC 
I27.130 and .131)?
[SFAS 109, par. 44 (AC I27.143)]
5. In a classified balance sheet:
a. Are deferred tax assets and deferred tax liabilities classified as 
current or noncurrent based on the classification of the related 
asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
b. Are deferred tax assets or liabilities not related to an asset or 
liability for financial reporting (including those related to carry­
forwards) classified according to the expected reversal date of the 
temporary difference?
[SFAS 109, pars. 41 and .288p (AC I27.140)]
c. Is the valuation allowance for a particular tax jurisdiction allocated 
between current and noncurrent deferred tax assets for that tax 
jurisdiction on a pro rata basis?
[SFAS 109, par. 41 (AC I27.140)]
d. Are the following items offset and presented as a single amount 
for a particular taxpaying component and within a particular 
taxpaying jurisdiction:
(1) All current deferred tax liabilities and assets?
(2) All noncurrent deferred tax liabilities and assets? 
[SFAS 109, par. 42 (AC I27.141)]
6. Do the financial statements include disclosure of the following:
a. Disclosures relating to "Policyholders' Surplus" as defined in the 
Internal Revenue Code and as prescribed by APB 23?
b. The portion of retained earnings in excess of statutory unassigned 
surplus for which neither current nor deferred federal income tax 
provisions have been made and the reasons therefor?
[AAG, par. 10.17]
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P. Current Liabilities, Notes Payable, and Long-Term Debt
1. For classified balance sheets, do current liabilities include:
a. Obligations for items that entered the operating cycle? ____
b. Collections received in advance of the performance of services? ____
c. Debts that arise from operations directly related to the operating
cycle? ____
d. Other liabilities whose regular and ordinary liquidation is likely
to occur within a relatively short time period? ____
e. Obligations that, by their terms, are due on demand or will be due 
within one year (or operating cycle, if longer) from the balance- 
sheet date, even though liquidation may not be expected within
that period? ____
[ARB 43, Ch. 3A, pars. 7 and 8 (AC B05.108 and .109); SFAS 78, par.
5 (AC B05.109A)]
2. Do current liabilities exclude short-term obligations that the provider
intends to refinance on a long-term basis, provided the provider has 
demonstrated the ability to consummate the long-term financing? ____
[SFAS 6, pars. 8-14 (AC B05.113-.116); FASBI 8, pars. 2-4 (AC B05.117,
.138 and .139)]
3. Is there adequate disclosure of interest rates, maturities, and other 
terms and conditions provided in loan agreements and bond inden­
tures (such as assets pledged as collateral, and covenants to reduce
debt, and maintain working capital)? ____
[FASCON 5, par. 11; SFAS 5, par. 18 (AC C59.120)]
4. Are the following disclosed for each of the five years following the
date of the latest balance sheet presented:
a. The aggregate amount of payments for unconditional purchase
obligations that meet the criteria of SFAS 47, Disclosure of Long- 
Term Obligations, and that are recognized on the purchaser's bal­
ance sheet? ____
b. The combined aggregate amount of maturities and sinking fund
requirements for all long-term borrowings? ____
c. The amount of redemption requirements for all issues of capital 
stock that are redeemable at fixed or determinable prices on fixed
or determinable dates, separately by issue or combined? ____
[SFAS 47, par. 10 (AC C32.105)]
5. Are conversion features appropriately accounted for and disclosed? ____
[APB 14, par. 12 (AC D10.103); APB 15, par. 19 (AC E09.110)]
6. If a note is noninterest bearing or has an inappropriate stated interest 
rate:
a. Is the discount or premium presented as a deduction from or
addition to the face amount of the note? ____
b. Does the disclosure include the effective interest rate and face
amount of the note? ____
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c. Is amortization of the discount or premium reported as interest 
expense?
d. Are issue costs reported in the balance sheet as deferred charges? 
[APB 21, par. 16 (AC I69.109)]
7. If a short-term obligation is to be excluded from current liabilities in 
a classified balance sheet, do disclosures include:
a. A general description of the financing agreement?
b. The terms of any new obligation incurred or expected to be in­
curred, or equity securities issued or expected to be issued as a 
result of the refinancing?
[SFAS 6, par. 15 (AC B05.118)]
8. For a troubled debt restructuring occurring during the current period, 
do disclosures include:
a. Description of the principal changes in terms, the major features 
of settlement, or both?
b. Aggregate gain on restructuring of payables and the related in­
come tax effect?
c. Aggregate net gain or loss on transfers of assets recognized during 
the period?
d. Per-share amount of the aggregate gain on restructuring of pay­
ables, net of related income tax effect?
[SFAS 15, par. 25 (AC D22.121)]
9. For periods after a troubled debt restructuring, do disclosures include:
a. Extent to which amounts contingently payable are included in the 
carrying amount of restructured payables?
b. Total amounts that are contingently payable, if applicable, and 
conditions under which those amounts would become payable or 
forgiven?
[SFAS 15, par. 26 (AC D22.122)]
10. If there is an extinguishment of debt, is the difference between reac­
quisition price and carrying amount identified as a separate or ex­
traordinary item?
[SFAS 4, par. 8, as amended by SFAS 64, par. 4 (AC D14.105)]
11. If there is an early extinguishment of debt, is the difference between 
reacquisition price and carrying amount identified as income in the 
period of extinguishment as gain or loss?
[APB 26, pars. 20 and 21 (AC D14.103 and .104)]
12. Do disclosures for extinguishments of debt classified as extraordinary 
items include:
a. Description of the extinguishment transactions, including the 
source of any funds used to extinguish debt if it is practicable to 
identify the sources?
b. Income tax effect in the period of extinguishment?
c. The per-share amount of the aggregate gain or loss net of related 
income tax effect?
[SFAS 4, par. 9 (AC D14.107)]
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13. Is the following disclosed if debt was considered to be extinguished 
by in-substance defeasance under the provisions of SFAS 76, Extin­
guishment of Debt, prior to the effective date of SFAS 125:
a. A general description of the transaction?
b. The amount of debt that is considered extinguished at the end of 
the period so long as that debt remains outstanding?
[SFAS 125, par. 17b (AC L35.109a)]
14. If assets are set aside after January 1, 1997 solely for satisfying sched­
uled payments of a specific obligation, is disclosure made describing 
the nature of restrictions placed on those assets?
[SFAS 125, par. 17c (AC L35.109b)]
15. Are long-term obligations that are or will be callable by the creditor, 
either because the debtor's violation of the debt agreement at the 
balance-sheet date makes the obligation callable, or because the vio­
lation (if not cured within a specified grace period) will make the 
obligation callable, classified as current unless one of the following 
conditions is met:
a. The creditor waives or subsequently loses the right to demand 
repayment for more than one year (or operating cycle, if longer) 
from the balance-sheet date?
b. The obligation contains a grace period within which the debtor 
may cure the violation and it is probable that the violation will be 
cured within that period, thus preventing the obligation from 
becoming callable?
[SFAS 78, par. 5 (AC B05.109A)]
16. If a covenant on a long-term loan agreement is not met, and thus, the 
lender has the right to call the debt, and the lender waives that right 
for a period of greater than one year but retains the future covenant 
requirements, is the debt classified as noncurrent unless both of the 
following are met:
a. The covenant violation occurred at the balance-sheet date or 
would have occurred absent a loan modification?
b. It is probable the company will not be able to comply with the 
covenant at a measurement date within the next 12 months? 
[EITF 86-30]
17. If the company issued debt securities convertible into a fixed number 
of common shares, and upon conversion the company either is re­
quested or has the option to satisfy all or part of the obligation in cash, 
is the conversion features and debt obligation presented on the bal­
ance sheet as one amount?
[EITF 90-19]
18. If the company enters into a binding contract with a holder of its debt 
obligation to redeem the debt security at a future date within one year 
for a specified amount greater than (or less than) the company's 
carrying amount of the debt, is the debt obligation classified as a 
current liability?
[EITF 95-15]
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19. Are borrowings outstanding under a revolving credit agreement that 
includes both a subjective acceleration clause and a requirement to 
maintain a lock-box arrangement, whereby remittances from the 
borrower's customers reduce the debt outstanding, classified as short­
term obligations?
[EITF 95-22]
Q. Other Liabilities
1. Are liabilities appropriately accrued and reported for employees' 
compensation for future absences?
[SFAS 43, par. 6 (AC C44.104)]
2. Are net credits arising from financing-type reinsurance agreements 
treated as a deferred credit or liability by the ceding company? 
[AAG, par. 8.110]
3. If an obligation for postemployment benefits is not accrued in accord­
ance with SFAS 5 (AC C59) or SFAS 43, Accounting for Compensating 
Absences (AC C44), only because the amount cannot be reasonably 
estimated, is this fact of nonaccrual disclosed in the financial state­
ments?
[SFAS 112, par. 7 (AC P32.105)]
4. Are amounts recoverable on unpaid losses deducted from the applicable 
claim reserve in the liability section of the statement of condition? 
[AAG, par. 5.06]
R. Shareholders' Equity
1. For each class of stock, do disclosures include the number of shares 
authorized, issued, and outstanding, and par or stated value per 
share?
[Generally Accepted]
2. Are classes of capital stock presented in order of priority in liquida­
tion?
[Generally Accepted]
3. Do the financial statements include a description, in summary form, 
sufficient to explain the pertinent rights and privileges of the various 
securities outstanding (e.g., dividend and liquidation preferences, 
participation rights, call prices and dates, conversion or exercise 
prices or rates and pertinent dates, sinking fund requirements, un­
usual voting rights, and significant terms of contracts to issue addi­
tional shares)?
[SFAS 129, par. 4 (AC C24.102)]
4. Do disclosures include the number of shares issued upon conversion, 
exercise, or satisfaction of required conditions during at least the most 
recent annual fiscal period and any subsequent interim period pre­
sented?
[SFAS 129, par. 5 (AC C24.103)]
5. For preferred stock that has a preference in involuntary liquidation 
considerably in excess of par or stated value of the shares, is the liqui-
28
Yes No N/A
dation preference disclosed in the equity section of the balance sheet 
in the aggregate, either parenthetically or "in short," rather than on a 
per share basis or in the notes to the financial statements? ____
[SFAS 129, par. 6 (AC C24.104)]
6. Are the following disclosed on the face of the balance sheet or in the 
notes:
a. The aggregate or per-share amounts at which preferred stock may
be called or are subject to redemption through sinking-fund op­
erations or otherwise? ____
b. The aggregate and per-share amounts of arrearages in cumulative
preferred dividends? ____
[SFAS 129, par. 7 (AC C24.105)]
7. For redeemable stock, do disclosures include the amount of redemp­
tion requirements, separately by issue or combined, for all issues of 
capital stock that are redeemable at fixed or determinable prices on 
fixed or redeemable dates in each of the five years following the date
of the latest balance sheet? ____
[SFAS 129, par. 8 (AC C24.106)]
8. Are appropriations of retained earnings for loss contingencies clearly
identified and included in shareholders' equity? ____
[SFAS 5, par. 15 (AC R70.103)]
9. Are restrictions on payment of dividends disclosed? ____
[SFAS 5, pars. 18 and 19 (AC C59.120)]
10. After completion of a quasi-reorganization, is a new retained earnings
account established and dated with the date being disclosed in sub­
sequent financial statements until it is no longer deemed significant? ____
[ARB 43, Ch. 7A, par. 10 (AC Q15.111); ARB 46 (AC Q15.111)]
11. Are the carrying basis, cost and number of shares of any treasury stock
held by the reporting entity disclosed? ____
[Generally Accepted]
12. If treasury stock is purchased for purposes other than retirement or if 
ultimate disposition has not yet been decided is its cost:
a. Shown separately as a deduction from the total of capital stock,
additional paid-in capital, and retained earnings? ____
or
b. Accorded the accounting treatment appropriate for retired stock? ____
or
c. Shown as an asset in accordance with paragraph 4 of Chapter 1A
of ARB 43? ____
[APB 6, par. 12b (AC C23.103)]
13. In the rare circumstances in which treasury stock is shown as an asset,
are the circumstances for that classification disclosed? ____
[ARB 43, Ch. 1A, par. 4 (AC R36.105)]
14. If state laws relating to acquisition of stock restrict the availability of
retained earnings for payment of dividends or other significant ef­
fects, is appropriate disclosure made? ____
[APB 6, par. 13 (AC C23.104)]
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15. If an additional liability required to be recognized pursuant to SFAS
87, paragraph 36 (AC P16.130), exceeds unrecognized prior-service 
cost, is the excess (which would represent a net loss not yet recognized 
as net periodic pension cost) reported as a separate component (e.g., 
a reduction) of equity, net of any tax benefits that result from consid­
ering such losses as temporary differences, for purposes of applying 
the provisions of SFAS 87, paragraph 37 (AC I27) and SFAS 109, 
paragraph 287? ____
[SFAS 87, par. 37 (AC P16.131)]
16. For treasury shares purchased at a stated price significantly in excess
of current market price, is the allocation of amounts paid and the 
accounting treatment for such amounts disclosed? ____
[FTB 85-6, pars. 1-3 (AC C23.501-.503)]
17. If statutory surplus is below the minimum required by law, is disclo­
sure of the relevant facts made? ____
[AAG, par. 10.15]
18. Is the following information relating to stockholders' equity, statutory 
capital and surplus, and the effects of statutory accounting practices 
on the ability to pay dividends to stockholders disclosed:
a. The amount of statutory capital and surplus? ____
b. The amount of statutory capital and surplus necessary to satisfy
regulatory requirements (based on current operations) if signifi­
cant in relation to the statutory capital and surplus? ____
c. The nature of statutory restrictions on the payment of dividends
and the amount of retained earnings that is not available for the 
payment of dividends to stockholders? ____
[SFAS 60, par. 60h (AC In6.166h); AAG, par. 10.10]
19. If the company receives a note rather than cash as a contribution to its 
equity, is the note classified as a reduction of stockholders' equity 
unless (in the very limited circumstance) there is substantial evidence
of ability and intent to pay within a reasonably short period of time? ____
[EITF 85-1]
20. Is the Mandatory Securities Valuation Reserve included in the equity
section of the balance sheet as an appropriation of surplus, and not 
recorded as a valuation reserve? ____
[AAG, par. 8.116]
Income Statement
A. Premium Revenue
1. Are premiums from universal life contracts no longer included in 
revenue but recorded in the balance sheet policyholder accounts? ____
[SFAS 97, par. 59]
B. Investment Income
1. Are amounts of loan origination, commitment, and other fees and 
costs recognized as an adjustment of yield reported as part of interest 
income? ____
[SFAS 91, par. 22 (AC L20.121)]
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2. Is investment income presented net of investment expenses? ____ ___
[SFAS 97, par. 23 (AC In6.137B)]
3. Are realized gains and losses on all investments (except investments 
that are classified as trading securities and those that are accounted 
for as hedges as described in SFASs 52 and 80) reported in the 
statement of income as a component of other income, on a pretax
basis? ____ ___
[SFAS 97, par. 28 (AC In6.156)]
C. Other Income
1. Is amortization of other fees, such as commitment fees that are being 
amortized on a straight-line basis over the commitment period or 
included in income when the commitment expires, reported as service
fee income? ____ ___
[SFAS 91, par. 22 (AC L20.121)]
2. Are gains/losses on pension plan settlements or curtailments or 
termination benefits disclosed, including a description of the nature
of the event(s)? ____ ___
[SFAS 88, par. 17 (AC P16.187)]
D. Benefits and Expenses
1. Do disclosures for advertising costs include:
a. The accounting policy selected from the two alternatives in para­
graph 26 of SOP 93-7, Reporting on Advertising Costs, for reporting 
advertising, indicating whether such costs are expensed as in­
curred or the first time the advertising takes place? ____ ___
b. A description of the direct-response advertising reported as assets
(if any), the accounting policy, and the amortization period? ____ ___
c. The total amount charged to advertising expense for each income 
statement presented, with separate disclosure of amounts, if any, 
representing a write-down to net realizable value and the reasons
for such a write-down? ____ ___
d. The total amount of advertising reported as assets in each balance
sheet? ____ ___
[SOP 93-7, par. 49]
E. Income Taxes
1. Are the types of significant temporary differences and carryforwards
disclosed? ____ ___
[SFAS 109, par. 43 (AC I27.142)]
2. Are the following significant components of income tax expense 
attributable to continuing operations for each year presented dis­
closed in the financial statements or notes thereto:
a. Current tax expense or benefit? ____ ___
b. Deferred tax expense or benefit (exclusive of the effects of other
components listed below)? ____ ___
31
Yes No N/A
c. Investment tax credits?
d. The benefits of operating loss carryforwards?
e. Tax expense that results from allocating certain benefits, either 
directly to contributed capital or to reduce goodwill or other 
noncurrent intangible assets, of an acquired company?
f. Adjustments of a deferred tax liability or asset for enacted changes 
in tax laws or rates or a change in the tax status of the enterprise?
g. Adjustments of the beginning-of-the-year balance of a valuation 
allowance because of a change in circumstances that causes a 
change in judgment about the realizability of the related deferred 
tax asset in future years?
[SFAS 109, par. 45a-h (AC I27.144a-h)]
h. The amounts and expiration dates of operating loss and tax credit 
carryforwards for tax purposes?
i. Any portion of the valuation allowance for deferred tax assets for 
which subsequently recognized tax benefits will be allocated to 
reduce goodwill or other noncurrent intangible assets of an ac­
quired entity or directly to contributed capital?
[SFAS 109, pars. 45 and 48 (AC I27.144 and .147)]
3. Is the amount of income tax expense or benefit allocated to continuing 
operations and the amounts separately allocated to other items (in 
accordance with the provisions of paragraphs 35-39 of SFAS 109 
(ACI27.134-.138)) disclosed for each year for which those items are 
presented?
[SFAS 109, par. 46 (AC I27.145)]
4. If the company is a public enterprise, do the financial statements 
disclose a reconciliation using percentages or dollar amounts of (i) the 
reported amount of income tax expense attributable to continuing 
operations for the year to (ii) the amount of income tax expense that 
would result from applying domestic federal statutory tax rates to 
pretax income from continuing operations?
5. If the company is a public enterprise, is the estimated amount and the 
nature of each significant reconciling item disclosed?
6. If the company is a non-public enterprise, is the nature of significant 
reconciling items disclosed (a numerical reconciliation may be omitted)? 
[SFAS 109, par. 47 (AC I27.146)]
7. If the company is a member of a group that files a consolidated tax 
return, are the following items disclosed in its separately issued 
financial statements:
a. The aggregate amount of current and deferred tax expense for 
each statement of income presented and the amount of any tax-re­
lated balances due to or from affiliates as of the date of each 
statement of financial position presented?
b. The principal provisions of the method by which the consolidated 
amount of current and deferred tax expense is allocated to mem­
bers of the group and the nature and effect of any changes in that 
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method (and in determining related balances to or from affiliates) 
during the years for which the disclosures in Step a. above are 
presented?
[SFAS 109, par. 49a and b (AC I27.148a and b)]
8. Are the amounts of income taxes applicable to the results of discon­
tinued operations disclosed on the statement of income or in related 
notes?
[APB 30, par. 8 (AC I13.105)]
9. Are the income taxes applicable to extraordinary events disclosed on 
the face of the statement of income or in related notes?
[APB 30, par. 11 (AC I17.102)]
F. Discontinued Operations
1. Are operations of a discontinued segment or one that is the subject of 
a formal plan for disposition:
a. Reported separately from income from continuing operations and 
as a component (including applicable income taxes) of income 
before extraordinary items?
b. Accompanied by disclosure in the notes of revenue applicable to 
the discontinued operations?
[APB 30, pars. 8 and 13-18 (AC I13.101-.103, .105, .106, .108, and 
.109)]
2. Is gain or loss from disposal of a discontinued segment reported 
separately (including applicable income taxes) in conjunction with 
results of discontinued operations as a component of income before 
extraordinary items or in related notes?
[APB 30, pars. 8,13, and 18 (AC I13.105, .106, .108, and .109)]
3. For the period encompassing the measurement date, do notes to the 
financial statements disclose:
a. Identity of the segment discontinued?
b. Expected disposal date, if known?
c. Expected manner of disposal?
d. Description of the remaining assets and liabilities of the discontin­
ued segment at the balance-sheet date?
e. Income or loss from operations and any proceeds from disposal 
of the discontinued segment during the period from the measure­
ment date to the balance-sheet date?
f. A statement that the loss on disposal cannot be estimated within 
reasonable limits?
[APB 30, par. 18 (AC I13.108 and .109)]
4. For periods after the measurement date and including the period of 
disposal, do notes to the financial statements disclose the information 
required by Steps 3.a.-d. above and the information required by Step
3.e  above compared with prior estimates?
[APB 30, par. 18 (AC I13.108 and .109)]
5. If the company accounts for the discontinuance of a segment in 
accordance with APB 30, Reporting the Results of Operations—Reporting 
the Effects of Disposal of a Segment of a Business, and Extraordinary, 
Unusual and Infrequently Occurring Events and Transactions, and sub­
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sequently decides to retain the segment, is any impairment write­
down of the individual assets classified in continuing operations? 
[EITF 90-16]
6. If the company plans to dispose of two segments of a business, and a 
net gain is expected (one has a net gain and the other a net loss), is that 
gain shown net of the loss?
[EITF 85-36]
7. For discontinued operations or sale of a portion of a line of business 
that is not a segment of a business, is the gain or loss from disposal 
reported as a separate component of income from continuing opera­
tions, and is it not reduced for income taxes (information similar to 
that in Steps 3a.-f. above should be disclosed, and disclosures for 
revenues and related costs and expenses included in the income 
statement that relate to the disposed portion of the line of business for 
the period prior to the measurement date is encouraged)? 
[AIN-APB 30, par. 1 (AC I22.502)]
8. If the company decides to dispose of a segment of a business ac­
counted for in accordance with APB 30 and the measurement date 
occurs after the balance-sheet date but before the financial statements 
for the prior period have been issued and a loss is expected, are the 
segment's operating results presented as discontinued operations in 
the income statement of the not yet released financial statements 
(assuming that the loss does not result from a discrete and identifiable 
event that occurs unexpectedly after the balance-sheet date?
[EITF 95-18]
G. Extraordinary Items
1. Do extraordinary items meet both criteria of (1) unusual nature and 
(2) infrequency of occurrence?
[APB 30, par. 20 (AC I17.107)]
2. Are extraordinary items segregated and shown (including applicable 
income taxes) following income before extraordinary items and be­
fore net income?
[APB 30, par. 11 (AC I17.102)]
3. Are descriptive captions and amounts (including applicable income 
taxes) presented for individual extraordinary events or transactions, 
preferably on the face of the income statement?
[APB 30, par. 11 (AC I17.102)]
4. Do disclosures include descriptions of an extraordinary event or 
transaction and the principal items entering into determination of 
extraordinary gain or loss?
[APB 30, par. 11 (AC I17.102)]
5. Is each adjustment in the current period of an element of an extraor­
dinary item that was reported in a prior period separately disclosed 
as to year of origin, nature, and amount and classified separately in 
the current period as an extraordinary item?
[SFAS 16, par. 16c (AC I17.119)]
6. Are material events or transactions that are either unusual in nature 
or of infrequent occurrence, but not both (and therefore not meeting 
criteria for extraordinary items):
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a. Reported as a separate component of income from continuing 
operations?
b. Accompanied by disclosure of the nature and financial effects of 
each event?
[APB 30, par. 26 (AC I22.101)]
H. Earnings Per Share
Note: SFAS 128, Earnings per Share, which applies only to entities with 
publicly held common stock or potential common stock is effective for 
financial statements for both interim and annual periods ending after 
December 15, 1997. Earlier application is not permitted. If SFAS 128 is not 
yet effective, refer to APB 15, Earnings per Share, for disclosure require­
ments.
1. If the reporting entity has a simple capital structure (only common 
stock outstanding), are basic per-share amounts for income from 
continuing operations and for net income presented on the face of the 
income statement for all periods for which an income statement or 
summary of earnings is presented?
[SFAS 128, pars. 36 and 38 (AC E11.131 and .133)]
2. If the reporting entity has other than a simple capital structure, are 
basic and diluted per-share amounts for income from continuing 
operations and for net income presented on the face of the income 
statement with equal prominence for all periods for which an income 
statement or summary of earnings is presented?
(Note: If diluted EPS data are reported for at least one period, they 
should be reported for all periods presented, even if they are the same 
amounts as basic EPS.)
[SFAS 128, pars. 36 and 38 (AC E11.131 and .133)]
3. If discontinued operations, extraordinary items, or the cumulative 
effect of accounting changes are reported in the period, are the basic 
and diluted per share amounts for those line items presented on the 
face of the income statement or in the notes?
[SFAS 128, par. 37 (AC E11.132)]
4. If per share amounts not required to be presented by SFAS 128 are 
disclosed, are they disclosed only in the notes and do the disclosures 
indicate whether the per share amounts are pretax or net of tax? 
[SFAS 128, par. 37 (AC E11.132)]
5. Are the following disclosed for each period for which an income 
statement is presented:
a. A reconciliation of the numerators and denominators of the basic 
and diluted per share computations for income from continuing 
operations?
b. The effect that has been given to preferred dividends in arriving 
at income available to common shareholders' in computing basic 
EPS?
c. Securities (including those issuable pursuant to contingent stock 
agreements) that could potentially dilute basic EPS in the future
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that were not included in the computation of diluted EPS because 
to do so would have been antidilutive for the period(s) presented? ____ ____ ____
[SFAS 128, par. 40 (AC E11.135)]
6. For the latest period for which an income statement is presented, do 
disclosures include a description of any transaction that occurs after 
the end of the most recent period but before issuance of the financial 
statements that would have changed materially the number of com­
mon shares or potential common shares outstanding at the end of the 
period if the transaction had occurred before the end of the period? ____ ____ ____
[SFAS 128, par. 41 (AC E11.136)]
I. Comprehensive Income
Note: SFAS 130, Reporting Comprehensive Income, is effective for fiscal years 
beginning after December 15, 1997 with earlier application permitted.
Practice Tip
Components of comprehensive income include:
• Foreign currency translation adjustments determined in accordance with SFAS 52, Foreign Currency 
Translation.
• Changes in the market value of futures contracts that qualify as hedges as described in SFAS 80, Ac­
counting for Futures Contracts.
• Adjustments of minimum pension liability recognized in accordance with SFAS 87, Employers' Account­
ing for Pensions.
• Unrealized gains and losses on certain investments in debt and equity securities recognized in accord­
ance with SFAS 115, Accounting for Certain Investments in Debt and Equity Securities.
Additional items may result from future accounting standards.
1. Are all components of comprehensive income reported in the finan­
cial statements in the period in which they are recognized?
[SFAS 130, par. 14 (AC C49.108)]
2. Is a total amount for comprehensive income displayed in the financial 
statement where the components of other comprehensive income are 
reported?
[SFAS 130, par. 14 (AC C49.108)]
3. Is an amount for net income displayed and included as a component 
of comprehensive income?
[SFAS 130, pars. 15 and 22 (AC C49.109 and .116)]
4. Are items included in other comprehensive income classified sepa­
rately into foreign currency items, minimum pension liability adjust­
ments, and unrealized gains and losses on certain investments in debt 
and equity securities?
[SFAS 130, par. 17 (AC C49.111)]
5. Are reclassification adjustments made to avoid double counting in 
comprehensive income of items that are displayed as part of net 
income for a period that also had been displayed as part of other 
comprehensive income in that period or other periods presented on 
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the face of the financial statement in which comprehensive income is 
reported or disclosed in the notes?
[SFAS 130, par. 20 (AC C49.114)]
6. Are comprehensive income and its components displayed in a finan­
cial statement that is displayed with the same prominence as the other 
financial statements?
(Note: SFAS 130 encourages but does not require that the compo­
nents of other comprehensive income and total comprehensive in­
come be displayed below the total for net income in a statement that 
reports results of operations or in a separate statement of comprehen­
sive income that begins with net income.)
[SFAS 130, pars. 22 and 23 (AC C49.116 and .117)]
Are the components of other comprehensive income displayed either 
net of related tax effects, or before related tax effects with one amount 
shown for the aggregate tax effect related to the total of other compre­
hensive income items?
[SFAS 130, par. 24 (AC C49.118)]
8. Is the amount of income tax expense or benefit allocated to each 
component of other comprehensive income (including reclassifica­
tion adjustments) displayed on the face of the statement in which 
those components are displayed or disclosed in the notes to the 
financial statements?
[SFAS 130, par. 25 (AC C49.119)]
9. Is the total of other comprehensive income for a period transferred to 
a component of equity that is displayed separately from retained 
earnings and additional paid-in-capital in the balance sheet with a 
descriptive title such as accumulated other comprehensive income? 
[SFAS 130, par. 26 (AC C49.120)]
10. Are accumulated balances for each classification within accumulated 
other comprehensive income disclosed on the face of the balance 
sheet, in the statement of changes in shareholders' equity, or in the 
notes?
[SFAS 130, par. 26 (AC C49.120)]
11. If condensed interim financial statements are issued, is total compre­
hensive income reported?
[SFAS 130, par. 27 (AC C49.121)]
J. Other
1. Are the following excluded from determination of net income or 
results of operations under all circumstances:
a. Adjustments or charges or credits resulting from transactions in 
the company's own capital stock?
b. Transfers to and from accounts properly designated as appropri­
ated retained earnings?
c. Adjustments made pursuant to a quasi reorganization? 
[APB 9, par. 28 (AC C08.101)]
2. For nonpublic entities, if there is a restructuring charge, is it reflected 
using the most meaningful statement of income presentation within 
the framework of APB 30?
[EITF 87-4]
37
Yes No N/A
3. For freestanding contracts indexed to and potentially settled in the 
company's own stock and when those contracts require a net cash 
settlement or settlement in shares, are gains and losses included in
earnings and disclosed in the financial statements? ____ ____ ____
[EITF 94-7]
4. Are gains or losses on written put options that require net cash
settlement, included in earnings and disclosed in the financial state­
ments? ____ ____ ____
[EITF 96-1]
Statement of Changes in Shareholders' Equity
1. Are changes in the separate component accounts of shareholders'
equity disclosed? ____ ____ ____
[APB 12, par. 10 (AC C08.102)]
2. Are changes in the number of shares of equity securities disclosed? ____ ____ ____
[APB 12, par. 10 (AC C08.102)]
3. If prior-period adjustments have been recorded during the current 
year, are their resulting effects (both gross and net of applicable 
income taxes and including the amounts of income tax applicable to 
the prior period adjustments) appropriately disclosed:
a. For single-period statements, does the disclosure indicate the
effects of such restatement on the balance of retained earnings at 
the beginning of the period and on the net income of the immedi­
ately preceding period? ____ ____ ____
b. If financial statements of more than one period are presented, does 
disclosure include the effects for each of the periods presented in
the statements? ____ ____ ____
[APB 9, par. 26 (AC A35.107)]
Practice Tip
Disclosure of restatements in annual reports issued subsequent to the first such post-revision disclosure 
would ordinarily not be required.
4. If interim financial reports contain an adjustment related to prior 
interim periods of the current fiscal year, do disclosures include:
a. The effect on income from continuing operations, net income, and 
related per share amounts for each prior interim period of the
current fiscal year? ____
b. Income from continuing operations, net income, and related per
share amounts for each prior interim period restated? ____
[SFAS 16, par. 15 (AC A35.111)]
5. If the reporting entity is a publicly traded company and if interim 
financial data and disclosures are not separately reported for the 
fourth quarter, are accounting changes made during the fourth quar­
ter, disposals of segments of a business, extraordinary, unusual, or 
infrequently occurring items recognized in the fourth quarter, and the 
aggregate effect of year end adjustments that are material to the
results of that quarter disclosed in a note to the financial statements? ____
[APB 28, par. 31 (AC I73.147)]
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6. If the reporting entity is a publicly traded company, is disclosure 
about the effect of accounting changes on interim periods that are 
required by paragraphs 23-26 of APB 28 or by paragraphs 9-13 of 
SFAS 3 included in a note to the financial statements for the fiscal year 
in which the change is made?
[SFAS 3, par. 14 (AC I73.147)]
7. For a correction of an error, is the nature of the error disclosed in the 
period in which the error was discovered and corrected:
a. Nature of the error in previously issued financial statements?
b. Effect of its correction on income before extraordinary items, net 
income, and related per-share amounts, if applicable?
[APB 20, par. 37 (AC A35.105)]
Statement of Cash Flows
1. Is a statement of cash flows presented as a basic financial statement 
for each period for which an income statement is presented?
[SFAS 95, par. 3 (AC C25.101)]
2. Are cash receipts and cash payments from operating activities shown 
separately on the statement of cash flows?
[SFAS 95, pars. 27 and 28 (AC C25.125 and .126)]
a. Are cash receipts and cash payments from purchases and sales of 
securities and other assets acquired for resale and carried at mar­
ket value in a trading account classified as operating cash flows? 
[SFAS 102, par. 8, as amended by SFAS 115 (AC C25.122A)]
b. Are cash receipts and cash payments resulting from acquisitions 
and sales of loans (if those loans are acquired specifically for resale 
and are carried at market value or the lower of cost or market) 
classified as operating cash flows?
[SFAS 102, par. 9 (AC C25.122B)]
3. Are cash receipts and cash payments for the following transactions 
classified as cash flows from operating activities:
a. Cash receipts from sales of goods or services?
b. Cash receipts from interest and dividends?
c. All other cash receipts that do not stem from transactions defined 
as investing or financing activities?
d. Cash payments to suppliers and employees, such as benefits 
paid to policyholders, surrender benefits, and dividends paid 
to policyholders?
e. Cash payments to governments for taxes, duties, fines, and other 
fees or penalties?
f. Cash payments to lenders and other creditors for interest?
g. Payments to settle lawsuits?
h. Contributions to charities?
i. Cash flows from purchases, sales, and maturities of trading secu­
rities?
j. All other cash payments that do not stem from transactions de­
fined as investing or financing activities?
[SFAS 95, pars. 22 and 23 (AC C25.120 and .121)]
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4. Are cash receipts and cash payments from investing activities shown
separately on statement of cash flows? ____ ____  ____
[SFAS 95, par. 31 (AC C25.129)]
5. Are cash receipts and cash payments for the following transactions 
classified as cash flows from investing activities:
a. Receipts from collections or sales of loans? ____ ____  ____
b. Purchases of and proceeds from sales of available-for-sale securi­
ties? ____ ____  ____
c. Proceeds from maturities of available-for-sale and held-to-matur­
ity securities? ____ ____  ____
d. Purchases of held-to-maturity securities? ____ ____  ____
e. Net purchases of property and equipment? ____ ____ ____
[SFAS 95, pars. 16 and 17, as amended by SFAS 102, as amended
by SFAS 115 (AC C25.114 and .115)]
6. Are cash receipts and cash payments from financing activities shown
separately on the statement of cash flows? ____ ____  ____
[SFAS 95, par. 31 (AC C25.129)]
7. Are cash receipts and cash payments for the following transactions 
classified as cash flows from financing activities:
a. Proceeds from issuing equity instruments? ____ ____  ____
b. Proceeds from issuing bonds, mortgages, and notes, and from
other short- or long-term borrowing? ____ ____ ____
c. Repayment of amounts borrowed? ____ ____ ____
d. Dividend payments to stockholders? ____ ____  ____
e. Acquisition of treasury stock? ____ ____  ____
f. Other principal payments to creditors who have extended long­
term credit? ____ ____  ____
g. Debt issue costs? ____ ____ ____
[SFAS 95, pars. 19 and 20 (AC C25.117 and .118); EITF 95-13]
8. If applicable, is the effect of exchange rate changes on cash balances 
held in foreign currencies shown separately on statement of cash
flows? ____ ____ ____
[SFAS 95, par. 25 (AC C25.123)]
9. Is the change in cash and cash equivalents shown? ____ ____ ____
[SFAS 95, pars. 7 and 26 (AC C25.105 and .124)]
10. Is the policy for defining cash equivalent disclosed? ____ ____ ____
[SFAS 95, par. 10 (AC C25.108)]
Practice Tip
Any change in policy for determining which items are treated as cash equivalents is a change in accounting 
principle.
11. Are noncash investing and financing activities, such as converting 
debt to equity, summarized in a separate schedule?
[SFAS 95, par. 32 (AC C25.134)]
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12. If the direct method is used, is a separate schedule provided to
reconcile net income to net cash flow from operating activities? ____
[SFAS 95, par. 29 (AC C25.128)]
13. If the indirect method is used:
a. Is the same amount for net cash flow from operating activities 
reported indirectly, by adjusting net income to reconcile it to net
cash flow from operating activities? ____
b. Is the reconciliation of net income to net cash flows from operating
activities reported, either within the statement of cash flows or 
provided in a separate schedule, with the statement of cash flows 
reporting only the net cash flow from operating activities? ____
[SFAS 95, par. 30 (AC C25.128)]
14. If the indirect method is used, are the amounts of interest paid (net of
amounts capitalized) and income taxes paid during the period(s) 
disclosed? ____
[SFAS 95, par. 29 (AC C25.127)]
15. Are the following classes of operating cash receipts and payments for 
life insurance companies using the direct method, at a minimum, 
separately disclosed:
a. Cash collected from customers, including lessees, licensees, and
the like? ____
b. Interest and dividends received? ____
c. Other operating cash receipts, if any? ____
d. Cash paid to employees and other suppliers of goods or services,
including suppliers of insurance, advertising, and the like? ____
e. Interest paid? ____
f. Income taxes paid? ____
g. Other operating cash payments, if any? ____
[SFAS 95, par. 27 (AC C25.125)]
General
A. Titles and References
1. Are the financial statements suitably titled? ____
[Generally Accepted]
2. Does each statement include a general reference to the notes indicat­
ing they are an integral part of the financial statement presentation? ____
[Generally Accepted]
B. Disclosure of Accounting Policies
1. Is a description of all significant accounting policies of the reporting
company presented as an integral part of the financial statements? ____
[APB 22, par. 8 (AC A10.102)]
2. Does disclosure of significant accounting policies encompass impor­
tant judgments as to the appropriateness of principles concerning 
recognition of revenue and allocation of asset costs to current and
future periods? ____
[APB 22, par. 12 (AC A10.105)]
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3. Does disclosure of significant accounting policies include appropriate 
reference to details presented elsewhere (in the statements and notes 
thereto) so duplication of details is avoided?
[APB 22, par. 14 (AC A10.107); AAG, par. 10.01]
4. For GAAP reporting purposes, are the following regulatory account­
ing practices avoided (not all-inclusive):
a. Nonrecognition of certain assets such as furniture and equipment?
b. Nonrecognition of deferred taxes?
c. Use of NAIC prescribed values for the amount of goodwill and 
other intangible assets related to the carrying value of investments 
in subsidiaries?
d. Calculation of liability for reinsurance in unauthorized compa­
nies?
e. Calculation of asset valuation reserve and interest maintenance 
reserve?
[NAIC, Introduction]
5. Are the principles relating to the recognition of premium revenue and 
related expenses disclosed?
[AAG, par. 10.02]
6. Do mutual life insurance companies disclose the principles and meth­
ods used to account for marketable securities and insurance activities? 
[FASBI 40, par. 5 (AC A10.102A)]
7. When the permitted practices differ from the prescribed statutory 
accounting practices, is the following information about permitted 
statutory accounting practices that individually or in the aggregate 
affect statutory surplus or risk-based capital, including GAAP prac­
tices, disclosed:
a. A description of the permitted statutory accounting practices?
b. A statement that the permitted statutory accounting practice dif­
fers from prescribed statutory accounting practices?
c. The monetary effect on statutory surplus? 
[SOP 94-5, par. 8]
8. When prescribed statutory accounting practices do not address the 
accounting for the transaction, is the following information about 
permitted statutory accounting practices, excluding GAAP practices 
used, disclosed:
a. A description of the transaction and of the permitted statutory 
accounting practice used?
b. A statement that prescribed statutory accounting practices do not 
address the accounting for the transaction?
[SOP 94-5, par. 8]
9. If material, is the accounting policy used in recognizing amounts 
related to a modification of an operating lease (that does not change 
the lease classification) disclosed?
[EITF 95-17]
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□
C. Comparative Financial Statements
1. Are comparative statements considered?
[ARB 43, Ch. 2A, pars. 1 and 2 (AC F43.101 and .102)]
2. Are the notes and other disclosures included in the financial state­
ments of the preceding year(s) presented, repeated, or at least referred 
to, to the extent that they continue to be of significance?
[ARB 43, Ch. 2A, par. 2 (AC F43.102)]
3. If changes occurred in the manner of or basis for presenting corre­
sponding items for two or more periods, are appropriate explanations 
of the changes disclosed?
[ARB 43, Ch. 2A, par. 3, as amended by APB 20 (AC F43.103)]
4. If comparative annual financial statements are presented for earlier 
periods, are those financial statements reclassified (or restated) to 
reflect retroactive application of the provisions of SFAS 116? 
[SFAS 116, par. 30]
D. Accounting Changes
1. For all changes in accounting principles, are the following disclosures 
made in the year of change:
a. Nature of the change?
b. Justification for the change?
c. Effect on income before extraordinary items and on net income?
d. Effect on related per-share amounts?
[APB 20, pars. 17 and 19 (AC A06.113 and .115)]
2. For all changes in accounting principles, except those concerning a 
change in entity and those recognized in paragraphs 27-30 of APB 20:
a. Are financial statements for prior periods, included for compara­
tive purposes, presented as previously reported?
b. Is the effect of adopting the new accounting principle on income 
before extraordinary items and on net income and the related 
per-share amounts disclosed in the period of the change?
c. Are income before extraordinary items and net income computed 
on a pro forma basis shown on the face of the income statements 
for all periods presented as if the newly adopted accounting 
principle had been applied during all periods affected?
[APB 20, pars. 19-21 and 25 (AC A06.115-.117 and .121)]
3. If appropriate, is the cumulative effect of a change in accounting 
principle shown separately between the captions "extraordinary 
items" and "net income"?
[APB 20, pars. 19b, 20, and 21 (AC A06.114-.122 and E09.104)]
4. Is the reason for not reporting the cumulative effect of the change and 
not disclosing the pro forma amounts for prior years disclosed if it is 
impossible to determine such effects?
[APB 20, pars. 25 and 26 (AC A06.121 and .122)]
5. For changes in accounting principle that are required to be accounted 
for by applying retroactively the new method in restatements of prior 
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periods, is the effect of the change on income before extraordinary 
items, net income, and related per share amounts disclosed?
[APB 20, par. 28 (AC A10.115)]
6. For a change in accounting estimate affecting several future periods, 
are the following disclosures made in the year of change:
a. Effect on income before extraordinary items and on net income? ____
b. Effect on related per-share amounts? ____
[APB 20, par. 33 (AC A06.132)]
7. For correction of an error, is the nature of the error disclosed in the 
period in which the error was discovered and corrected:
a. Nature of the error in previously issued financial statements? ____
b. Effect of its correction on income before extraordinary items, net
income, and related per-share amounts, if applicable? ____
[APB 20, par. 37 (AC A35.105)]
8. If any accounting change has no material effect in the period of change
but is reasonably certain to materially affect later periods, is the 
change disclosed in the financial statements of the period of the 
change? ____
[APB 20, par. 38 (AC A06.133)]
9. For an accounting change that is in effect a change in reporting 
entity, are the financial statements of all prior periods restated in 
order to show financial information for the new reporting entity 
for all periods and are the following disclosures made for all 
periods presented:
a. The nature of the change? ____
b. The reason for the change? ____
c. The effect of the change on income before extraordinary items, net
income, and related per share amounts? ____
[APB 20, pars. 34 and 35 (AC A35.112-.113)]
E. Risks and Uncertainties
1. Is a description of the major products and services the entity sells or
provides and the principal markets, including the location of those 
markets, disclosed? ____
[SOP 94-6, par. 10]
2. If the company operates in more than one business, are the relative
importance of its operations in each business and the basis for the 
determination (for example, assets, revenues, or earnings) dis­
closed? ____
[SOP 94-6, par. 10]
3. Is an explanation that the preparation of financial statements in
conformity with GAAP requires the use of management's estimates 
included in the financial statements? ____
[SOP 94-6, par. 11]
4. Is disclosure regarding an estimate made when known information 
available before the financial statements are issued indicates that it is 
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at least reasonably possible that the estimate of the effect on the 
financial statements of a condition, situation, or set of circumstances 
that existed at the date of the financial statements will change in the 
near term due to one or more future confirming events, and the effect 
of the change will be material?
[SOP 94-6, par. 13]
5. Does the disclosure in Step 4 above, indicate the nature of the uncer­
tainty and include an indication that it is reasonably possible that a 
change in estimate will occur in the near term?4
4 If risk reduction techniques are used to mitigate losses or the uncertainty that may result from certain events, these disclosures are 
encouraged but not required.
5 See footnote 4.
[SOP 94-6, par. 14]
6. If the estimate in Step 4 above involves a loss contingency covered by 
SFAS 5, do disclosures include an estimate of the possible loss or range 
of loss, or state that such an estimate cannot be made?5
[SOP 94-6, par. 14]
7. Is disclosure of the concentrations described in paragraph 22 of SOP 
94-6 made if, based on information known to management before the 
financial statements are issued, the criteria in paragraph 21 of SOP 
94-6 are met?
[SOP 94-6, pars. 21 and 22]
8. For those concentrations of labor subject to collective bargaining 
agreements and concentrations of operations located outside of the 
company's home country that meet the criteria of paragraph 21 of SOP 
94-6, are the following disclosed:
a. The percentage of labor force covered by a collective agreement 
and the percentage of the labor force covered by a collective 
bargaining agreement that will expire in one year?
b. The carrying amounts of net assets and the geographic areas in 
which they are located for operations located outside the com­
pany's home country?
[SOP 94-6, par. 24]
9. Have the optional disclosures in paragraphs 14 and 15 of SOP 94-6 
been considered?
[SOP 94-6, pars. 14 and 15]
F. Contingencies and Commitments
1. Is the nature and amount of significant accrued loss contingencies not 
related to life insurance disclosed as necessary to keep the financial 
statements from being misleading?
[SFAS 5, par. 9 (AC C59.108)]
2. For loss contingencies not accrued, do disclosures indicate:
a. Nature of the contingency?
b. Estimate of possible loss or range of loss, or a statement that such 
estimate cannot be made?
[SFAS 5, par. 10 (AC C59.109)]
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3. Is the nature and amount of guarantees disclosed (e.g., obligations under
standby letters of credit, guarantees to repurchase loans that are sold)? ____
[SFAS 5, par. 12 (AC C59.113); FASBI 34, pars. 2 and 3 (AC C59.114)]
4. Are gain contingencies adequately disclosed with care to avoid any
misleading implications about likelihood of realization? ____
[SFAS 5, par. 17 (AC C59.118)]
5. Is there adequate disclosure of commitments, such as those for capital
expenditures, for purchase or sale of securities under financial futures 
contracts, and for funding of loans and unused letters of credit? ____
[SFAS 5, pars. 18 and 19 (AC C59.120); FASB 80 (AC F80)]
6. If the company as guarantor "lends" its creditworthiness to another
party (borrower) for a fee, is the guarantee disclosed in a note, if 
material? ____
[EITF 85-20]
7. If exposure to loss exists in excess of the amount accrued for a loss 
contingency, do disclosures include the excess amount or state that
no estimate is possible? ____
[SFAS 5, par. 10 (AC C59.109)]
8. When, after considering management's plans, the auditor concludes 
there is substantial doubt about the entity's ability to continue as a 
going concern for a reasonable period of time, is adequate disclosure
of the situation made in the financial statements? ____
[SAS 59, par. 10 (AU 341.10)]
G. Environmental Remediation Liabilities
Note: SOP 96-1, Environmental Remediation Liabilities, does not provide guid­
ance on recognizing liabilities of insurance companies for unpaid claims. 
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1. Is there disclosure of the following accounting policies:
a. Whether accruals for environmental remediation liabilities are 
measured on a discounted basis?
b. The policy concerning the timing of recognition of recoveries? 
(Encouraged, but not required.)
[SOP 96-1 (Ch. 7, pars. 11 and 12)]
2. Do the financial statements disclose the event, situation, or set of 
circumstances that triggered recognition of loss contingencies that 
arose out of the reporting entity's environmental remediation-related 
obligations? (Encouraged, but not required.)
[SOP 96-1 (Ch. 7, par. 12)]
Recognized Losses and Recoveries of Losses, and Reasonably Possible 
Loss Exposures
3. With respect to recorded accruals for environmental remediation loss 
contingencies and assets for third-party recoveries related to environ­
mental remediation obligations, are the following disclosed:
a. The nature of the accruals, if such disclosure is necessary for the 
financial statements not to be misleading, and, in situations where 
disclosure of the nature of the accruals is necessary, the total amount
Yes No N/A
accrued for the remediation obligation, if such disclosure is also 
necessary for the financial statements not to be misleading?
b. If any portion of the accrued obligation is discounted, the undis­
counted amount of the obligation and the discount rate used in the 
present-value determinations?
c. If the criteria of SOP 94-6 (it is at least reasonably possible that an 
estimate of the effect on the financial statements of a matter that 
existed at the balance-sheet date will change in the near term and 
the effect of the change would be material to financial statements) 
are met with respect to the accrued obligation or to any recognized 
asset for third-party recoveries, an indication that it is at least 
reasonably possible that a change in the estimate of the obligation 
or of the asset will occur in the near term?
[SOP 96-1 (Ch. 7, par. 20)]
4. With respect to reasonably possible loss contingencies, including 
reasonably possible loss exposures in excess of the amount accrued, 
are the following disclosed:
a. The nature of the reasonably possible loss contingency, that is, a 
description of the reasonably possible remediation obligation, and 
an estimate of the possible loss exposure or the fact that such an 
estimate cannot be made?
b. If the criteria of SOP 94-6 are met with respect to estimated loss (or 
gain) contingencies, an indication that it is at least reasonably 
possible that a change in the estimate will occur in the near term?
c. The estimated time frame of disbursements for recorded amounts 
if expenditures are expected to continue over the long term? 
(Encouraged, but not required.)
d. The estimated time frame for realization of recognized probable 
recoveries, if realization is not expected in the near term? (Encour­
aged, but not required.)
e. If the criteria of SOP 94-6 are met with respect to the accrued 
obligation, to any recognized asset for third-party recoveries, or to 
reasonably possible loss exposures or disclosed gain contingen­
cies, the factors that cause the estimate to be sensitive to change? 
(Encouraged, but not required.)
f. If an estimate of the probable or reasonably possible loss or range 
of loss cannot be made, the reasons why it cannot be made? 
(Encouraged, but not required.)
g. If information about the reasonably possible loss or the recognized 
and additional reasonably possible loss for an environmental 
remediation obligation related to an individual site is relevant to 
an understanding of the financial position, cash flows, or results 
of operations of the entity, the following with respect to the site: 
(Encouraged, but not required.)
(1) The total amount accrued for the site?
(2) The nature of any reasonably possible loss contingency or 
additional loss, and an estimate of the possible loss or the fact 
that an estimate cannot be made and the reasons why it 
cannot be made?
(3) Whether other potentially responsible parties are involved 
and the entity's estimated share of the obligation?
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(4) The status of regulatory proceedings?
(5) The estimated time frame for resolution of the contingency? 
[SOP 96-1 (Ch. 7, pars. 21 and 22)]
Probable But Not Reasonably Estimable Losses
5. If the reporting entity's probable but not reasonably estimable envi­
ronmental remediation obligations may be material, are the nature of 
the probable contingency (that is, a description of the remediation 
obligation) and the fact that a reasonable estimate cannot currently be 
made disclosed?
[SOP 96-1 (Ch. 7, par. 25)]
6. Is the estimated time frame for resolution of the uncertainty as to the 
amount of the loss disclosed? (Encouraged, but not required.)
[SOP 96-1 (Ch. 7, par. 25)]
Environmental Remediation Costs Recognized Currently
7. Is the amount of environmental remediation costs recognized in the 
income statement disclosed in the following detail: (Encouraged, but 
not required.)
a. The amount recognized for environmental remediation loss con­
tingencies in each period?
b. The amount of any recovery from third parties that is credited to 
environmental remediation costs in each period?
c. The income statement caption in which environmental remedia­
tion costs and credits are included?
[SOP 96-1 (Ch. 7, par. 29)]
Other Matters
8. Do the financial statements include a contingency conclusion that ad­
dresses the estimated total unrecognized exposure to environmental 
remediation and other loss contingencies? (Optional.)
[SOP 96-1 (Ch. 7, par. 30)]
9. Is there a description of the general applicability and impact of 
environmental laws and regulations upon their business and how the 
existence of such laws and regulations may give rise to loss contin­
gencies for future environmental remediation? (Optional.)
[SOP 96-1 (Ch. 7, par. 31)]
H. Related-Party Transactions and Economic Dependency
1. For related-party transactions, do disclosures include:
a. The nature of the relationship(s) involved (e.g., parent, subsidiary, 
and affiliate companies, officers, stockholders, etc.)?
b. A description of the transactions, including transactions to which 
no amounts or nominal amounts were ascribed, for each of the 
periods for which an income statement is presented, and such 
other information deemed necessary to an understanding of the 
effects of the transactions on the financial statements?
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c. The dollar amounts of transactions for each of the periods for 
which an income statement is presented and the effects of any 
change in the method of establishing the terms from that used in
the preceding period? ____ ____ ____
d. Amounts due from or to related parties as of the date of each 
balance sheet presented and, if not otherwise apparent, the terms
and manner of settlement? ____ ____  ____
[SFAS 57, par. 2 (AC R36.102)]
2. Is the nature of a controlled relationship disclosed, even though there 
are no transactions between the enterprises, if the reporting company 
and one or more other enterprises are under common ownership or 
management control, and the existence of the control could result in 
operating results or financial position of the reporting company being 
significantly different from those that would have resulted if the
company were autonomous? ____ ____  ____
[SFAS 57, par. 4 (AC R36.104)]
3. If the company is part of a group that files a consolidated tax return, 
is the aggregate amount of current and deferred tax expense disclosed 
for each of the periods for which an income statement is presented 
and the amount of any tax-related balance due to or from affiliates as
of the date of each balance sheet presented? ____ ____ ____
[SFAS 109, par. 49a (AC 127.148a)]
4. If the company is a part of a group that files a consolidated tax 
return, are the principal provisions of the method by which current 
and deferred tax expense is allocated to members of the group and 
the nature and effect of any changes in the method disclosed for
each of the periods for which an income statement is presented? ____ ____ ____
[SFAS 109, par. 49b (AC 127.148b)]
5. Is information about economic dependency disclosed when necessary
for a fair presentation? ____ ____  ___
[SFAS 21, par. 9]
I. Pension and Employee Stock Ownership Plans □
1. If there is a defined benefit plan, do disclosures include:
a. A description of the plan, including employee groups covered, 
type of benefit formula, funding policy, types of assets held and 
significant nonbenefit liabilities, if any, and the nature and effect 
of significant matters affecting comparability of information for all
periods presented? ____ ____ ___
[SFAS 87, par. 54a (AC P16.150a)]
b. The amount of net periodic pension cost for the period showing 
separately the service cost component, the interest cost compo­
nent, the actual return on assets for the period, and the net total of
other components?6 ____ ____  ___
6 The net total of other components is the net effect during the period of certain delayed recognition provisions of SFAS 87, Employers' 
Accounting for Pensions (AC P16). That net total includes:
a. The net asset gain or loss during the period deferred for later recognition (in effect, an offset or a supplement to the actual return 
on assets)?
b. Amortization of the net gain or loss from earlier periods?
c. Amortization of unrecognized prior service cost?
d. Amortization of the unrecognized net obligation or net asset existing at the date of initial application of SFAS 87 (AC P16)? 
[SFAS 87, par. 54 (AC P16.150)]
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c. Measurement of plan assets and obligations within three months 
of the balance-sheet date using a consistent date from year to year 
(estimates may be necessary)?
[SFAS 87, par. 52 (AC P16.148)]
d. A schedule reconciling the funded status of the plan with amounts 
reported in the employer's balance sheet, showing separately:
(1) The fair value of plan assets?
(2) The projected benefit obligation identifying the accumulated 
benefit obligation and the vested benefit obligation?
(3) The amount of unrecognized prior-service cost?
(4) The amount of unrecognized net gain or loss (including asset 
gains and losses not yet reflected in market-related value)?
(5) The amount of any remaining unrecognized net obligation or 
net asset existing at the date of initial application of SFAS 87 
(AC P16)?
(6) The amount of any additional liability recognized pursuant 
to SFAS 87, paragraph 36 (AC P16.130)?
(7) The amount of net pension asset or liability recognized in the 
statement of financial position pursuant to SFAS 87, para­
graphs 35 and 36 (AC P16.129 and .130), which is the net result 
of combining the preceding six items?
[SFAS 87, par. 54 (AC P16.150)]
e. The weighted-average assumed discount rate and rate of compen­
sation increase (if applicable) used to measure the projected bene­
fit obligation and the weighted-average expected long-term rate 
of return on plan assets?
[SFAS 87, par. 54 (AC P16.150)]
f. If applicable, the amounts and types of securities of the employer 
and related parties included in plan assets and the approximate 
amount of annual benefits of employees and retirees covered by 
annuity contracts issued by the employer and related parties? 
[SFAS 87, par. 54 (AC P16.150)]
g. If applicable, the alternative amortization method used pursuant 
to SFAS 87, paragraphs 26 and 33 (AC P16.120 and .127), and the 
existence and nature of the commitment discussed in SFAS 87, 
paragraph 41 (AC P16.135)?
[SFAS 87, par. 54 (AC P16.150)]
2. If more than one defined benefit plan exists:
a. Are the required disclosures in Step 1 above aggregated for all of 
the employer's single-employer defined benefit plans or disaggre­
gated in groups so as to provide the most useful information?
b. Are plans with assets in excess of accumulated benefit obligations 
not aggregated with plans that have accumulated benefit obliga­
tions that exceed plan assets?
c. Are disclosures for plans outside the U.S. not combined with those 
for U.S. plans unless those plans use similar economic assump­
tions?
[SFAS 87, par. 56 (AC P16.153)]
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3. If there is a defined contribution plan, do disclosures include:
a. A description of the plan(s), including employee groups covered, 
the basis for determining contributions, and the nature and effect 
of significant matters affecting comparability of information for all 
periods presented?
b. The amount of cost recognized during the period? 
[SFAS 87, par. 65 (AC P16.162)]
4. If the pension plan has characteristics of both a defined benefit plan 
and a defined contribution plan:
a. Is the substance of the plan to provide a defined benefit?
b. If yes, are disclosures required for a defined benefit plan made? 
[SFAS 87, par. 66 (AC P16.163)]
5. If there is a multiemployer plan, do disclosures include:
a. A description of the multiemployer plan(s), including the em­
ployee groups covered, the type of benefits provided (defined 
benefit or defined contribution), and the nature and effect of 
significant matters affecting comparability of information for all 
periods presented?
b. The amount of cost recognized during the period? 
[SFAS 87, par. 69 (AC P16.166)]
6. For a multiemployer plan where a situation arises where the with­
drawal from the plan may result in the employer having an obligation 
to the plan for a portion of its unfunded benefit obligations that is 
either probable or reasonably possible, are the provisions of SFAS 5, 
Accounting for Contingencies (AC C59), applied?
[SFAS 87, par. 70 (AC P16.167)]
7. If there is a settlement or curtailment of a defined benefit pension plan, 
or termination benefits under such plan, do disclosures include:
a. A description of the nature of the events?
b. The amount of gain or loss recognized? 
[SFAS 88, par. 17 (AC P16.187)]
8. If the company terminates a defined benefit plan and (1) contributes 
the assets withdrawn to a defined contribution plan, (2) the amount 
contributed is in excess of the employer's required annual contribu­
tion to the plan, and (3) the risk and rewards of the ownership of the 
assets are retained by the employer, are the following disclosures 
considered:
a. Is the excess contribution that is not allocated to individual par­
ticipants accounted for as an asset regardless of the source of the 
funds?
b. Is the unallocated amount treated as if it were part of the em­
ployer's investment portfolio and recorded as an asset?
(1) Is the income attributed to such securities including divi­
dends, interest and realized gains and losses reported in a 
manner consistent with the employer's reporting of similar 
items?
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c. Are the unallocated assets consisting of the employer's own stock 
recorded as treasury stock in the employer's financial statements?
d. Are the unallocated assets consisting of the employer's debt secu­
rities recorded as assets (rather than debt extinguishment) in the 
employer's financial statements?
[EITF 86-27]
9. If an employer sponsors an employee stock ownership plan (ESOP), 
do the employer's disclosures include:
a. A description of the plan, the basis for determining contributions, 
including the employee groups covered, and the nature and effect 
of significant matters affecting comparability of information for all 
periods presented?
(1) For leveraged ESOPs and pension reversion ESOPs, does the 
description include the basis for releasing shares and how 
dividends on allocated and unallocated shares are used?
b. A description of the accounting policies followed for ESOP trans­
actions, including the method of measuring compensation, the 
classification of dividends on ESOP shares, and the treatment of 
ESOP shares for EPS computations?
(1) If the entity has both old ESOP shares for which it does not 
adopt the guidance in SOP 93-6 and new ESOP shares for 
which the guidance in SOP 93-6 is required, are the account­
ing policies for both blocks of shares disclosed?
c. The amount of compensation cost recognized during the period?
d. The number of allocated shares, committed-to-be-released shares, 
and suspense shares held by the ESOP at the balance-sheet date?
(1) If the entity has both old ESOP shares for which it does not 
adopt the guidance in SOP 93-6 and new ESOP shares for 
which the guidance in SOP 93-6 is required, is the above 
disclosure made separately for both blocks of shares?
e. The fair value of unearned ESOP shares at the balance-sheet date 
for shares accounted for under SOP 93-6?7
f. The existence and nature of any repurchase obligation, including 
disclosure of the fair value of the shares allocated as of the balance- 
sheet date, which are subject to a repurchase obligation?8
7 This disclosure need not be made for old ESOP shares for which the entity does not apply the guidance in SOP 93-6.
8 Employers may wish to disclose additional information about the obligation, particularly information about the timing of 
payments. [SOP 93-6, par. 95]
[SOP 93-6, par. 53]
10. Are all the items listed in Step 8 above disclosed even if the employer 
with an ESOP does not adopt SOP 93-6 for shares held by the ESOP 
on December 31, 1992?
[SOP 93-6, par. 55]
11. For leveraged ESOPs and for nonleveraged ESOPs where the assets 
from the pension plan are used by the ESOP to purchase shares, when 
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□
the employer reports the issuance of shares or the sale of treasury 
shares to the ESOP, is the charge to unearned ESOP shares presented 
as a separate item in the balance sheet as a contra-asset account? 
[SOP 93-6, pars. 13 and 46]
12. If the employer sponsors an ESOP with an indirect loan, is the outside 
loan reported as a liability and the receivable from the ESOP not 
reported on the employer's balance sheet?
[SOP 93-6, par. 26]
13. If the employer sponsors an ESOP with an employer loan, is the 
ESOP's note payable and the employer's note receivable from the 
ESOP not reported in the employer's balance sheet?
[SOP 93-6, par. 27]
J. Postretirement Health Care and Life Insurance Benefits
1. If there are one or more defined benefit postretirement plans, do 
disclosures include:
a. A description of the substantive plan(s) that is the basis for the 
accounting, including the nature of the plan, any modifications 
of the existing cost-sharing provisions that are encompassed 
by the substantive plan(s), and the existence and nature of any 
commitment to increase monetary benefits provided by the 
postretirement benefit plan, employee groups covered, types of 
benefits provided, funding policy, types of assets held and sig­
nificant nonbenefit liabilities, and the nature and effect of signifi­
cant matters affecting the comparability of information for all 
periods presented, such as the effect of a business combination or 
divestiture?
b. The amount of net periodic postretirement benefit cost showing 
separately the service cost component, the interest cost compo­
nent, the actual return on plan assets for the period, amortization 
of the unrecognized transition obligation or transition asset, and 
the net total of other components?9
c. A schedule reconciling the funded status of the plan(s) with 
amounts reported in the employer's statement of financial posi­
tion, showing separately:
9 The net total of other components is the net effect during the period of certain delayed recognition provisions of SFAS 106 (AC P40). 
That net total includes:
a. The net asset gain or loss during the period deferred for later recognition (in effect, an offset or a supplement to the actual return 
on plan assets).
b. Amortization of unrecognized prior service cost.
c. Amortization of the net gain or loss from earlier periods. [SFAS 106, par. 62 (AC P40.157)]
d. Any gain or loss recognized due to a temporary deviation from the substantive plan. [SFAS 106, par. 61 (AC P40.156)]
(1) The fair value of plan assets?
(2) The accumulated postretirement benefit obligation, identify­
ing separately the portion attributable to retirees, other fully 
eligible plan participants, and other active plan participants?
(3) The amount of unrecognized prior-service cost?
(4) The amount of unrecognized net gain or loss (including plan 
asset gains and losses not yet reflected in market-related 
value)?
53
Yes No N/A
(5) The amount of any remaining unrecognized transition obli­
gation or transition asset?
(6) The amount of net postretirement benefit asset or liability 
recognized in the statement of financial position, which is the 
net result of combining the preceding five items?
d. The assumed health care cost trend rate(s) used to measure the 
expected cost of benefits covered by the plan (gross eligible 
changes) for the next year and a general description of the direc­
tion and pattern of change in the assumed trend rate(s) thereaf­
ter, together with the ultimate trend rate(s), and when the 
rate(s) is expected to be achieved?
e. The weighted average of the assumed discount rate(s) and rate(s) 
of compensation increase (for pay-related plans) used to measure 
the accumulated postretirement benefit obligation and the 
weighted average of the expected long-term rate(s) of return on 
plan assets and, for plans whose income is segregated from the 
employer's investment income for tax purposes, the estimated 
income tax rate(s) included in that rate of return?
f. The effect of a one-percentage-point increase in the assumed 
health care cost trend rates for each future year on:
(1) The aggregate of the service and interest cost components of 
net periodic postretirement health care benefit cost?
(2) The accumulated postretirement benefit obligation for health 
care benefits (for purposes of this disclosure, all other as­
sumptions should be held constant and the effects should be 
measured based on the substantive plan that is the basis for 
the accounting)?
g. The amounts and types of securities of the employer and related 
parties included in plan assets, and the approximate amount of 
future annual benefits of plan participants covered by insurance 
contracts issued by the employer and related parties?
h. Any alternative amortization method used pursuant to paragraph 
53 or 60 of SFAS 106, Employers' Accounting for Postretirement 
Benefits Other Than Pensions (AC P40.148 or .155)?
i. The amount of gain or loss recognized during the period for a 
settlement or curtailment and a description of the nature of the 
event(s)?
j. The cost of providing special or contractual termination benefits 
recognized during the period and a description of the nature of 
the event(s)?
[SFAS 106, par. 74a-j (AC P40.169a-j)]
2. If more than one defined benefit postretirement plan exists:
a. Are the disclosures required by Step 1 above aggregated for all of 
an employer's single-employer defined benefit postretirement 
plans or disaggregated in groups so as to provide the most useful 
information (except for purposes of the disclosures required by 
Step 1.c. above, the aggregate plan assets and the aggregate accu­
mulated postretirement benefit obligation of the underfunded 
plans should be separately disclosed)?
[SFAS 106, par. 77 (AC P40.172)]
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□
b. Are plans that primarily provide postretirement health care bene­
fits and plans that primarily provide other postretirement welfare 
benefits separately disclosed if the accumulated postretirement 
benefit obligation of the latter plans is significant relative to the 
aggregate accumulated postretirement benefit obligation for all of 
the plans?
[SFAS 106, par. 78a (AC P40.173a)]
c. Are plans inside the U.S. and plans outside the U.S. separately 
disclosed if the accumulated postretirement benefit obligation of 
the latter plans is significant relative to the aggregate accumulated 
postretirement benefit obligation for all of the plans?
[SFAS 106, par. 78b (AC P40.173b)]
3. If there is a multiemployer plan, do disclosures include:
a. A description of the multiemployer plan(s), including the em­
ployee groups covered, the type of benefits provided (defined 
benefits or defined contribution), and the nature and effect of 
significant matters affecting comparability of information for all 
periods presented?
b. The amount of postretirement benefit cost recognized during the 
period, if available (otherwise, the amount of the aggregate re­
quired contribution for the period to the general health and wel­
fare benefit plan that provides health and welfare benefits to both 
active employees and retirees)?
[SFAS 106, par. 82 (AC P40.178)]
c. Are the provisions of SFAS 5 (AC C59) applied if the situation 
arises where withdrawal from a multiemployer plan may result 
in an employer's having an obligation to the plan for a portion of 
the plan's unfunded accumulated postretirement benefit obliga­
tion, and it is either probable or reasonably possible that:
(1) An employer would withdraw from the plan under circum­
stances that would give rise to an obligation?
or
(2) An employer's contribution to the fund would be increased 
during the remainder of the contract period to make up a 
shortfall in the funds necessary to maintain the negotiated 
level of benefit coverage?
[SFAS 106, par. 83 (AC P40.179)]
4. If there are one or more defined contribution postretirement plans, 
are the following items disclosed separately from defined benefit 
postretirement plan disclosures:
a. A description of the plan(s), including employee groups covered, 
the basis for determining contributions, and the nature and effect 
of significant matters affecting comparability of information for 
all periods presented?
b. The amount of cost recognized during the period? 
[SFAS 106, par. 106 (AC P40.198)]
K. Consolidations
1. If consolidated statements are presented:
a. Is the consolidation policy disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par. 13 (AC A10.106)]
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Yes No
b. Are material intercompany balances and transactions eliminated? ____ ___
[ARB 51, par. 6 (AC C51.109)]
c. If the financial reporting periods of subsidiaries differ from that of
the parent, is recognition given to the effect of intervening events 
that materially affect financial position or the results of opera­
tions? ____ ___
[ARB 51, par. 4 (AC C51.107); FASBI 13, pars. 5 and 6 (AC I89.120-
.122)]
2. Are the accounts of majority-owned subsidiaries consolidated (sub­
ject to the exceptions described in SFAS 94, paragraph 13 (AC
C51.102))? ____ ___
[SFAS 94, par. 13 (AC C51.103)]
3. Are the separate financial statements of all consolidated and uncon­
solidated subsidiaries presented in conformity with GAAP? ____ ___
[AAG, par. 8.107]
4. Are combined financial statements considered for entities under com­
mon control? ____ ___
[ARB 51, pars. 22 and 23 (AC C51.121 and .122)]
L. Financial Instruments
1. For financial instruments with off-balance-sheet risk (except for those 
excluded by SFAS 105, paragraphs 14 and 15), are the following 
disclosed either in the body of the financial statements or in the notes 
by category of financial instrument:
a. The face or contract amount (or notional principal amount if there
is no face or contract amount)? ____ ___
b. The nature and terms, including, at a minimum, a discussion of:
(1) The credit and market risk of those instruments? ____ ___
(2) The cash requirements of those instruments? ____ ___
(3) The related accounting policy pursuant to the requirements
of APB 22, Disclosure of Accounting Policies (AC A10)? ____ ___
[SFAS 105, par. 17, as amended by SFAS 119, par. 14 (AC 
F25.112)]
2. Do the disclosures in Steps 1.a. and 1.b. distinguish between financial 
instruments with off-balance-sheet risk held or issued for trading 
purposes, including dealing and other trading activities measured at 
fair value with gains and losses recognized in earnings, and financial 
instruments with off-balance-sheet risk held or issued for purposes
other than trading? ____ ___
[SFAS 105, par. 17, as amended by SFAS 119, par. 14 (AC F25.112)]
3. For financial instruments with off-balance-sheet risk (except for those 
excluded in SFAS 105), are the following disclosed, either in the body 
of the financial statements or in the notes, by category of financial 
statement:
a. The amount of accounting loss the company would incur if any 
party to the financial instrument failed completely to perform 
according to the terms of the contract and if the collateral or other 
security, if any, for the amount due proved to be of no value to the 
company? ____ ___
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b. The company's policy of requiring collateral or other security to 
support financial instruments subject to credit risk, information 
about the company's access to that collateral or other security, and 
the nature and a brief description of the collateral or other security 
supporting those financial instruments? ____ ____ ____
[SFAS 105, par. 18, as amended by SFAS 119, par. 14 (AC F25.113)]
4. Do disclosures of all significant concentrations of credit risk arising 
from all financial instruments, whether from individual counterparty 
or groups of counterparties (except for certain insurance and invest­
ment contracts, purchase and pension obligations), include:
a. Information about the (shared) activity, region, or economic char­
acteristic that identifies the concentration? ____ ____ ____
b. The amount of the accounting loss due to credit risk the company 
would incur if parties to the financial instruments that make up 
the concentration failed completely to perform according to the 
terms of the contracts and if the collateral or other security, if any,
for the amount due proved to be of no value to the company? ____ ____ ____
c. The company's policy of requiring collateral or other security to 
support financial instruments subject to credit risk, information 
about the company's access to that collateral or other security, and 
the nature and a brief description of the collateral or other security
supporting those financial instruments? ____ ____ ____
[SFAS 105, par. 20 (AC F25.115)]
Note: SFAS 126, Exemption from Certain Required Disclosures about Financial 
Instruments for Certain Nonpublic Entities, amends SFAS 107, Disclosures 
about Fair Value of Financial Instruments, to make the disclosures prescribed 
in SFAS 107 optional for entities that meet all of the following criteria:
a. The entity is nonpublic.
b. The entity's total assets are less than $100 million on the date of the 
financial statements.
c. The entity has not held or issued any derivative financial instruments, 
as defined in SFAS 119, Disclosure about Derivative Financial Instru­
ments and Fair Value of Financial Instruments, other than loan commit­
ments, during the reporting period.
5. Is the fair value of financial instruments for which it is practicable to 
estimate that value (except for those excluded in paragraphs 8 and 13 
of SFAS 107) disclosed, together with the related carrying amount in 
a form that makes it clear whether the fair value and carrying amount 
represent assets or liabilities and how the carrying amounts relate to 
what is reported in the statement of financial condition?10
10 If disclosed in more than a single note, one of the notes should include a summary table containing the fair value and related 
carrying amounts and cross-references to the location(s) of the remaining disclosures required by SFAS 107, as amended.
[SFAS 107, par. 10, as amended by SFAS 119, par. 15 (AC F25.115C)]
6. Do the disclosures in Step 5 distinguish between financial instruments 
held or issued for trading purposes, including dealing and other 
trading activities measured at fair value with gains and losses recog­
nized in earnings, and financial instruments held or issued for pur­
poses other than trading?
[SFAS 107, par. 10, as amended by SFAS 119, par. 15 (AC F25.115C)]
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□
7. Are the method(s) and significant assumptions used to estimate the 
fair value of financial instruments disclosed?
[SFAS 107, par. 10 (AC F25.115C)]
8. If it is not practicable to estimate the fair market value of financial 
instruments, are the following disclosed:
a. Information pertinent to estimating the fair value of that financial 
instrument or class of financial instruments, such as the carrying 
amount, effective interest rate, and maturity?
b. The reasons why it is not practicable to estimate fair value? 
[SFAS 107, par. 14 (AC F25.115G)]
9. If the offsetting of derivative financial instruments against nonderi­
vative financial instruments is not permitted under FASB Interpreta­
tion 39, Offsetting of Amounts Related to Certain Contracts, does the 
company, in disclosing the fair value of a derivative financial instru­
ment, not:
a. Combine, aggregate, or net the fair value with the fair value of the 
fair value of a nonderivative financial instrument?
b. Net the fair value with the fair value of other derivative financial 
instruments?
[SFAS 107, par. 13, as amended by SFAS 119, par. 15 (AC F25.115J)]
10. For all fiscal years subsequent to the year of transition, are SFAS 107 
disclosures included for each year for which a balance sheet is pre­
sented for comparative purposes?
[SFAS 107, par. 17]
M. Foreign Currency
1. Is the aggregate transaction gain or loss included in net income for the 
period disclosed?
[SFAS 52, par. 30 (AC F60.140)]
2. Does the analysis of changes during the period in the separate com­
ponent of equity for cumulative translation adjustments disclose:
a. Beginning and ending amounts of cumulative translation adjust­
ments?
b. The aggregate adjustment for the period resulting from translation 
adjustments and gains and losses from certain hedges and inter­
company balances?
c. The amount of income taxes for the period allocated to translation 
adjustments?
d. The amounts transferred from cumulative translation adjustments 
and included in the determination of net income for the period as 
a result of the sale or complete or substantially complete liquida­
tion of an investment in a foreign entity?
[SFAS 52, par. 31 (AC F60.141)]
3. Are rate changes occurring after the date of the financial statements 
and the effects on unsettled balances related to foreign currency 
translations disclosed, if significant?
[SFAS 52, par. 32 (AC F60.142)]
4. Are any foreign earnings reported in addition to amounts received in 
the U.S. disclosed, if significant?
[ARB 43, Ch. 12, par. 5 (AC F65.102)]
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5. Are the following disclosures made for hedging foreign currency risks 
with complex options and similar transactions:
a. The method of accounting for currency options, option combina­
tions, and similar instruments including a description of the 
events or transactions that result in recognition in income of
changes in value? ____ ____ ____
b. The nature of the anticipated transactions, for which there is no 
firm commitment, that are hedged with currency options, option
combinations, or similar instruments? ____ ____ ____
c. The maximum number of years over which anticipated, but not
firmly committed, foreign currency transactions are hedged? ____ ____ ____
d. The combined realized and unrealized net gain or loss deferred as 
of each balance-sheet date on currency options, option combina­
tions, or similar instruments that are designated as hedges of
anticipated transactions for which there is no firm commitment? ____ ____ ____
[EITF 91-4]
6. If the company entered into a foreign currency swap contract to 
replace foreign currency debt with reporting currency debt, is the 
contract accounted for separately and not netted against the foreign 
currency debt (they are two separate legal transactions and do not
have the right of setoff except as expanded below)? ____ ____  ____
[FASBI 39, par. 5 (AC B10.101)]
Practice Tip
A right of setoff exists only when all of the following conditions are met:
• Each of two parties owes the other determinable amounts.
• The reporting party has the right to set off the amount owed with the amount owed by the other party.
• The reporting party intends to set off.
• The right of setoff is enforceable by law.
7. Are foreign currency translation disclosures encouraged (but not 
required) to be supplemented with an analysis and discussion of the 
effects of rate changes on reported results of operations? ____ ____ ____
[SFAS 52, par. 144 (AC F60.143)]
N. Futures Contracts □
1. If a futures contract is accounted for as a hedge, does the disclosure 
include:
a. The nature of the assets, liabilities, firm commitments, or antici­
pated transactions that are hedged with futures contracts? ____ ____ ____
b. The method of accounting for the futures contract, including a 
description of the events or transactions that result in recognition
in income of changes in value of the futures contracts? ____ ____ ___
[SFAS 80, par. 12 (AC F80.112]
O. Derivatives □
1. For options held and other derivative financial instruments not within 
the scope of SFAS 105 that do not have off-balance-sheet risk, are the 
following disclosures made by category of financial instrument:
a. The face or contract amount (or notional principal amount if there 
is no face or contract amount)? ____ ____ ___
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b. The nature and terms, including a discussion of:
(1) Credit and market risk?
(2) Cash requirements?
(3) Related accounting policy as required by APB 22?
c. Do disclosures in Steps a. and b. above distinguish between finan­
cial instruments held or issued for:
(1) Trading purposes, including dealing and other trading activi­
ties measured at fair value with gains and losses recognized 
in earnings?
(2) Purposes other than trading?
[SFAS 119, pars. 8 and 9 (AC F25.115L and .115M)]
2. If the company holds or issues derivative financial instruments for 
trading purposes, are the following disclosed:
a. The average fair value during the reporting period and the 
related end-of-period fair value, distinguishing between assets 
and liabilities?
b. The net gains or losses (net trading revenue) arising from trading 
activities during the reporting period disaggregated by class, busi­
ness activity, risk or other category consistent with management 
of those activities and where those net trading gains or losses are 
reported in the income statement?
(1) If the disaggregation is other than by class, did the company 
also disclose for each category the classes of derivative finan­
cial instruments, other financial instruments, and nonfinan­
cial assets and liabilities from which the net trading gains and 
losses arose?
c. The average fair value for assets and liabilities from the trading of 
other types of financial instruments or nonfinancial assets? (This 
disclosure is encouraged but not required.)
[SFAS 119, par. 10 (AC F25.115N)]
3. Does a company that holds or issues derivative financial instruments 
for purposes other than trading disclose:
a. A description of:
(1) The objectives for holding or issuing?
(2) The context needed to understand those objectives?
(3) The strategies for achieving those objectives?
(4) The classes of derivative financial instruments used?
b. A description of how each class of derivative financial instrument 
is reported in the financial statements, including:
(1) The policies for recognition and measurement or nonrecog­
nition of the derivative financial instruments?
(2) When recognized, where the instruments and related gains 
and losses are reported?
c. For derivative financial instruments that are held or issued and 
accounted for as hedges of anticipated transactions, both firm and 
forecasted transactions for which there is no firm commitment, 
including:
(1) A description of the anticipated transactions whose risks are 
hedged, including the expected time period of occurrence?
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(2) A description of the classes of derivative financial instru­
ments used to hedge? ____
(3) The amount of explicitly deferred hedging gains and losses? ____
(4) A description of the transaction or events that result in recog­
nition in earnings of the deferred gains or losses? ____
[SFAS 119, par. 11 (AC F25.115O)]
4. Are the following encouraged, but not required, quantitative disclo­
sures made:
a. Interest rate? ____
b. Foreign exchange? ____
c. Commodity price? ____
d. Other market risks consistent with management's strategies? ____
e. Information of the risk of other financial instruments or nonfinan-
cial assets and liabilities related by risk management strategy 
pertaining to the objectives for holding or issuing derivative finan­
cial instruments?11 ____
11 Suggested methods of disclosure of the above include:
a. Additional details about current positions and period activity.
b. Hypothetical effects on equity or on annual income due to several possible changes in market prices.
c. Gap analysis of interest rate repricing or maturity dates.
d. Duration of financial instruments.
e. The entity's value at risk from derivative financial instruments and other positions at period end and the average value at risk 
during the year.
f. Any other informative disclosures.
[SFAS 119, pars. 12 and 13 (AC F25.115P and .115Q)]
P. Transfers and Servicing of Financial Assets
Note: In December 1996, the FASB issued SFAS 127, Deferral of the Effective 
Date of Certain Provisions of FASB Statement No. 125. As issued, SFAS 125 
was effective for all transfers and servicing of financial assets and extin­
guishments of liabilities occurring after December 31, 1996. SFAS 127 
defers for one year the effective date (a) of paragraph 15 of SFAS 125 and 
(b) for repurchase agreement, dollar-roll, securities lending, and similar 
transactions, of paragraph 9-12 and 237 (b) of SFAS 125.
1. Is the policy for requiring collateral or other security disclosed if the 
entity has entered into repurchase agreements or securities lending 
transactions?
[SFAS 125, par. 17a]
2. If it is not practicable to estimate the fair value of certain assets 
obtained or liabilities incurred in transfers of financial assets during 
the period, are those items and the reasons why it is not practicable to 
estimate fair value described in the notes to the financial statements? 
[SFAS 125, par. 17d]
3. For all servicing assets and servicing liabilities are the following 
disclosures made:
a. The amounts of servicing assets or liabilities recognized and am­
ortized during the period?
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b. The fair value of recognized servicing assets and liabilities for 
which it is practicable to estimate that value and the method and 
significant assumptions used to estimate the fair value?
c. The risk characteristics of the underlying financial assets used to 
stratify recognized servicing assets for purposes of measuring 
impairment in accordance with paragraph 37 of SFAS 125?
d. The activity in any valuation allowance for impairment of recog­
nized servicing assets—including beginning and ending balances, 
aggregate additions charged and reductions credited to opera­
tions, and aggregate direct write-downs charged against the al­
lowances—for each period for which results of operations are 
presented?
[SFAS 125, par. 17e]
Q. Nonmonetary Transactions
1. Do disclosures for nonmonetary transactions during the period in­
clude:
a. Nature of the transactions?
b. Basis of accounting for the assets transferred?
c. Gains or losses recognized on the transfers?
[APB 29, par. 28 (AC C11.102 and N35.120); FASBI 30 (AC 
N35.114-.119)]
R. Subsequent Events
1. Are the financial statements adjusted for any changes in estimates 
resulting from subsequent events that provide additional evidence 
about conditions that existed at the balance-sheet date?
[SFAS 5, par. 8 (AC C59.105); SAS 1, secs. 560.03, .04, .07, and 561.01- 
.09 (AU 560.03, .04, .07 and 561.01-.09)]
2. Are subsequent events that provide evidence about conditions that 
did not exist at the balance-sheet date, but arose subsequent to that 
date, adequately disclosed to keep the financial statements from being 
misleading?
[SFAS 5, par. 11 (AC C59.U2); APB 16, par. 61 (AC B50.120); SAS 1, secs. 
560.05-.07, .09, and 561.01-.09 (AU 560.05-.07, .09, and 561.01-.09)]
[Consider the appropriateness of dual-dating the auditor's report if a 
subsequent event is disclosed in the financial statements. (AU 530.05)]
S. Costs to Exit an Activity
1. If a material liability is recognized for certain employee termination 
benefits in accordance with Section A of EITF Issue 94-3, Liability 
Recognition for Certain Employee Termination Benefits and Other Costs to 
Exit an Activity (including Certain Costs Incurred in a Restructuring), are 
the following disclosures made in all periods until the plan of termi­
nation is completed:
a. The amount of termination benefits accrued and charged to ex­
pense and the classification of those costs in the income statement?
□
□
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□
b. The number of employees to be terminated?
c. A description of the employee group(s) to be terminated?
d. The amount of actual termination benefits paid and charged 
against the liability and the number of employees actually termi­
nated as a result of the plan to terminate employees?
e. The amount of any adjustment(s) to the liability? 
[EITF 94-3, Section A]
2. If management commits to an exit plan that meets the criteria in 
Section B of EITF Issue 94-3, are the following reporting requirements 
followed:
a. Reporting the statement of income effect of recognizing a liability 
at the commitment date in income from continuing operations and 
not on the face of the statement of income net of taxes?
b. No disclosure made on the face of the statement of income for 
earnings per share effect?
c. Revenue and related costs and expenses of activities that will not 
be continued should not be combined and reported as a separate 
component of income?
[EITF 94-3, Section B]
3. If the activities that will not be continued are significant to the com­
pany's revenue or operating results, or if the exit costs recognized at 
the commitment date are material, are the following disclosures made 
in all periods until the exit plan is completed:
a. A description of the major actions comprising the exit plan, activi­
ties that will not be continued, including the method of disposi­
tion, and the anticipated date of completion?
b. A description of the type and amount of exit costs recognized as 
liabilities and the classification of those costs in the income state­
ment?
c. A description of the type and amount of exit costs paid and 
charged against the liability?
d. The amount of any adjustment(s) to the liability?
e. For all periods presented, the revenue and net operating income 
or losses from activities that will not be continued if those activities 
have separately identifiable operations?
[EITF 94-3, Section B]
T. Business Combinations
Pooling of Interests Method
1. If a business combination occurred during the period and met the 
specified conditions for a pooling-of-interests, are the following dis­
closed:
a. The fact that a combination accounted for by the pooling-of-inter­
ests method has occurred during the period disclosed?
[APB 16, pars. 63 and 64b (AC B50.122 and .123b)]
b. The name and a brief description of the enterprises combined? 
[APB 16, par. 64a (AC B50.123a)]
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c. A description and the number of shares of stock issued in the
combination? ____ ____  ____
[APB 16, par. 64c (AC B50.123c)]
d. Details (including revenue, extraordinary items, net income, other 
changes in shareholders' equity, and amount of and manner of 
accounting for intercompany transactions) of the results of opera­
tions of the previously separate enterprises for the period before 
the combination is consummated that are included in the current
combined net income? ____ ____ ____
[APB 16, par. 64d (AC B50.123d)]
e. Descriptions of the nature of adjustments of net assets of the
combining enterprises to adopt the same accounting practices and 
the effects of the changes on net income previously reported 
separately and now presented in comparative financial state­
ments? ____ ____ ____
[APB 16, par. 64e (AC B50.123e)]
f. Details (including at least revenue, expenses, extraordinary items, 
net income, and other changes in shareholders' equity for the 
period excluded from the reported results of operations) of in­
creases or decreases in retained earnings from changing the fiscal
year of a combining enterprise? ____ ____  ____
[APB 16, par. 64f (AC B50.123f)]
g. Reconciliations of amounts of revenue and earnings previously 
reporting by the enterprise that issued the stock to effect the 
combination with the combined amounts currently presented in 
financial statements and summaries? (Or if a new enterprise was 
formed to effect the combination, the earnings of the separate 
enterprises that comprise combined earnings for prior periods
may be disclosed.) ____ ____ ____
[APB 16, par. 64g (AC B50.123g)]
2. If a business combination that was either incomplete as of the date of 
the financial statements or initiated after that date is consummated 
before the financial statements are issued, are details (including reve­
nue, net income, earnings per share, and the effects of anticipated 
changes in accounting methods as if the combination had been con­
summated at the date of the financial statements) of the effects of the 
combination disclosed? ____ ____ ____
[APB 16, par. 65 (AC B50.124)]
Practice Tip
Information relating to several relatively minor acquisitions may be combined for disclosure.
Purchase Method
3. If a business combination occurred during the period and is to be 
accounted for under the purchase method, are the following dis­
closed:
a. The name and a brief description of the acquired enterprise? 
[APB 16, par. 95a (AC B50.164a)]
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b. The method of accounting for the combination—that is, the pur­
chase method?
[APB 16, par. 95b (AC B50.164b)]
c. The period for which results of operations of the acquired enter­
prise are included in the income statement of the acquiring enter­
prise?
[APB 16, par. 95c (AC B50.164c)]
d. The cost of the acquired enterprise and, if applicable, the number 
of shares of stock issued or issuable and the amount assigned to 
the shares?
[APB 16, par. 95d (AC B50.164d)]
e. A description of the plan for amortization of acquired goodwill, 
the amortization method, and period?
[APB 16, par. 95e (AC B50.164e)]
f. Contingent payments, options, or commitments specified in the 
acquisition agreement and their proposed accounting treatment 
(including consideration that is issued or issuable at the end of a 
contingency period or that is held in escrow)?
[APB 16, pars. 78 and 95f (AC B50.136 and .164f)]
g. For public companies only, the following as supplemental infor­
mation (including at least revenue, income before extraordinary 
items, net income, and earnings per share) on a pro forma basis:
(1) Results of operations for the current period as though the 
enterprises had combined at the beginning of the period, 
unless the acquisition was at or near the beginning of the 
period?
[APB 16, par. 96a (AC B50.165a); SFAS 79, par. 6 (AC B50.165)]
(2) Results of operations for the immediately preceding period 
as though the enterprises had combined at the beginning of 
that period if comparative statements are presented?
[APB 16, par. 96b (AC B50.165b); SFAS 79, par. 6 (AC 
B50.165)]
4. If the reporting entity elects not to include a preacquisition contin­
gency (other than the effects of tax loss carryforwards) in the purchase 
price allocation or, for those that arise after the end of the allocation 
period, are not included in net income of the period in which the 
adjustment is determined as described in SFAS 38, is there disclosure 
of the amount and nature of adjustments, including the effect of the 
adjustments on current or expected future cash flows?
[SFAS 38, par. 10 (AC B50.166)]
5. If, as part of a business combination accounted for as a purchase, a 
material liability is recognized by the combined company for costs 
incurred to (a) exit an activity, (b) involuntarily terminate employees 
of an acquired company, or (c) relocate employees of an acquired 
company:
a. Are the following disclosures made for the period in which a 
purchase business combination occurs:
(1) If the plans to exit an activity or involuntarily terminate 
(relocate) employees of the acquired company are not final as 
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of the balance sheet date, a description of any unresolved 
issues, the types of additional liabilities that may result in an 
adjustment to the purchase price allocation, and how any 
adjustment will be reported?
(2) A description of the type and amount of liabilities assumed 
in the purchase price allocation for costs to exit an activity or 
involuntary terminate (relocate) employees?
(3) A description of the major actions comprising the plan to exit 
an activity or involuntarily terminate (relocate) employees of 
an acquired company?
(4) A description of activities of the acquired company that will 
not be continued, including the method of disposition, and 
the anticipated date of completion and description of em­
ployee group(s) to be terminated (relocated)?
b. Are the following disclosures made for all periods presented 
subsequent to the acquisition date in which a purchase business 
combination occurred, until a plan to exit an activity or involun­
tarily terminate or relocate employees of an acquired company is 
fully executed:
(1) A description of the type and amount of exit costs, involun­
tary employee termination costs, and relocation costs paid 
and charged against the liability?
(2) The amount of any adjustment to the liability account and 
whether the corresponding entry was an adjustment of the 
costs of the acquired company or included in the determina­
tion of net income for the period?
[EITF 95-3]
U. Segment Information
Note: SFAS 131, Disclosures about Segments of an Enterprise and Related 
Information, is effective for fiscal years beginning after December 15, 1997, 
with earlier application encouraged. Public business enterprises are re­
quired to provide the disclosures described in SFAS 131 and nonpublic 
business enterprises are encouraged to do so.
1. Are the factors used to identify the reporting entity's reportable 
segments, including the basis of organization (for example, whether 
management has chosen to organize the reporting entity around 
differences in products and services, geographic areas, regulatory 
environments, or a combination of factors and whether operating 
segments have been aggregated) disclosed?
[SFAS 131, par. 26 (AC F30.125)]
2. Are the types of products and services from which each reportable 
segment derives its revenues disclosed?
[SFAS 131, par. 26 (AC F30.125)]
3. Is a measure of profit or loss reported for each reportable segment? 
[SFAS 131, par. 27 (AC F30.126)]
4. If the following amounts are included in the measure of segment 
profit or loss reviewed by the chief operating decision maker, are they 
disclosed for each reportable segment:
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a. Revenues from external customers?
b. Revenues from transactions with other operating segments of the 
reporting entity?
c. Interest revenue?
d. Interest expense?
e. Depreciation, depletion, and amortization expense?
f. Unusual items as described in paragraph 26 of APB 30?
g. Equity in the net income of investees accounted for by the equity 
method?
h. Income tax expense or benefit?
i. Extraordinary items?
j. Significant noncash items other than depreciation, depletion, and 
amortization expense?
[SFAS 131, par. 27 (AC F30.126)]
5. If the following amounts are included in the determination of segment 
assets reviewed by the chief operating decision maker, are they dis­
closed for each reportable segment?
a. The amount of investment in equity method investees?
b. Total expenditures for additions to long-lived assets other than 
financial instruments and deferred tax assets?
[SFAS 131, par. 28 (AC F30.127)]
6. Is an explanation of the measurements of segment profit or loss and 
segment assets that discloses the following for each reportable seg­
ment provided:
a. The basis of accounting for any transactions between reportable 
segments?
b. The nature of any differences between the reporting entity's con­
solidated income before taxes, extraordinary items, discontinued 
operations, and the cumulative effect of changes in accounting 
principle?
c. The nature of any differences between the measurements of the 
reportable segments' assets and the reporting entity's consoli­
dated assets?
d. The nature of any changes from prior periods in the measurement 
methods used to determine reported segment profit or loss and 
the effect, if any, of those changes on the measure of segment profit 
or loss?
e. The nature and effect of any asymmetrical allocations to seg­
ments?
[SFAS 131, par. 31 (AC F30.130)]
7. Are reconciliations of the totals of the reportable segments' revenues, 
measures of profit or loss, assets, and every other significant item of 
information disclosed to corresponding consolidated amounts pre­
sented with all significant reconciling items separately identified and 
described?
[SFAS 131, par. 32 (AC F30.131)]
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8. If the reporting entity changes the structure of its internal organization 
in a manner that changes the composition of its reportable segments, 
is the corresponding information for prior periods restated and is the 
fact that the corresponding items of segment information for earlier 
periods have been restated disclosed?
[SFAS 131, par. 34 (AC F30.133)]
9. If the reporting entity changes the structure of its internal organization 
in a manner that changes the composition of its reportable segments 
and the corresponding information for prior periods is not restated, 
does disclosure in the year in which the change occurs include seg­
ment information for the current period under both the old basis and 
the new basis?
[SFAS 131, par. 35 (AC F30.134)]
10. For all reporting entities subject to SFAS 131, including those that have 
a single reportable segment, are the following enterprise-wide items 
disclosed:
a. Revenues from external customers for each product and service or 
each group of similar products and services unless it is impracti­
cable to do so?
[SFAS 131, par. 37 (AC F30.136)]
b. The following geographic information unless it is impracticable to 
do so:
(1) Revenues from external customers (a) attributed to the re­
porting entity's country of domicile and (b) attributed to all 
foreign countries in total from which the reporting entity 
derives revenue?
(2) Revenues from external customers attributed to an individ­
ual foreign country, if material?
(3) The basis for attributing revenues from external customers to 
individual countries?
(4) Long-lived assets other than financial instruments and de­
ferred tax assets (a) located in the reporting entity's country 
of domicile and (b) located in all foreign countries in total in 
which the reporting entity holds assets?
(5) Long-lived assets as described above in an individual foreign 
country, if material?
[SFAS 131, par. 38 (AC F30.137)]
c. Information about the extent of the reporting entity's reliance on 
its major customers, including the following:
(1) If revenues from transactions with any single customer 
amount to 10 percent or more of the reporting entity's reve­
nues, that fact, the total amount of revenues from each such 
customer, and the identity of the segment or segments report­
ing the revenue?
[SFAS 131, par. 39 (AC F30.138)]
11. If the information described in Step 10.a. and b. above has not been 
disclosed because it is impracticable, is that fact disclosed?
[SFAS 131, pars. 37 and 38 (AC F30.136 and .137)]
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V. Stock Compensation Plans
1. If the reporting entity continues to apply APB 25 in accounting for its 
stock-based compensation arrangements, is the pro forma net income 
and, if earnings per share are presented, pro forma earnings per share 
determined as if the fair-value based method (described in SFAS 123) 
had been applied in measuring compensation cost, disclosed for each 
year for which an income statement is presented?
[SFAS 123, par. 45 (AC C36.144)]
2. Is a description of the plan(s), including the general terms of awards 
under the plan(s) disclosed?
[SFAS 123, par. 46 (AC C36.145)]
3. Are the following disclosed for each year for which an income state­
ment is presented:
a. The number and weighted-average exercise prices of options for 
each of the following groups of options:
(1) Those outstanding at the beginning of the year?
(2) Those outstanding at the end of the year?
(3) Those exercisable at the end of the year?
(4) Those granted during the year?
(5) Those exercised during the year?
(6) Those forfeited during the year?
(7) Those expired during the year?
b. The weighted-average grant-date fair value of options granted 
during the year?
(Note: That if the exercise prices of some options differ from the 
market price of the stock on the grant date, weighted-average fair 
values of options shall be disclosed separately for options whose 
exercise price (1) equals, (2) exceeds, or (3) is less than the market 
price of the stock on the grant date.)
c. The number and weighted-average grant date-fair value of equity 
instruments other than options granted during the year?
d. A description of the method and significant assumptions used 
during the year to estimate the fair values of options, including the 
following weighted-average information: (1) risk-free interest 
rate, (2) expected life, (3) expected volatility, and (4) expected 
dividends?
e. Total compensation cost recognized in income for stock-based 
employee compensation awards?
f. The terms of significant modifications of outstanding awards? 
[SFAS 123, par. 47a-f (AC C36.146)]
4. If the reporting entity grants options under multiple stock-based 
employee compensation plans, are the items in Step 3 above disclosed 
separately for different types of awards to the extent that the differ­
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ences in the characteristics of the awards make separate disclosure 
important to an understanding of the reporting entity's use of stock­
based compensation?
[SFAS 123, par. 47 (AC C36.146)]
5. For options outstanding at the date of the latest balance sheet pre­
sented, are the following disclosed:
a. The range of exercise prices?
b. The weighted-average exercise price?
c. The weighted-average remaining contractual life? 
[SFAS 123, par. 48 (AC C36.147)]
6. If the range of exercise prices is wide (the highest exercise price 
exceeds approximately 150 percent of the lowest exercise price), are 
the exercise prices segregated into ranges that are meaningful for 
assessing the number and timing of additional shares that may be 
issued and the cash that may be received as a result of option exercises 
and are the following disclosed for each range:
a. The number, weighted-average exercise price, and weighted-av­
erage remaining contractual life of options outstanding?
b. The number and weighted-average exercise price of options cur­
rently exercisable?
[SFAS 123, par. 48 (AC C36.147)]
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FSP Section 20,400
Auditors’ Reports Checklist
.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of 
the AICPA as a nonauthoritative practice aid.
.02 Explanation of References:
SAS = AICPA Statement on Auditing Standards
SOP = AICPA Statement of Position
AU = Reference to section number in AICPA Professional Standards (vol. 1)
SSARS = AICPA Statement on Standards for Accounting and Review Services
AR = Reference to section number in AICPA Professional Standards (vol. 2)
App. M = Appendix M of AAG containing SOP 94-1, Inquiries of State Insurance Regulators
.03 Checklist Questionnaire:1
Yes No N/A
1. Does the auditor's report include appropriate:
a. Addressee? ____ ____ ____
[SAS 58, par. 9 (AU 508.09)]
b. Date (or dual dates) of the report? ____ ____ ____
[SAS 1, sec. 530.05 (AU 530.05)]
c. A title that includes the word "independent"? ____ ____ ____
[SAS 58, par. 8a (AU 508.08a)]
2. If the accountant is not independent, is a compilation report the
highest level of service performed? ____ ____ ____
[SAS 26, par. 10 (AU 504.10); SSARS 1, pars. 22 and 38 (AR 100.22 and .38)]
3. Does the reporting language conform with the auditor's standard 
report on:
a. Financial statements of a single year or period? ____ ____ ____
b. Comparative financial statements? ____ ____ ____
[SAS 58, par. 8 (AU 508.08)]
4. Does the report include appropriate language for the following situ­
ations:
a. Only one basic financial statement is presented and there are no 
scope limitations? ____ ____ ____
[SAS 58, pars. 33 and 34, as amended by SAS 78 (AU 508.33 and .34)]
1 In December 1995, Statement on Auditing Standards 79, Amendment to Statement on Auditing Standards No. 58, Reports on Audited 
Financial Statements, was issued. This Statement amends SAS 58 to eliminate the requirement that, when certain criteria are met, the 
auditor add an uncertainties explanatory paragraph to the auditor's report. This Statement is effective for reports issued after February 
29, 1996 and has been reflected in this checklist.
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b. Audited and unaudited financial statements are presented in com­
parative form?
[SAS 26, pars. 14-17 (AU 504.14-.17)]
c. A refusal by management to allow the auditor to review communi­
cations from, or to communicate with, state insurance regulators? 
[AAG, App. M (SOP 94-1, par. 5)]
5. Is an explanatory paragraph (or other explanatory language) added 
to the standard report if:
Note: Consult the Topical Index to the AICPA Professional Standards 
under "Uncertainties" for references to specific types of uncertainties.
a. There is substantial doubt about the company's ability to continue as 
a going concern for a reasonable period of time and that conclusion 
is expressed through the use of the phrase "substantial doubt about
its (the company's) ability to continue as a going concern"? ____
[SAS 59, par. 13, as amended by SAS 64, par. 1 and SAS 77 (AU 
341.12 and 13)]
b. There is a material change between periods in accounting princi­
ples or in the method of their application? ____
[SAS 58, pars. 16-18, as amended by SAS 79 (AU 508.16-18)]
c. In an updated report on comparative financial statements, the
current opinion on the prior period is different from the one 
previously expressed? ____
[SAS 58, pars. 68 and 69, as amended by SAS 79, and 72 and 73
(AU 508.68, .69, .72, and .73)]
d. The prior-period financial statements are audited by a predecessor
auditor whose report is not presented? ____
[SAS 58, as amended by SAS 64, par. 2 and SAS 79 (AU 508.74)]
e. The auditor's opinion is based in part on the report of another
auditor? ____
[SAS 1, sec. 543 (AU 543); SAS 58, pars. 12 and 13 (AU 508.12 and .13)]
f. The financial statements contain a departure from a promulgated 
accounting principle when conformity with GAAP would result 
in a misleading presentation? ____
[SAS 58, pars. 14 and 15 (AU 508.14 and .15)]
g. Other information in a document containing audited financial 
statements is materially inconsistent with information appearing
in the financial statements? ____
[SAS 8, par. 4 (AU 550.04)]
h. The auditor decides to emphasize a matter in the report? ____
[SAS 58, par. 19, as amended by SAS 79 (AU 508.19); Interpretation
38 of SAS 1, sec. 410 (AU 9410.17); Interpretation 1 of SAS 57 (AU 
9342.03)]
6. In a going-concern explanatory paragraph, is conditional language 
not used in expressing a conclusion concerning the existence of sub­
stantial doubt about the entity's ability to continue as a going concern? ____
[SAS 59, as amended by SAS 77, par. 13, fn. 5]
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7. Is a qualified opinion or disclaimer of opinion expressed if scope 
limitations preclude application of one or more auditing procedures 
considered necessary in the circumstances?2
2 This includes when the auditor is unable to obtain sufficient, evidential matter to support management's assertions about the 
nature of a matter involving an uncertainty and its presentations or disclosure in the financial statements. [SAS 58, as amended by SAS 
79, par. 31 (AU 508.31)]
3 The auditor should express a qualified or an adverse opinion if the auditor concludes that (a) a matter involving a risk or an 
uncertainty is not adequately disclosed, (b) the accounting principles used cause the financial statements to be materially misstated 
when the inability to make a reasonable estimate raises questions about the appropriateness of the accounting principles used, and (c) 
management's estimate is unreasonable and that its effect is to cause the financial statements to be materially misstated. [SAS 58, as 
amended by SAS 79, pars. 46-49 (AU 508.46-.49)]
[SAS 58, pars. 22-27, as amended by SAS 79 (AU 508.40-.45); SAS 19, 
par. 12 (AU 333.12)]
Note: Consult the Topical Index to the AICPA Professional Standards 
under "Scope of Audit—Limitations" for additional references to specific 
types of scope limitations that could result in either a qualified or dis­
claimer of opinion.
8. Is a qualified opinion or adverse opinion expressed:
a. If a lack of conformity with GAAP (including inadequate disclo­
sure) is present?3
[SAS 58, pars. 20 and 35-57, as amended by SAS 79 (AU 508.20 and 
.35-57); SAS 32, par. 3 (AU 431.03)
b. Financial statements reflect regulatory practice of immediate 
write-off of goodwill or other regulatory practices that differ from 
GAAP and the resulting difference is material?
[SAS 1 (AU 544.20)]
Note: Consult the Topical Index to the AICPA Professional Standards 
under "Departures from Established Principles," "Adverse Opinions," 
and "Qualified Opinions" for additional references to specific types of 
GAAP departures that could result in either a qualified or adverse 
opinion.
9. If a qualified opinion, adverse opinion, or disclaimer of opinion is 
expressed, are all the substantive reasons for the opinion or dis­
claimer disclosed and is the reporting language appropriately 
modified?
[SAS 58, pars. 21, 59, 60, and 62, as amended by SAS 79 (AU 508.21, 
.59, .60, and .62)]
10. If information accompanies the basic financial statements and audi­
tor's report in an auditor-submitted document, does the report on the 
accompanying information:
a. State that the audit was performed for the purpose of forming an 
opinion on the basic financial statements taken as a whole?
b. Specifically identify the accompanying information?
c. State that the accompanying information is presented for purposes 
of additional analysis and is not a required part of the basic 
financial statements?
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d. State whether the accompanying information was subjected to the 
auditing procedures applied in the audit of the basic financial 
statements and includes the appropriate expression of opinion or 
disclaimer?
[SAS 29, pars. 6-11 (AU 551.06-.11)]
11. Is the reporting form and content of SAS 60, paragraphs 9-19, fol­
lowed when communicating internal control structure-related mat­
ters noted in an audit?4
4 Reportable conditions in internal control structure that have not been corrected must be communicated, preferably in writing, to 
senior management and the board of trustees or its audit committee. [SAS 60]
[SAS 60, pars. 9-19 (AU 325.09-.19); SOP 95-4]
12. Is the reporting form and content of SAS 72, as amended by SAS 76, 
followed for comfort letters submitted to underwriters and other 
requesting parties on tax-exempt bond offerings?
[SAS 72, as amended by SAS 76 (AU 634)]
Statutory Basis Financial Statements
13. Does the report on statutory financial statements as to fair presenta­
tion in conformity with the statutory basis of accounting not include 
a disclaimer of opinion as to fair presentation in conformity with 
GAAP?
[SOP 95-5, par. 10]
14. Is an adverse opinion expressed with respect to conformity with 
GAAP, unless the auditor determines the differences between GAAP 
and the statutory basis of accounting are not material and pervasive? 
[SOP 95-5, par. 12]
15. Do the notes to the statutory financial statements discuss the statutory 
basis of accounting and describe how that basis differs from GAAP? 
[SOP 95-5, par. 13]
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Supplemental Checklist for Life 
Insurance Companies That Are 
SEC Registrants
.01 This supplemental checklist for life insurance companies contains additional disclosures that are 
required in financial statements of life insurance companies that are SEC registrants. Footnote 3 to SAS 69 
states, in part, that for Securities and Exchange Commission registrants, rules and releases of the SEC have 
an authority similar to other officially established accounting principles.
.02 Regulation S-X is the principal accounting regulation of the SEC. It contains substantially all of the 
requirements for financial statements filed with the SEC. Insurance companies are subject to the requirements 
of Articles 1-4, 7, 10, and 12 of Regulation S-X.
.03 This checklist does not contain all of the possible disclosures a company may be required to make 
when filing financial statements with the SEC. The checklist is intended to present the more common and 
significant disclosures required by Regulation S-X for annual insurance company financial statements. This 
checklist has been updated through Financial Reporting Release 46 and Staff Accounting Bulletin 97.
.04 Except as permitted by the SEC, the disclosures, if applicable, should appear on the face of the 
financial statements or in the notes thereto.
.05 Explanation of References:
SAB = SEC Staff Accounting Bulletin
S-X Rule = SEC Regulation S-X
.06 Checklist Questionnaire:
Yes No N/A
General
1. Do the financial statements conform to the Regulation S-X's Rules of
General Application? ____ ____  ____
[S-X Rule, 4-01-08]
2. Are the principles of consolidation or combination disclosed? ____ ____  ____
[S-X Rule 4-08(a) and 3A-03]
3. Are the amounts of related party transactions stated on the face of the
balance sheet, income statement or statement of cash flows? ____ ____  ____
[S-X Rule 4-08(k)]
Balance Sheet
A. General
1. Is the company filing balance sheets as of the end of each of the two 
most recent fiscal years? ____ ____  ____
[S-X Rule 3-01]
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2. Are assets mortgaged, pledged, or otherwise subject to lien and the 
approximate amounts thereof disclosed and are the obligations col­
lateralized briefly identified?
[S-X Rule 4-08(b)]
B. Investments—Other Than Investments in Related Parties (S-X Rule 
7-03-1)
1. Do the following captions appear separately on the balance sheet:
a. Fixed maturities, including bonds, notes, marketable certificates 
of deposit with maturities beyond one year, and redeemable pre­
ferred stocks?
b. Equity securities, including common stocks and nonredeemable 
preferred stocks?
c. Mortgage loans on real estate?
d. Investment real estate, excluding real estate acquired in settling 
title claims, mortgage guaranty, and insurance claims (which 
should be included in "Other Assets")?
(1) Is the amount of accumulated depreciation and amortization 
deducted disclosed in the balance sheet or in the notes to 
financial statements?
e. Policy loans?
f. Other long-term investments?
(1) Do the notes state the amount of any class of investment 
exceeding 10 percent of stockholders' equity?
g. Short-term investments, including investments maturing in one 
year (e.g., commercial paper, marketable certificates of deposit, 
savings accounts, time deposits, cash accounts, or cash equivalents 
earning interest)?
(1) Do the notes disclose any amounts subject to withdrawal or 
usage restrictions?
2. Does the balance sheet include, parenthetically or otherwise:
a. The basis of determining the investment amounts shown in the 
balance sheet?
b. The aggregate cost or aggregate carrying value at the balance sheet 
date of fixed maturities and equity securities?
3. Is consideration given to discussion of "Valuation Securities" in sec­
tion 404.03 of the SEC Codification of Financial Reporting Practices?
4. Do the notes state the name of any person in which the total amount 
invested (aggregate indebtedness, stocks issued, and real estate pur­
chased) in the person and its affiliates exceeds 10 percent of total 
stockholders' equity?
a. Is the amount included in each subcaption disclosed (no disclosure 
needs to be made of investments in bonds and notes of the U.S. 
government or its agencies that exceed 10 percent of stockholders' 
equity)?
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5. For investments in fixed maturities, mortgage loans on real estate, 
investment real estate and other long-term investments, do the notes 
disclose the amount of nonincome-producing investments for the 12 
months preceding the balance-sheet date?
6. Is the amount of total investments disclosed?
C. Cash (S-X Rule 7-03-2)
1. Is cash on hand or on deposit restricted as to withdrawal or usage 
disclosed separately on the balance sheet?
a. Are the provisions of any restrictions, including legally restricted 
deposits held as compensating balances, contracts entered into 
with others or the companies' intentions about particular deposits, 
described in the notes?
b. Are nonlegally restricted compensating balance arrangements 
disclosed?
c. Do the notes disclose compensating balances maintained under an 
agreement to assure future credit availability?
D. Securities and Indebtedness of Related Parties (S-X Rule 7-03-3)
1. Are investments in related parties disclosed?
2. Is indebtedness from related parties disclosed?
E. Accrued Investment Income (S-X Rule 7-03-4)
1. Is the amount of accrued investment income reported separately?
F. Accounts and Notes Receivable (S-X Rule 7-03-5)
1. Are the amounts receivable from agents and insureds included?
2. Is the amount of uncollected premiums included?
3. Is the amount of other receivables included?
4. Are other receivables in excess of 5 percent of total assets stated 
separately or disclosed in the notes?
5. Is the amount of the allowance for doubtful accounts disclosed sepa­
rately in the balance sheet or in a note?
G. Reinsurance Recoverable on Paid Losses (S-X Rule 7-03-6)
1. Are the amounts disclosed?
H. Deferred Policy Acquisition Costs (S-X Rule 7-03-7)
1. Are the amounts disclosed?
I. Property and Equipment (S-X Rule 7-03-8)
1. Is the basis of determining the amounts disclosed?
2. Does the balance sheet or the notes disclose the amount of accumu­
lated depreciation and amortization of property and equipment?
J. Title Plant (S-X Rule 7-03-9)
1. Is the amount disclosed?
K. Other Assets (S-X Rule 7-03-10)
1. Is there separate disclosure on the balance sheet or in the notes of the 
amount of any "other asset" in excess of 5 percent of total assets?
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2. If a company acquires a life insurance company in a transaction 
accounted for as a purchase and the acquirer recognizes an asset for 
the present value of future profits (PVP), are the following disclosed:
a. A description of the registrant's accounting policy?
b. An analysis of the PVP asset account for each year for which an 
income statement is presented?
c. The estimated amount or percentage of the end-of-the-year PVP 
balance to be amortized during each of the next five years? 
[EITF 92-9]
L. Assets Held in Separate Accounts (S-X Rule 7-03-11)
1. Does the caption include aggregate amount of assets used to fund
liabilities related to variable annuities, pension funds, and similar 
activities? ____
2. Do the notes to the financial statements describe the general nature of
the activities being reported on in the separate accounts? ____
M. Total Assets (S-X Rule 7-03-12)
1. Is the amount of total assets disclosed? ____
N. Policy Liabilities and Accruals (S-X Rule 7-03-13)
1. Is the amount of future policy benefits and losses, and claims and
losses, separately disclosed in the balance sheet? ____
2. Is the amount of unearned premiums separately disclosed in the
balance sheet? ____
3. Are other policy claims and benefits payable separately disclosed in
the balance sheet? ____
4. Do the notes disclose the basis of assumptions (e.g., interest rates,
mortality, withdrawals) for future policy benefits and claims and 
settlements stated at present value? ____
5. Do the notes disclose the general nature of reinsurance transactions,
including a description of significant types of reinsurance agreements 
executed? ____
a. Do the disclosures include the nature of the contingent liability in
connection with insurance ceded? ____
b. Do the disclosures include the nature and effect of material non­
recurring reinsurance transactions? ____
O. Other Policyholders' Funds (S-X Rule 7-03-14)
1. Does the caption include the amount of supplementary contracts
without life contingencies, policyholders' dividend accumulations, 
undistributed earnings on participating policies, dividends to policy- 
holders and retrospective return premiums and similar items? ____
2. Is there separate disclosure in the balance sheet or in the notes of any
item the amount of which is in excess of 5 percent of total liabilities? ____
3. Do the notes disclose the relative significance of participating insur­
ance as a percentage of (1) insurance in force and (2) premium income? ____
a. Do the notes disclose the method by which earnings and dividends 
allocable to such insurance is determined? ____
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P. Other Liabilities (S-X Rule 7-03-15)
1. Is there separate disclosure in the balance sheet or in the notes of any
item the amount of which is in excess of 5 percent of total liabilities? ____
2. Is there separate disclosure in the balance sheet or in the notes of (1)
income taxes payable and (2) deferred income taxes? ____
a. Is there separate disclosure of the amount of deferred income taxes 
applicable to unrealized appreciation of equity securities? ____
Q. Notes Payable, Bonds, Mortgages, and Similar Obligations (Including 
Capitalized Leases) (S-X Rule 7-03-16)
1. Is the amount of short-term debt separately disclosed? ____
a. If the aggregate of short-term borrowings (from banks, factors,
and other financial institutions and commercial paper issued) 
exceeds 5 percent of total liabilities, do the notes disclose the 
amount and terms (including commitment fees and the conditions 
under which lines may be withdrawn) of unused lines of credit for 
short-term financing? ____
b. Is the amount of the lines of credit that support commercial paper
borrowing arrangements separately identified? ____
[S-X Rule 5-01-19(b)]
2. Is the amount of long-term debt including capitalized leases sepa­
rately disclosed? ____
a. Is there disclosure of the general character of each type of debt? ____
b. Is the interest rate disclosed? ____
c. Is the maturity date or, if maturing serially, a brief indication of
the serial maturities disclosed? ____
d. If the payment of principal or interest is contingent, is there
appropriate indication of such contingency? ____
e. Is there a brief indication of priority? ____
f. If convertible, is the basis disclosed? ____
[S-X Rule 5-02-22]
3. If applicable, are the following matters disclosed:
a. The facts and amounts concerning any default in principal, inter­
est, sinking fund, or redemption provisions with respect to any 
issue of securities or credit agreements, or any breach of covenant 
of a related indenture or agreement, which default or breach 
existed at the date of the most recent balance sheet being filed and 
which has not been subsequently cured? ____
4. If a default or breach exists but acceleration of the obligation has been 
waived for a stated period of time beyond the date of the most recent 
balance sheet being filed, is the amount of the obligation and the
period of the waiver disclosed? ____
R. Indebtedness to Related Parties (S-X Rules 4-08(k) and 7-03-17)
1. Are related-party transactions identified and the amount stated on the 
face of the balance sheet, income statement, or statement of cash 
flows? ____
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2. If there are separate financial statements for the registrant, certain 
investees or subsidiaries, is there separate disclosure of the amounts 
in the related consolidated statements that are:
a. Eliminated? ____
b. Not eliminated? ____
3. If any intercompany profit or losses resulting from transactions with
related parties are not eliminated, are the effects disclosed? ____
S. Liabilities Related to Separate Accounts (S-X Rule 7-03-18)
1. Is the amount disclosed? ____
T. Commitments and Contingent Liabilities (S-X Rule 7-03-19)
1. Are the proper disclosures made? ____
U. Minority Interest in Consolidated Subsidiaries (S-X Rules 5-02-27 and
7-03-20)
1. Do the notes disclose the amounts represented by preferred stock and 
the applicable dividend requirements, if the preferred stock is mate­
rial in relation to the consolidated stockholders' equity? ____
V. Preferred Stock Subject to Mandatory Redemption (S-X Rules 5-02-28 
and 7-03-21)
1. Is the title of each issue, the carrying amount, and redemption amount
stated on the balance sheet? ____
2. Is the dollar amount of any shares subscribed, but unissued, shown
together with the deduction of subscriptions receivable? ____
3. If the carrying value is different from the redemption amount, is there
a description of the accounting treatment for such difference? ____
4. Is there disclosure, for each issue, of the number of shares authorized,
issued, and outstanding? ____
W. Nonredeemable Preferred Stock (S-X Rules 5-02-29 and 7-03-22)
1. Is the title of each issue and the carrying amount disclosed on the
balance sheet or in the notes? ____
2. Is the dollar amount of any shares subscribed, but unissued, shown
together with the deduction of subscriptions receivable? ____
3. Is there disclosure, for each issue, of the number of shares authorized,
issued, and outstanding? ____
4. Is there disclosure in a note or in a separate statement of changes in
each class of preferred stock for which an income statement is re­
quired to be filled? ____
X. Common Stock (S-X Rules 5-02-30 and 7-03-23)
1. Does the face of the balance sheet disclose the number of shares issued
and outstanding? ____
2. If convertible, is this fact indicated on the face of the balance sheet? ____
3. Is there disclosure, for each class of common stock, of the title of each
issue, the number of shares authorized, and the basis of conversion? ____
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Yes No N/A
4. Is the dollar amount of any shares subscribed, but unissued, shown 
together with the deduction of subscriptions receivable?
5. Do the notes or a separate statement disclose the changes in each class 
of common stock for which an income statement is required to be 
filed?
Y. Other Stockholders' Equity (S-X Rules 5-02-31(b) and 7-03-24)
1. Are separate captions shown for:
a. Additional paid-in capital?
b. Other additional capital?
c. Unrealized appreciation or depreciation of equity securities less 
applicable deferred income taxes?
d. Appropriated retained earnings?
e. Unappropriated retained earnings?
2. If there has been a quasi-reorganization in the last 10 years, is the 
retained earnings account dated?
3. Do the notes disclose, for each life insurance legal company, the 
amount of statutory stockholders' equity as of the date of each balance 
sheet presented?
4. Is there disclosure of the amount of statutory net income or loss for 
each period for which an income statement is presented?
Z. Total Liabilities and Stockholders' Equity (S-X Rule 7-03-25)
1. Is the amount disclosed?
AA. Dividend Payment Restrictions (S-X Rule 4-08(e))
1. When disclosing restrictions on dividend payments, are the sources 
of the restrictions and their pertinent provisions described, as well as 
the amount of retained earnings or net income restricted or free of 
restrictions?
2. Is disclosure made of the amount of consolidated retained earnings 
which represents undistributed earnings of 50 percent or less owned 
entities accounted for by the equity method?
3. If the restricted net assets of consolidated and unconsolidated subsidi­
aries and the parent's equity in the undistributed earnings of 50 
percent or less owned entities accounted for by the equity method 
together exceed 25 percent of consolidated net assets as of the end of 
the most recently completed fiscal year:
a. Is the nature of any restrictions on the ability of consolidated 
subsidiaries and unconsolidated subsidiaries to transfer funds to 
the registrant in the form of cash dividends, loans or advances 
disclosed?
b. Are the amounts of such restricted net assets for unconsolidated 
subsidiaries and consolidated subsidiaries as of the end of the 
most recently completed fiscal year disclosed separately?
BB. Warrants or Rights Outstanding (S-X Rule 4-08 (i))
1. Is information with respect to warrants or rights outstanding at the 
date of the related balance sheet set forth as follows:
a. Title of issue of securities called for by warrants or rights?
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Yes No N/A
b. Aggregate amount of securities called for by warrants or rights
outstanding? ____
c. Date from which warrants or rights are exercisable? ____
d. Price at which warrant or right is exercisable? ____
Income Statement
A. General
1. Is the company filing statements of income for each of the three fiscal
years preceding the date of the most recent balance sheet being filed? ____
[S-X Rule 3-02]
B. Premiums (S-X Rule 7-04-1)
1. Does the amount include premiums from reinsurance assumed and
are premiums on reinsurance ceded deducted from the amount? ____
2. Do the amounts represent premiums earned? ____
C. Net Investment Income (S-X Rule 7-04-2)
1. Do the notes disclose (in tabular form) the amount of investment 
income for each category of investment listed in the balance sheet
above that exceeds 5 percent of total investment income? ____
2. Do the notes disclose total investment income? ____
3. Do the notes disclose applicable investment expenses? ____
4. Do the notes disclose net investment income? ____
D. Realized Investment Gains and Losses (S-X Rule 7-04-3)
1. Are net realized investment gains and losses disclosed separately
regardless of size? ____
2. Is the following disclosed in a footnote? ____
The company's policy with respect to whether investment income 
and realized gains and losses allocable to policyholders and sepa­
rate accounts are included in the investment income and realized 
gain and loss amounts reported in the income statement.
3. If the income statement includes investment income and realized 
gains and losses allocable to policyholders and separate accounts, are 
the amounts of such allocable investment income and realized gains
and losses disclosed? ____
a. Is the manner in which the company's obligation with respect to 
allocation of such investment income and realized gains and losses 
is otherwise accounted for disclosed? ____
4. Is the method followed in determining the cost of investments sold
disclosed? ____
5. For each period for which an income statement is filed, is an analysis
of realized and unrealized investment gains and losses on fixed 
maturity and equity securities disclosed in a footnote? ____
6. For each period, are the following presented separately for fixed 
maturities and for equity securities:
a. Realized investment gains and losses? ____
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Yes No N/A
b. The change during the period in the difference between value and 
cost (the change shall be given for both categories of investments 
even though they may be shown on the related balance sheet on a 
basis other than value)? ____
E. Other Income (S-X Rule 7-04-4)
1. Are items in excess of 5 percent of total revenue separately disclosed? ____
F. Benefits, Claims, Losses, and Settlement Expenses (S-X Rule 7-04-5)
1. Are the amounts disclosed? ____
G. Policyholders' Share of Earnings on Participating Policies, Dividends, 
and Similar Items (S-X Rules 7-03-14(b) and 7-04-6)
1. Are the amounts disclosed? ____
2. Is the relative significance of participating insurance expressed as 
percentages of insurance in force and premium income and the 
method by which earnings and dividends allocable to such insurance
is determined stated in a note to the financial statements? ____
H. Underwriting, Acquisition, and Insurance Expenses (S-X Rule 7-04-7)
1. Do the statements or notes disclose:
a. The amount of deferred policy acquisition cost amortized to in­
come for each period? ____
b. The amount of other operating expenses with separate disclosure
of any material amounts? ____
I. Income or Loss Before Income Tax Expense and Other Appropriate 
Items (S-X Rule 7-04-8)
1. Is the amount disclosed? ____
J. Income Tax Expense (S-X Rules 4-08(h) and 7-04-9)
1. Does the income statement or do the notes disclose:
a. The domestic component of income (loss) before income tax ex­
pense (benefit)? ____
b. The foreign component of income (loss) before tax expense (bene­
fit)? ____
c. Taxes currently payable? ____
d. The net tax effects of timing differences? ____
2. Is there a reconciliation between the amount of reported total income
tax expense (benefit) and the amount of tax computed at the applica­
ble statutory federal income tax rate? ____
K. Minority Interest in Income of Consolidated Subsidiaries (S-X Rule 
7-04-10)
1. Are the amounts disclosed? ____
L. Equity in Earnings of Unconsolidated Subsidiaries and 50% or Less 
Owned Persons (S-X Rule 7-04-11)
1. Is the amount of dividends received disclosed? ____
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Yes No N/A
M. Income or Loss From Continuing Operations (S-X Rule 7-04-12)
1. If appropriate, is the amount disclosed?
N. Discontinued Operations (S-X Rule 7-04-13)
1. Is any amount separately reported?
O. Income or Loss Before Extraordinary Items and Cumulative Effects of 
Changes in Accounting Principles (S-X Rule 7-04-14)
1. If appropriate, is the amount disclosed?
P. Extraordinary Items, Less Applicable Tax (S-X Rule 7-04-15)
1. Is any amount separately reported?
Q. Cumulative Effect of Changes in Accounting Principles (S-X Rule 7-04-16)
1. Is any amount separately reported?
2. For reinsurance contracts with retrospective rating provisions result­
ing in changes in the amount or timing of future contractual cash flows 
(including premium adjustments, settlement adjustments, or refunds 
to the ceding company) or changes in the contract's future coverage 
pursuant to EITF 93-6, are the nature and the significance of the 
transactions giving rise to the change disclosed?
[EITF 93-6]
3. Are disclosures made in accordance with SAB 74 in the financial 
statements filed prior to the period in which this change is adopted? 
[EITF 93-6; SAB 74]
R. Net Income or Loss (S-X Rule 7-04-17)
1. Is the amount disclosed?
S. Earnings-Per-Share Data (S-X Rule 7-04-18)
1. Are applicable amounts reported?
T. Cash Flows
1. Is the company filing statements of cash flows for each of the three 
fiscal years preceding the date of the most recent balance sheet being 
filed?
[S-X Rule 3-02]
U. Changes in Other Stockholders' Equity
1. Is an analysis of the changes in each caption of other stockholders' 
equity presented in the balance sheets presented in a note or separate 
statement?
[S-X Rule 3-04]
2. With regard to the aforementioned analysis:
a. Is it presented in the form of a reconciliation of the beginning 
balance to the ending balance for each period for which an income 
statement is required to be filed?
b. Are all significant reconciling items described by appropriate 
captions?
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Yes No N/A
c. If items are retroactively applied to periods prior to the earliest 
period presented, are the adjustments to the balance at the begin­
ning of the earliest period presented stated separately?
d. With respect to any dividends, is the amount per share and in the 
aggregate for each class of shares stated?
[S-X Rule 3-04]
V. Schedules (S-X Rule 7-05)
1. Is Schedule I—Summary of Investments—Other Than Investments in 
Related Parties (refers to Rule 12-15) filed for the most recent audited 
balance sheet?
2. Is Schedule II—Condensed Financial Information of Registrant (refers 
to Rule 12-04) filed for the periods specified in the schedule, if re­
stricted net assets (Rule 4-08(e)(3)) of consolidated subsidiaries exceed 
25 percent of consolidated net assets as of the end of the most recently 
completed fiscal year?
3. Is Schedule III—Supplementary Insurance Information (refers to Rule 
12-16) presented for the periods specified in the schedule?
4. Is Schedule IV—Reinsurance (refers to Rule 12-17) filed for each 
period for which an audited income statement is required?
5. Is Schedule V—Valuation and Qualifying Accounts (refers to Rule 
12-09) filed for each period for which an audited income statement is 
required?
W. Other SEC-Related Disclosures
1. As applicable, is the following guidance issued by the SEC through 
their Staff Accounting Bulletins appropriately considered and ap­
plied:
Practice Tip
Users of this checklist should consult all relevant SEC guidance (e.g., SABs, Regulation S-X, etc.) when 
preparing financial statements for filing with the SEC. Not all reporting situations are encompassed in this 
checklist.
a. SAB Topic 1-B, Allocation of Expenses and Related Disclosure in 
Financial Statements of Subsidiaries, Divisions or Lesser Business Com­
ponents of Another Entity?
b. SAB Topic 2-A, Business Combinations—Purchase Method?
c. SAB Topic 2-E, Business Combinations—Risk Sharing in Pooling of 
Interests?
d. SAB Topic 2-F, Treasury Stock Acquisitions Following Consummation 
of a Business Combination Accounted for as a Pooling-of-interests?
e. SAB Topic 4-A, Subordinated Debt?
f. SAB Topic 4-C, Change in Capital Structure?
g. SAB Topic 4-E, Receivables From Sale of Stock?
h. SAB Topic 4-G, Notes and Other Receivables From Affiliates?
i. SAB Topic 5-P, Income Statement Presentation of Restructuring 
Charges?
85
Yes No N/A
j. SAB Topic 5-U, Gain Recognition on the Sale of a Business or Operating 
Assets to a Highly Leveraged Entity?
k. SAB Topic 5-Y, Accounting and Disclosures Related to Loss Contin­
gencies?
l. SAB Topic 5-Z, Accounting and Disclosure Regarding Discontinued 
Operations?
m. SAB Topic 6-H, Disclosure of Compensating Balances and Short-Term 
Borrowing Arrangements?
n. SAB Topic 6-K, Separate Financial Statements Required by Regulation 
S-X?
o. SAB Topic 11-B, Depreciation and Depletion Excluded From Cost of 
Sales?
p. SAB Topic 11-D, Offsetting of Assets and Liabilities?
q. SAB Topic 11-E, Chronological Ordering of Data?
r. SAB Topic 11-J, Financial Guarantees?
s. SAB Topic 11-M, Disclosure of the Impact That Recently Issued Ac­
counting Standards Will Have on the Financial Statements of the Reg­
istrant When Adopted in a Future Period?
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FSP Section 20,600
Illustrative Financial Statements
.01 This section contains illustrative financial statements prepared in conformity with generally accepted 
accounting principles (GAAP). The financial statements are for illustrative purposes only, are not intended 
to be comprehensive and are not intended to establish preference among alternative principles acceptable 
under GAAP. Decisions about the application of the GAAP discussed in the accounting and financial 
reporting sections of the AICPA Industry Audit Guide Audits of Stock Life Insurance Companies, should not be 
made by reference to the illustrative financial statements but by a careful reading to the specified authorita­
tive literature. The illustrative financial statements reflect many of the minimum disclosure requirements for 
a life and health insurance entity but do not include all of the amounts or transactions discussed in other 
chapters of the Guide or that might be found in practice. For example, the illustrative notes indicate the 
subject matter generally required to be disclosed, but they should be expanded, reduced, or otherwise 
modified to suit individual circumstances based on a careful reading of the specified authoritative literature.
.02 The illustrative financial statements do not include other transactions not unique to life and health 
insurance entities, such as disclosures about segments, employee benefit plans, certain risks and uncertain­
ties, or postemployment benefits other than pensions. Preparers and auditors should consult authoritative 
pronouncements for guidance on presenting such other information.
.03 The illustrative financial statements do not reflect rules and releases of the Securities and Exchange 
Commission (SEC) that, for SEC registrants, have an authority similar to other officially established account­
ing principles. SEC Regulation S-X, Article 7, Insurance Companies, should be referred to.
.04 The illustrative financial statements are in conformity with accounting standards issued up to and 
including SFAS No. 125, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of 
Liabilities. Preparers and auditors of financial statements should refer to subsequent FASB Statements and 
other GAAP for additional requirements.
.05 Life and health insurance entities generally present unclassified balance sheets.
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ABC LIFE INSURANCE COMPANY 
Balance Sheet
December 31, 19X2 and 19X1 
(Amounts in Thousands)
19X2 19X1
Assets
Investments:
Debt and equity securities:
Fixed maturities, held to maturity, at amortized cost
(estimated fair value: $47,830 in 19X2 and $45,255 in 19X1) $ 44,864 $ 46,310
Fixed maturities, available for sale, at estimated fair value
See accompanying notes to financial statements.
(amortized cost: $247,525 in 19X2 and $219,565 in 19X1) 255,893 214,563
Trading account securities, at estimated fair value
(cost: $4,220 in 19X2 and $4,419 in 19X1) 3,950 4,190
Mortgage loans 79,258 106,692
Real estate 6,410 6,147
Policy loans 43,549 51,013
Short-term investments 7,515 6,321
Total investments 441,439 435,236
Cash and cash equivalents 5,285 3,343
Accrued investment income 6,660 8,026
Premiums due and other receivables, net of allowance
of $4,500 and $2,100 for doubtful accounts 1,647 1,092
Reinsurance receivable on paid and unpaid losses 596 407
Reinsurance receivable related to contractholder liabilities 5,714 3,048
Deferred policy acquisition costs 38,936 36,429
Property and equipment, net of accumulated depreciation 501 420
Other assets 152 158
Separate account assets 732 525
Total assets $501,662 $488,684
Liabilities
Future policy benefits $345,887 $341,207
Guaranteed interest contracts 21,342 23,555
Policyholders' funds on deposit 49,408 46,202
Unpaid claims 5,418 4,737
Policyholders' dividends 2,335 3,450
Amounts held in escrow and accrued expenses 4,977 4,562
Deferred federal income taxes 1,412 1,027
Other liabilities 253 4,465
Separate account liabilities 732 525
Total liabilities 431,764 429,730
Commitments and contingencies (Note 12)
Shareholders' Equity
Capital stock: authorized—5,000,000 shares of $2 par value;
3,341,624 shares issued and outstanding 6,683 6,683
Retained earnings 57,776 55,522
Net unrealized appreciation (depreciation) of available for
sale securities, net of taxes 5,439 (3,251)
Total shareholders' equity 69,898 58,954
Total liabilities and shareholders' equity $501,662 $488,684
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.07
ABC LIFE INSURANCE COMPANY
Statement of Income
Years Ended December 31, 19X2 and 19X1
(Amounts in Thousands, Except per Share Data)
19X2 19X1
Premiums and Other Revenues
Premiums:
Life and annuity premiums $24,833 $24,783
Accident and health premiums 10,141 9,153
Other premiums 20 43
Contractholder fees 1,961 1,844
Net investment income 32,998 35,141
Net realized gains (losses) on investments 4,222 (2,670)
Total premiums and other revenues 74,175 68,294
Benefits and Other Expenses
Policyholder benefits 39,158 30,815
Interest credited to policyholder accounts 4,363 4,156
General expenses 4,288 4,984
Amortization of deferred acquisition costs 1,276 1,305
Underwriting, acquisition, and insurance expenses 18,029 17,266
Policyholders' dividends 4,665 6,898
Total benefits and expenses 71,779 65,424
Income before income taxes 2,396 2,870
Income taxes:
Current 1,547 601
(Prepaid) Deferred (1,405) 540
Total income taxes 142 1,141
Net income 2,254 1,729
Net income per common share 
Dividends per common share
.67 .52
— .98
See accompanying notes to financial statements.
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ABC LIFE INSURANCE COMPANY
Statement of Shareholders' Equity
Years Ended December 31, 19X2 and 19X1
(Amounts in Thousands)
Balance at January 1, 19X1
Net income for 19X1
Shareholders' dividends
Net change in unrealized gains and 
losses of available for sale securities
Balance at December 31, 19X1
Net income for 19X2
Net change in unrealized gains and 
losses of available for sale securities
Balance at December 31, 19X2
Capital 
Stock
Retained
Earnings
Net Unrealized 
Appreciation 
(Depreciation), 
Net of Taxes
Total 
Shareholders' 
Equity
$6,683 $57,068 $(1,521) $62,230
— 1,729 — 1,729
— (3,275) — (3,275)
— — (1,730) (1,730)
6,683 55,522 (3,251) 58,954
— 2,254 — 2,254
— — 8,690 8,690
$6,683 $57,776 $ 5,439 $69,898
See accompanying notes to financial statements.
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ABC LIFE INSURANCE COMPANY
Statements of Cash Flows
Years Ended December 31, 19X2 and 19X1
(Amounts in Thousands)
See accompanying notes to financial statements.
19X2 19X1
Cash flows from operating activities:
Net income $ 2,254 $ 1,729
Adjustments to reconcile net income to net 
cash provided by operating activities:
Interest credited to interest sensitive contracts 4,564 6,289
Interest credited to universal life policies 3,363 4,156
Accrual of discount on investments, net (976) (1,328)
Net realized (gains) losses on investments (4,222) 2,670
Depreciation 194 181
Amortization of deferred policy acquisition costs 2,847 3,353
Deferred federal income taxes (2,538) 540
Change in operating assets and liabilities:
Accrued investment income 1,366 880
Deferred policy acquisition costs (7,354) (5,340)
Policy liabilities 1,407 (16,234)
Other items, net (644) 3,269
Net cash provided by operating activities 261 165
Cash flows from investing activities:
Cost of investments purchased:
Fixed maturities and equity securities (228,053) (122,495)
Mortgage loans and real estate (921) —
Proceeds from investments sold, redeemed, or matured:
Fixed maturities and equity securities 206,051 95,227
Mortgage loans and real estate 27,970 18,621
Policy loans, net 2,320 6,468
Short-term investments, net 409 15,446
Net cash provided by investing activities 7,776 13,217
Cash flows from financing activities:
Dividends to shareholders — (3,275)
Premiums and deposits to interest-sensitive contracts 677 1,082
Receipts from universal life policies credited to
contractholder account balances 7,241 7,283
Return of contractholder account balances on
universal life policies (4,165) (3,718)
Withdrawals from interest-sensitive contracts (9,848) (13,046)
Cash used in financing activities (6,095) (11,674)
Net increase in cash and cash equivalents 1,942 1,708
Cash and cash equivalents, beginning of year 3,343 1,635
Cash and cash equivalents, end of year $ 5,285 $ 3,343
Supplemental Cash Flow Information:
Income taxes paid $ 1,205 $ 785
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ABC LIFE INSURANCE COMPANY
Notes to Financial Statements
Note 1: Organization and Significant Accounting Policies
Organization. ABC Life Insurance Company (ABC or the Company) is a stock life insurance 
company incorporated in the state of ABC State that offers individual life, disability income, 
long-term care, annuity, and investment products. ABC does business in the continental United 
States, with a concentration in New York, New Jersey, and Connecticut.
Basis of Presentation. The significant accounting policies followed by ABC that materially affect 
financial reporting are summarized below. The accompanying financial statements have been 
prepared in accordance with generally accepted accounting principles (GAAP) which differ from 
statutory accounting practices used for regulatory authorities. The preparation of the financial 
statements in conformity with GAAP requires management to make estimates and assumptions 
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and 
liabilities at the date of the financial statements and the reported amounts of revenues and 
expenses during the reporting period. Actual results could differ from those estimates.
Investments. Fixed maturity securities available for sale consist of bonds, notes, redeemable and 
nonredeemable preferred stock not classified as either trading or held to maturity and are reported 
at estimated fair value, adjusted for other than temporary declines in fair value, with unrealized gains 
and losses shown net of applicable taxes, deferred policy acquisition cost offsets for universal life type 
contracts and amounts attributable to certain participating contracts are included in shareholders' 
equity as a separate component of shareholder's equity. Fixed maturity securities held to maturity 
consist of bonds, notes, redeemable, and nonredeemable preferred stock which the insurance com­
pany has the intent and ability to hold to maturity, and are reported at amortized cost, and are adjusted 
for amortization of premiums or discounts and other than temporary declines in fair value. Trading 
account securities consist of bonds, notes, redeemable and nonredeemable preferred stock, and 
common stock held principally for resale in the near term, and are recorded at their estimated fair 
values. Realized and unrealized gains and losses on trading account securities are included in net 
realized gains (losses) on investments. Mortgage loans on real estate are carried at unpaid balances, 
and adjusted for amortization of premium or discount, less allowance for losses. Real estate held for 
sale is carried at the lower of depreciated cost or fair value less estimated selling costs and losses which 
are considered other than temporary. Real estate, including real estate acquired in satisfaction of debt, 
is carried at depreciated cost. Impaired real estate is written down to fair value with the impairment 
loss being included in net realized gains (losses) on investments. Upon foreclosure (including 
in-substance foreclosure), the carrying value of the property is recorded at the lower of cost or fair 
value (less selling costs if to be sold), which becomes its new cost basis. The estimated fair value for 
real estate is determined based upon independent appraisals and other available information about 
the property, which may take into consideration a number of factors, including: (a) discounted cash 
flows; (b) sales of comparable properties; (c) geographic location of property and related market 
conditions; and (d) disposition costs. Foreclosed properties are actively managed by the company in 
order to maximize their value. Subsequent to foreclosure, the carrying value of the property is 
periodically evaluated and a valuation allowance is established, if necessary, to reflect any additional 
amounts considered unrecoverable upon sale. At the time of the sale, the difference between the sales 
price and the carrying value is recorded as a realized gain or loss. Policy loans are carried at unpaid 
balances. Short-term investments are stated at amortized cost which approximates market value. 
Provisions for impairments are included in net realized gains and losses. Realized gains and losses 
are determined by specific identification.
Cash and Cash Equivalents. Cash equivalents are carried at cost which approximates market value. 
Cash equivalents are highly liquid financial instruments with an original maturity of three months 
or less.
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Deferred Policy Acquisition Costs. Commissions and other costs of acquiring traditional life insur­
ance, universal life insurance and investment products, and accident and health insurance, that 
vary with and are primarily related to the production of new and renewal business have been 
deferred. Traditional life insurance and accident and health insurance acquisition costs are being 
amortized over the premium-paying period of the related policies using assumptions consistent 
with those used in computing future policy benefit liabilities. For universal life-type contracts and 
investment contracts that include significant surrender charges or that yield significant revenues 
from sources other than the investment of contractholders' funds, the deferred contract acquisi­
tion cost amortization is matched to the recognition of gross profit.
Otherwise, deferred contract acquisition costs on investment contracts are amortized using an 
accounting method that recognizes acquisition as expenses at a constant rate applied to net policy 
liabilities.
Property and Equipment. Property and equipment are reported at cost, net of accumulated 
depreciation of $1,915,000 and $1,721,000 in 19X2 and 19X1, respectively, using the straight-line 
method of depreciation over their estimated useful lives.
Future Policy Benefits and Expenses. The liabilities for traditional life insurance and accident and 
health insurance contract benefits and expenses are computed using a net level premium method 
including assumptions as to investment yields, mortality, withdrawals, and other assumptions based 
on ABC's experience modified as necessary to reflect anticipated trends and to include provisions for 
possible unfavorable deviations. Reserve interest assumptions are graded and range from 3 percent 
to 10 percent. Benefit liabilities for traditional life insurance contracts include certain deferred profits 
on limited-payment policies that are being recognized in income over the contract term. Contract 
benefit claims are charged to expense in the period that the claims are incurred.
Included in contractholders' account balances is a provision for contractholder dividends. Benefit 
liabilities for contractholders' account balances are computed under a retrospective deposit method 
and represent contract account balances before applicable surrender charges. Contract benefits and 
claims that are charged to expense include benefit claims incurred in the period in excess of related 
contract account balances. Interest crediting rates for universal life and investment products range 
from 5.50 percent to 9.25 percent. Benefits and expenses are charged against the account balance to 
recognize costs as incurred over the estimated lives of the contracts. Expenses include interest credited 
to contract account balances and benefits paid in excess of contract account balances.
Income Taxes. Federal income taxes are charged or credited to operations based upon amounts 
estimated to be payable or recoverable as a result of taxable operations for the current year. 
Deferred income taxes have been provided for temporary differences between the tax basis of 
assets and liabilities and their reported amounts in the financial statements using enacted income 
tax rates and laws.
Reinsurance. In the normal course of business, the Company seeks to limit its exposure to loss on 
any single insured and to recover a portion of benefits paid by ceding reinsurance to other 
insurance enterprises or reinsurers under excess coverage and coinsurance contracts. The Com­
pany retains a maximum of $400,000 of coverage per individual life. Amounts paid or deemed to 
have been paid for reinsurance contracts are recorded as reinsurance receivable.
Insurance Premium Revenues. Traditional life premiums, which include those products with fixed 
and guaranteed premiums and benefits and consist principally of whole life insurance contracts, 
limited-payment life insurance contracts, and certain annuities with life contingencies, are gener­
ally recognized as revenue when due. Revenues on universal life and investment-type contracts 
consist of contract charges against contractholders' funds for the cost of insurance, administration, 
surrender charges, actuarial margin and other fees. Accident and health insurance premiums are 
recognized as revenue pro rata over the terms of the contracts.
Separate Accounts. Separate account assets and liabilities generally represent funds maintained in 
accounts to meet specific investment objectives of contractholders who bear the investment risk. In­
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vestment income and investment gains and losses accrue directly to such contractholders. The 
assets of each account are legally segregated and are not subject to claims that arise out of any 
other business of the Company. The assets and liabilities are carried at market value. Deposits, 
net investment income, and realized and unrealized capital gains and losses on separate account 
assets are not reflected in the Statements of Income of ABC and are reflected directly in separate 
account liabilities.
Business Risks and Uncertainties. The development of liabilities for future policy benefits for the 
Company's products requires management to make estimates and assumptions regarding mor­
tality, morbidity, lapse, expense, and investment experience. Such estimates are primarily based 
on historical experience and, future expectations of mortality, morbidity, expense, persistency, 
and investment assumptions. Actual results could differ materially from those estimates. Man­
agement monitors actual experience, and where circumstances warrant, revises its assumptions 
and the related future policy benefit estimates.
The Company's investments are primarily comprised of fixed maturity securities, equity securi­
ties, real estate, and mortgage loans. Significant changes in prevailing interest rates and geo­
graphic conditions may adversely affect the timing and amount of cash flows on such investments, 
as well as their related values. In addition, the value of these investments is often derived from 
an appraisal, an estimate or opinion of value. A significant decline in the market value of these 
investments could have an adverse affect on the Company's balance sheet.
The Company regularly invests in mortgaged backed securities and other securities subject to 
prepayment and call risk. Significant changes in prevailing interest rates may adversely affect the 
timing and amount of cash flows on such securities. In addition, the amortization of market 
premium and accretion of market discount for mortgage backed securities is based on historical 
experience and estimates of future payment speeds on the underlying mortgage loans. Actual 
prepayment speeds will differ from original estimates and may result in material adjustments to 
amortization or accretion recorded in future periods.
Note 2: Investments
The aggregate fair value, gross unrealized holding gains, gross unrealized holding losses and 
amortized cost for available for sale and held to maturity securities by major security type are as 
follows:
Held to Maturity:
Total corporate debt securities
Available for Sale:
U.S. Treasury securities and obligations 
of U.S. government corporations and 
agencies
Obligations of states of the U.S. and 
political subdivisions of the states
Corporate debt securities
Mortgaged-backed securities
Total
December 31, 19X2 
(Amounts in Thousands)
Gross Gross Estimated
Amortized Unrealized Unrealized Fair
Cost Gains Losses Value
$ 44,864 $ 3,134 $ (168) $ 47,830
$ 2,340 $ 73 $ — $ 2,413
1,434 162 __ 1,596
142,075 7,109 (1,294) 147,890
101,676 2,673 (355) 103,994
$247,525 $10,017 $(1,649) $255,893
Fixed maturities held in the "held to maturity" category are stated at amortized cost on the balance 
sheet.
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Fixed maturities held in the "available for sale" category are stated at estimated fair value on the 
balance sheet.
The carrying amounts and estimated fair values of the company's fixed maturity investments at
December 31, 19X1 are as follows:
December 31, 19X1 
(Amounts in Thousands)
Amortized 
Cost
Gross 
Unrealized
Gains
Gross 
Unrealized
Losses
Estimated 
Fair 
Value
Held to Maturity:
Total corporate debt securities $ 46,310 $1,970 $(3,025) $ 45,255
Available for Sale:
U.S. Treasury securities and obligations
of U.S. government corporations and
agencies $ 3,569 $ 63 $ (29) $ 3,603
Obligations of states of the U.S. and
political subdivisions of the states 3,347 98 (1) 3,444
Corporate debt securities 138,831 1,818 (8,597) 132,052
Mortgaged-backed securities 73,818 1,989 (343) 75,464
Total $219,565 $3,968 $(8,970) $214,563
The amortized cost and estimated fair value of debt securities for each investment category, by 
contractual maturity, are as follows (expected maturities will differ from contractual maturities
because borrowers may have the right to call 
prepayment penalties):
Held to Maturity:
Due in one year or less
Due after one year through five years
Due after five years through ten years
Due after ten years
Other securities with multiple repayment dates
Total
Available for Sale:
Due in one year or less
Due after one year through five years
Due after five years through ten years
Due after ten years
Mortgaged-backed securities
Other securities with multiple repayment dates
Total
or prepay obligations with or without call or
December 31, 19X2 
(Amounts in Thousands)
Amortized
Cost
Estimated
Fair Value
$ 1,612 $ 1,700
9,544 10,323
4,282 4,452
15,438 16,475
29,426 31,355
$ 44,864 $ 47,830
$ 1,088 $ 1,090
21,753 22,626
83,057 86,244
26,826 28,478
132,724 138,438
101,676 103,994
13,125 13,461
$247,525 $255,893
The Company owned $22,318,000 and $20,304,000 of fixed maturities considered below invest­
ment grade at December 31, 19X2 and 19X1, respectively. Investment grade is defined as "Baa" 
and higher on Moody's ratings and "BBB" and higher on Standard & Poor's bond ratings.
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At December 31, 19X2 and 19X1, investments in bonds totaling $1,247,000 and $1,250,000, 
respectively, were on deposit with state insurance departments to satisfy regulatory require­
ments.
Proceeds, gross realized gains, and gross realized losses from the sales of available for sale 
securities follows:
December 31,
19X2 19X1
(Amounts in Thousands)
Proceeds
Gross realized gains
Gross realized losses
$181,137
5,132
(1,169)
$50,561
769
(1,409)
The Company's equity investments in preferred stocks at December 31, 19X1, are carried at their 
estimated fair value of $4,190,000. At December 31, 19X1 gross unrealized depreciation pertaining 
to equity securities was $229,000.
Changes in the difference between market value and cost of investments were as follows (brackets 
denote excess of cost over estimated fair value):
At December 31, 19X2, excess of estimated fair value over cost for "investments held to maturity" 
and "investments available for sale" were $ 2,966,000 and $ 8,368,000, respectively.
The carrying amounts and fair values of the Company's investments in mortgages were as 
follows:
December 31, 19X2 December 31, 19X1
Carrying 
Amount
(Amounts in Thousands)
Estimated
Fair Value
Estimated 
Fair Value
Carrying 
Amount
Commercial $81,849 $82,910 $103,686 $106,179
Residential 596
82,445
596
83,506
5,960
109,646
5,848
112,027
Less allowance for mortgages losses (3,187)
$79,258 $83,506
(2,954)
$106,692 $112,027
Mortgages are stated at their aggregate unpaid balances, less an allowance for loan losses of 
$3,187,000 (19X2) and $2,954,000 (19X1). Activity in the allowance for mortgage loss is summa­
rized as follows:
19X2 19X1
(Amounts in Thousands)
Balances at the beginning of the year $2,954 $3,200
Provisions for potential mortgage loan losses 668 3,145
Losses charged against the mortgage loan loss reserve (435) (3,391)
Balances at the end of the year $3,187 $2,954
The Company's mortgage portfolio is monitored closely through the review of loan and property 
information such as debt service coverage, annual operating statements, and property inspection 
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reports. This information is evaluated in light of current economic conditions and other factors 
such as geographic and property-type loan concentrations. This evaluation is part of the 
regular review to determine whether adjustments to the allowance for potential loan losses 
are warranted. Management believes the mortgage loss reserve is sufficient to provide for 
potential loan losses. However, management cannot predict with assurance where the econ­
omy is headed or how the mortgage and real estate portfolios would be affect be various 
economic circumstances.
Impairment of loans having carrying values of $4,524,000 in 19X2 and $3,962,000 in 19X1 has 
been recognized in conformity with Statement of Financial Accounting Standards (SFAS) No. 
114, Accounting by Creditors for Impairment of a Loan. The total allowance for credit losses related 
to those loans was $900,000 and $850,000 in 19X2 and 19X1, respectively. For impairment 
recognized in conformity with SFAS No. 114, the entire change in present value of expected 
cash flows is reported as bad debt expense in the same manner in which impairment initially 
was recognized or as a reduction in the amount of bad debt expense that otherwise would be 
reported.
The Company's mortgage loan portfolio is highly concentrated in the northeast section of the 
country. Approximately 58 percent of the Company's mortgages are in the Middle Atlantic region, 
predominantly New York City and State, with the remainder of the portfolio being fairly evenly 
dispersed among other geographic regions. The Company invests in a diversity of mortgages 
consisting of office, apartment, retail, industrial, and residential loans. Greater than 52 percent of 
these mortgages are invested in apartment and retail type investments. It is the Company's policy 
to generally obtain a first mortgage on properties for which the loan to value of collateral ratio is 
less than 75 percent.
At December 31, 19X2, the Company had six commercial real estate loans, with an aggregate 
principal balance of $14,765,000 and accrued interest of $1,950,000 which were 60 days or more 
delinquent. All of these loans were in process of foreclosure. Included in the commercial real 
estate loans are loans with an aggregate principal balance of $8,092,000 that were non-income 
producing for the twelve-month period ending December 31, 19X2. At December 31, 19X2, 
the Company had established a mortgage loss reserve of $3,187,000 as an allowance for 
potential mortgage losses.
Real estate acquired through foreclosure or "in-substance foreclosure" during the year at Decem­
ber 31, 19X2 and 19X1 amounted to $410,000 and $147,000.
Note 3: Net Investment Income
Revenues in the accompanying statement of income for the years ended December 31, 19X2 and 
19X1 include net investment income from the following sources:
19X2 19X1
Fixed maturities
(Amounts in
$22,049
Thousands)
$20,581
Preferred stock — 736
Mortgage loans 9,035 11,763
Real estate 817 105
Policy loans 3,159 3,461
Short-term investments 411 456
Other 41 17
Investment expenses
35,512
2,514
37,119
1,978
Net investment income $32,998 $35,141
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Net realized investment gains (losses) by class of investment are summarized as follows:
19X2 19X1
Fixed maturities
(Amounts in Thousands)
$5,192 $ 340
Preferred stock (324) 101
Mortgage loans (632) (3,132)
Real estate 16 —
Short-term investments (2) —
Other (28) 21
Net realized gains or (losses) $4,222 $(2,670)
Note 4: Fair Value of Financial Instruments
The following methods and assumptions were used to estimate the fair value of each class of 
financial instruments for which it is practicable to estimate that value:
Short-Term Investments. For those short term instruments amortized cost is a reasonable estimate 
of fair value.
Investment Securities and Trading Account Assets. For securities held for trading purposes and 
marketable equity securities held for investment purposes, fair values are based on quoted market 
prices or dealer quotes. For other securities held as investments, fair value equals quoted market 
price, if available. If a quoted market price is not available, fair value is estimated using quoted 
market prices for similar securities.
Mortgage Loans on Real Estate and Policy Loans. The fair value of mortgage loans on real estate is 
estimated using discounted cash flows. The fair value of policy loans is estimated by discounting 
the future cash flows using reasonable assumptions for mortality and repayments and using the 
current rates at which similar loans would be made to contractholders with similar credit ratings 
and the same remaining maturities.
The estimated fair values of ABC's mortgage loans on real estate and policy loans are as follows:
19X2 19X1
(Amounts in Thousands)
Mortgage loans on real estate 
Policy loans
Carrying 
Amount
$79,258
43,549
Carrying
Fair Value Amount Fair Value
$83,506 $106,692 $112,027
60,000 51,013 59,000
Note 5: Income Taxes
Significant components of the provision for income taxes attributable to continuing operations 
are as follows:
Current income tax expense
(Prepaid) deferred income tax (benefit) expense
Total income tax expense
19X2 19X1
(Amounts in Thousands)
$ 1,547 $ 601
(1,405) 540
$ 142 $1,141
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Deferred income taxes reflect the net tax effects of temporary differences between the carrying 
amounts of assets and liabilities for financial reporting purposes and the amounts used for income 
tax purposes. Significant components of the Company's deferred tax liabilities and assets are as 
follows (in thousands):
December 31,
19X2 19X1
(Amounts in Thousands)
Deferred Tax Liabilities:
Deferred policy acquisition costs $13,131 $12,297
Future policy benefits — 512
Accrual of discount on bonds 924 1,982
Other 3,641 1,024
Total deferred tax liabilities 17,696 15,815
Deferred Tax Assets:
Policyholder dividends 9,887 10,169
Future policy benefits 851 —
Deferred of policy acquisition costs 2,078 1,561
Investment valuation reserves 1,087 1,651
Retirement plan accruals 1,917 497
Investment income differences 574 556
Other 406 354
Total deferred tax assets 16,800 14,788
Valuation allowance for deferred tax assets (516) —
Net deferred tax assets 16,284 14,788
Net deferred tax liabilities $ 1,412 $ 1,027
A reconciliation of the provision for federal income taxes as presented in the financial statements 
and income taxes calculated using the statutory corporate tax rate follows:
19X2
(Amounts in
19X1
Thousands)
Income from operations $2,396 $2,870
Application of income tax rate 838 1,005
Small company deduction for life insurance companies (694) (496)
Policyholders' share of income (loss) in excess of
(less than) dividends paid (364) 752
Dividend received deduction (3) (50)
Change in valuation allowance 338 —
Other 27 (70)
Total tax expense $ 142 $1,141
Note 6: Financial Instruments With Off-Balance-Sheet Risk and Concentrations of Credit Risk
ABC enters into interest rate swap programs for the purpose of minimizing exposures to 
fluctuations in interest rates for certain assets and liabilities held. The notional amount of interest 
rate swaps outstanding at December 31, 19X2 and 19X1 was $500,000 and $800,000, respectively. 
The amount at risk, on a present value basis, of terminating or replacing at current market rates 
outstanding interest rate swaps in a loss position at December 31, 19X2 was $10,000. For 19X2 and 
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19X1, net gains (losses) of $200,000 and $(13,592), respectively, were recorded in connection with 
interest rate swap activity.
At December 31, 19X2, ABC held unrated or less-than-investment grade corporate debt securities 
of $8,000, net of reserves for losses, with an aggregate market value of $7,500. Those holdings 
amounted to 3 percent of ABC's corporate debt securities investments and less than 1 percent of 
total assets. The holdings of less-than-investment grade securities are widely diversified and of 
satisfactory quality based on ABC's investment policies and credit standards. ABC also invests 
in mortgage loans principally involving commercial real estate. At December 31, 19X2, 3 percent 
of such mortgages ($10,000) involved properties located in California and Arizona. Such invest­
ments consist of first mortgage liens on completed income-producing properties, and mortgages 
on individual properties do not exceed $5,000.
Note 7: Derivative Financial Instruments Held or Issued for Purposes Other Than Trading
The Company's principal objective in holding or issuing derivatives for purposes other than 
trading is asset-liability management. The operations of the Company are subject to a risk of 
interest-rate fluctuations to the extent that there is a difference between the amount of the 
Company's interest-earning assets and the amount of interest-bearing liabilities that mature or 
reprice in specified periods. The principal objective of the Company's asset-liability management 
activities is to provide maximum levels of net interest income while maintaining acceptable levels 
of interest-rate and liquidity risk and facilitating the funding needs of the Company. To achieve 
that objective, the Company uses a combination of derivative financial instruments, including 
interest-rate forwards, futures, forward rate agreements, swaps, options, caps, floors, and other 
conditional exchange contracts.
Interest-rate forward and futures contracts are commitments to either purchase or sell a financial 
instrument at a specific future date for a specified price and may be settled in cash or through 
delivery of the financial instrument. Forward rate agreements are forward-like contracts that settle 
in cash at a specified future date based on the differential between a specified market interest rate 
and a fixed interest rate applied to a notional principal amount.
An interest-rate swap is an agreement in which two parties agree to exchange, at specified 
intervals, interest payment streams calculated on an agreed-upon notional principal amount with 
at least one stream based on a specified floating-rate index. Interest-rate options are contracts that 
grant the purchaser, for a premium payment, the right to either purchase or sell a financial 
instrument at a specified price within a specified period of time or on a specified date from or to 
the writer of the option. Interest-rate caps and floors are option-like contracts that require the 
seller to pay the purchaser at specified future dates the amount, if any, by which a specified market 
interest rate exceeds the fixed cap rate or falls below the fixed floor rate, applied to a notional 
principal amount.
Interest-rate forward and swap agreements are used to modify the repricing characteristics of 
interest-earning assets, while options, caps, floors and other conditional exchange agreements are 
used to limit the interest expense associated with the Company's liabilities.
Income or expense on derivative financial instruments used to manage interest-rate exposure is 
recorded on an accrual basis as an adjustment to the yield of the related interest-earning assets or 
interest-bearing liabilities of the periods covered by the contracts. If a derivative financial 
instruments that is used to manage interest-rate risk is terminated early or results in a single 
payment based on the change in value of an underlying item, any resulting gain or loss is deferred 
and amortized as an adjustment to the yield of the designated assets or liabilities over the 
remaining periods originally covered by the derivative financial instrument.
Deferred gains totaling $675,000 at December 13, 19X2, resulting from terminated and expired 
option contracts are included in other liabilities and will be amortized as a reduction of interest 
expense from the Company's short-term liabilities over the next two years.
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Note 8: Liability for Unpaid Claims
The liability for unpaid claims and claim adjustment expenses is based on the estimated amount 
payable on claims reported prior to the balance sheet date which have not yet been settled, claims 
reported subsequent to the balance sheet date which have been incurred during the period then 
ended, and an estimate (based on prior experience) of incurred but unreported claims relating to 
such period.
Activity in the liability for impaid claims adjustment expenses for the Company's health and 
disability coverages is summarized as follows:
19X2 19X1
(Amounts in Thousands)
Balance at January 1 $81,638 $104,222
Less: reinsurance recoverables 4,021 13,831
Net balance at January 1 77,617 90,391
Amount incurred 334,699 370,409
Amount paid, related to:
Prior years 94,083 121,470
Current year 248,721 261,713
Total 342,804 383,183
Net balance at December 31 69,512 77,617
Plus: reinsurance recoverables 4,115 4,021
Balance at December 31 $73,627 $ 81,638
Note 9: Reinsurance
The Company utilizes indemnity reinsurance agreements to reduce its exposure to large losses 
in all aspects of its insurance business. Such reinsurance permits recovery of a portion of losses 
from reinsurers, although it does not discharge the primary liability of the Company as direct 
insurer of the risks reinsured. The Company evaluates the financial strength of potential reinsur­
ers and continually monitors the financial condition of reinsurers. The following tables includes 
premium amounts ceded/assumed to/from other companies.
Direct 
Amount
Ceded to Other
Companies
Assumed from
Other Companies
Net
Amount
(Amounts in Thousands)
Premiums:
19X2
Life insurance $2,090 $ 560 $3,330 $4,860
Accident and health 1,440 1,290 — 150
Annuities 3,130 — 70 3,200
Total earned premiums $6,660 $1,850 $3,400 $8,210
19X1
Premiums:
Life insurance $2,080 $ 520 $3,680 $5,240
Accident and health 1,510 1,370 — 140
Annuities 1,840 — 30 1,870
Total earned premiums $5,430 $1,890 $3,710 $7,250
Note 10: Statutory Financial Information
Under the law of ABC State, the state of incorporation, the maximum dividend that may be paid 
(without prior approval of the (State) Insurance Department), in any 12-month period is the 
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greater of (i) net investment income for the preceding calendar year or (ii) 10 percent of contracthold­
ers' surplus at the end of the preceding calendar year. In general, net investment income for dividend 
purposes is interpreted by the Insurance Department to be the statutory pretax net investment income 
including net realized capital losses but excluding net realized capital gains. The maximum permis­
sible amount of dividends for 19X3, based on statutory net investment income for 19X2, is $20,000.
The Company, which is domiciled in ABC State, prepares its statutory financial statements in 
accordance with accounting principles and practices prescribed or permitted by the ABC state 
insurance department. Prescribed statutory accounting practices include state laws, regulations, 
and general administrative rules, as well as a variety of publications of the National Association 
of Insurance Commissioners (NAIC). Permitted statutory accounting practices encompass all 
accounting practices that are not prescribed; such practices differ from state to state, may differ 
from company to company within a state, and may change in the future. Furthermore, the NAIC 
has a project to codify statutory accounting practices, the result of which is expected to constitute 
the only source of "prescribed" statutory accounting practices. Accordingly, that project, which 
is expected to be completed in 19X3, will likely change the definitions of what comprises 
prescribed versus permitted statutory accounting practices, and may result in changes to the 
accounting policies that insurance enterprises use to prepare their statutory financial statements. 
[Note: Although the following statutory financial information is not required to be disclosed in 
financial statements prepared in conformity with generally accepted accounting principles, 
insurance entities sometimes include such disclosures to facilitate use of those financial statements 
for purposes of filing with state regulatory authorities.]
The accounting practices of insurance companies are prescribed by certain regulatory authorities. 
Certain of these practices differ from the generally accepted principles used in preparing the 
financial statements of ABC.
The following reconciles ABC's statutory net income and statutory surplus and capital stock 
determined in accordance with accounting practices prescribed or permitted by the Insurance 
Department of Connecticut with net earnings (loss) and equity on a GAAP basis.
19X2 19X1
(Amounts in Thousands)
Statutory net income $ 3,572 $ 2,719
Adjustments:
Future policy benefits and policyholders' account balances 572 894
Deferred policy acquisition costs 60 40
Deferred federal income tax (expense) benefit (1,405) 540
Valuation of investments 115 270
Postretirement benefits 272 354
Other, net (932) (3,088)
GAAP net income $ 2,254 $ 1,729
Statutory surplus and capital stock $65,388 $54,505
Asset valuation reserves (1,054) (1,972)
Statutory surplus, capital stock and asset valuation reserves (875) (967)
Adjustments:
Fixed income securities (29,472) (27,905)
Future policy benefits and policyholders' account balances 115 270
Deferred Federal income taxes (1,412) (1,027)
Valuation of investments 772 891
Deferred policy acquisition costs 39,818 39,445
Postretirement benefits (2,272) (2,354)
Other, net (1,110) (1,932)
GAAP equity $69,898 $58,954
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Note 11: Commitments and Contingencies
Future minimum rental payments, principally for administrative offices, under noncancellable 
operating leases at December 31, 19X2, are (in thousands): 19X3, $1,113; 19X4, $1,064; 19X5, $1,011; 
19X6, $976; 19X7, $976; and $3,906 thereafter. Rental expense was $1,164 in 19X2, and $1,184 in 
19X1.
ABC is named as defendant in a number of legal actions arising primarily from claims made under 
insurance contracts or in connection with previous reinsurance agreements. These actions have 
been considered in establishing its contract benefit liability. Management and its legal counsel are 
of the opinion that the settlement of these actions will not have a material effect on ABC's financial 
position or results of operations.
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